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1 
RIASSUNTO 
 
Segnalazione cellulare 
È noto che tutte le cellule ricevono ed emettono segnali di differente natura. Dalla più 
semplice cellula procariotica fino ai più complessi organismi pluricellulari, dove i 
meccanismi di segnalazione raggiungono l’apice della complessità. 
La segnalazione cellulare è parte integrante dei processi di comunicazione che 
governano le attività basali delle cellule. Si tratta di meccanismi interconnessi, 
straordinariamente complessi, che sono oggetto di attiva ricerca da parte del mondo 
scientifico. 
Le cellule eucariotiche, utilizzando svariati meccanismi, sono in grado di trasferire 
informazioni alle cellule ed all’ambiente circostante, sotto forma di segnali biochimici o 
meccanici. Tali segnali influenzano il comportamento delle cellule circostanti e per 
questo si prestano a svariate applicazioni biotecnologiche. Pertanto, l’analisi degli 
effetti di questi segnali in condizioni fisiologiche o in risposta a precisi stimoli è basilare 
ai fini della determinazione dei possibili settori di applicazione delle “molecole segnale” 
individuate.  
 
Secrezione convenzionale e non convenzionale 
Il rilascio di sostanze nell’ambiente extracellulare risponde alla necessità di gestire 
diversi processi biologici come la crescita cellulare, il differenziamento, la 
neurotrasmissione, i processi infiammatori e le infezioni.  
Tutte le cellule eucariotiche dispongono di sistemi di secrezione costitutiva, mentre 
solo alcuni tipi specializzati di cellule, come neuroni, cellule epiteliali e cellule 
endocrine, in aggiunta alla secrezione costitutiva hanno sistemi regolati che dipendono 
da precisi stimoli extracellulari. Entrambi i processi rientrano nella “Secrezione 
Proteica Convenzionale”, nota anche come via classica o canonica di secrezione. La 
Secrezione Proteica Convenzionale riguarda proteine che hanno una sequenza 
segnale che ne causa l’indirizzamento dal sito di traduzione al Reticolo 
Endoplasmatico (RE); da qui il rilascio tramite vescicole rivestite dalla proteina COPII 
che consente il raggiungimento del Golgi ed in seguito la membrana plasmatica. 
Molte molecole, utilizzano meccanismi indipendenti dal RE e dal Golgi e rientrano nella 
Secrezione Proteica definita “Non Convenzionale”. 
Si tratta di proteine che non dispongono della sequenza segnale per l’indirizzamento 
al Reticolo Endoplasmatico e che tramite tre differenti sistemi attraversano la 
membrana plasmatica per essere rilasciate nello spazio extracellulare. 
Tra i sistemi non canonici si distinguono: Tipo 1 o translocazione mediata da pori, in 
cui il cargo attraversa la membrana plasmatica a seguito della formazione di pori; Tipo 
2 o sistema basato su cassette ABC, specifico per la secrezione di proteine acetilate; 
Tipo 3 sistema basato su autofagosoma/endosoma.  
Interessante notare che alcune proteine, pur disponendo di una sequenza segnale di 
indirizzamento al RE, eludono i sistemi di secrezione convenzionale, dando luogo ad 
una seconda tipologia di secrezione non convenzionale che non utilizza, di fatto, i tre 
sistemi precedentemente descritti. 
In linea generale questa tipologia di secrezione è innescata dallo stress cellulare. 
Sostanze come FGF-1 (Fattore di crescita dei Fibroblasti), LPS (lipopolisaccaride) o 
stress meccanici, inducono il rilascio di citochine e altre molecole come risposta 
cellulare, da intendersi come segnalazione a beneficio delle cellule che si trovano 
nell’ambiente circostante. 
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YB-1 come nuovo player 
YB-1, acronimo di Y box binding protein 1, è una proteina pleiotropica, coinvolta in 
numerosi processi cellulari come proliferazione, apoptosi e risposta allo stress. Grazie 
alla dinamicità della sua struttura tridimensionale in grado di modificarsi adattandosi ai 
differenti partner cellulari, YB-1 svolge funzioni differenti a seconda delle specifiche 
condizioni e del distretto cellulare in cui si trova.  
La proteina full length del peso di 45-50 kDa è prevalentemente citoplasmatica, mentre 
la forma proteolizzata da 37 kDa, è nucleare. 
La forma citoplasmatica interagisce con RNA di diversa tipologia, in modo particolare 
con gli RNA messaggeri, gestendone il destino sia in condizioni fisiologiche, sia in 
condizione di stress cellulare. 
YB-1, infatti, in condizioni fisiologiche è in parte localizzata in particelle 
ribonucleoproteiche (mRNPs), polisomi o nei corpi-P, deputata al controllo 
traduzionale degli mRNA 5’-cap dipendente ed indipendente. In condizioni di stress, 
YB-1, insieme ad altre proteine, sequestra gli RNA messaggeri nei Granuli da Stress, 
foci citoplasmatici composti da RNA e proteine che gestiscono la traduzione degli 
mRNA evitando che la cellula sprechi energie ed ottimizzando la risposta cellulare al 
particolare tipo di stress.  
In caso di danno al DNA, YB-1 trasloca nel nucleo dove partecipa ai meccanismi di 
riparazione del DNA. 
Recentemente la proteina è stata ritrovata nei fluidi corporei umani di pazienti affetti 
da tumore, processi infiammatori e sepsi. Sebbene il ruolo della forma secreta di YB-
1 come biomarcatore tumorale sia sempre più accreditato, il ruolo della sua forma 
extracellulare è pressoché ignoto. È stato dimostrato che la proteina è secreta da 
cellule eucariotiche in coltura sia in condizioni fisiologiche sia in seguito al trattamento 
con LPS (lipopolisaccaride) o stimoli pro-infiammatori. Evidenze sperimentali 
mostrano che la proteina è secreta con meccanismo non convenzionale; ossia, YB-1 
viene prima poli-ubiquitinata dalla ubiquitin ligasi HACE1, tale modifica consente 
l’interazione tra YB-1 e la proteina TSG101, componente del Corpi Multivescicolari, 
che si traduce nella secrezione della proteina. 
Le proteine secrete si prestano a molte applicazioni biotecnologiche per la loro 
capacità di modulare la risposta cellulare. 
I sistemi batterici, al pari di alcuni lieviti, sono ampiamente applicati come piattaforme 
di produzione di proteine secrete. Un esempio è costituito dai cosiddetti Protein 
Transduction Domains (PTD) o Cell Penetrating Pepides (CPP), corte sequenze di 
aminoacidi derivanti da proteine secrete che vengono opportunamente ingegnerizzate 
e prodotte in batteri per poi essere aggiunte a macromolecole impiegate dal punto di 
vista farmaceutico e clinico. Tuttavia, esistono ad oggi molti peptidi di interesse 
farmacologico che non vengono espressi correttamente in procarioti; di qui, il 
crescente interesse dell’industria biotecnologica nell’impiego della secrezione di 
molecole solubili nelle cellule eucariotiche. Ciò premesso è importante, effettuare 
analisi comparative fra la proteina ricombinante prodotta in batteri e quella secreta 
dalle cellule eucariotiche per evidenziarne le similitudini strutturali e le eventuali 
differenze funzionali. 
Nel presente progetto di dottorato ho condotto uno studio sulla proteina YB-1 secreta 
in condizioni fisiologiche ed in risposta allo stress, con l’intento di caratterizzarne le 
proprietà per potenziali applicazioni biotecnologiche nel settore farmaceutico e 
cosmeceutico e validarne l’utilizzo come biomarcatore associato allo stress cellulare. 
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Analisi preliminari sulla secrezione 
 
 
1. YB-1 nella linea cellulare HEK293T in condizioni fisiologiche ed in condizioni 
di stress 
 
La gran parte degli studi sulla secrezione della proteina YB-1 è stata condotta in 
HEK293T, una linea cellulare embrionale umana derivante da rene. Questa linea è 
considerata un ottimo modello cellulare per studiare la secrezione perché in grado di 
secernere attivamente proteine in risposta a stimoli esterni. 
Il primo passo è stato analizzare il comportamento della proteina in condizioni 
fisiologiche; la proteina è principalmente diffusa nel citoplasma dove, come già 
suggerito dalla letteratura, esplica il suo ruolo principale di gestione degli RNA 
messaggeri (mRNA); si localizza, infatti, anche all’interno dei corpi-P, sede in cui si 
verifica il sorting degli mRNA.  
Mediante tecniche di immunofluorescenza e microscopia confocale ho verificato 
l’assemblaggio di YB-1 nei granuli da stress, insieme ad altri marcatori canonici dei 
granuli come PABP-1, G3BP1, TIA1 e TIAR, a seguito di trattamento con sostanze 
chimiche in grado di indurre stress ossidativo, come sodio arsenite (Na Ars) o 
perossido di idrogeno (H2O2). Esperimenti di co-immunoprecipitazione hanno rivelato 
che l’interazione fisica fra YB-1 e PABP1, è evidente solo in presenza di stress 
ossidativo. Inoltre, esperimenti di silenziamento dell’mRNA di YB-1 (siRNA) hanno 
mostrato che la formazione di granuli da stress PABP1 positivi è compromessa da una 
sostanziale riduzione (almeno 50%) dei livelli intracellulari della proteina YB-1. 
Simultaneamente alla formazione dei granuli da stress, ho osservato però la 
diminuzione della quantità totale della proteina ed in particolare della componente 
citoplasmatica mediante western blot e relative analisi densitometriche. 
L’ipotesi di lavoro da me formulata era che la diminuzione della componente 
citoplasmatica della proteina fosse associata alla sua secrezione da parte della cellula, 
in risposta allo stress. Pertanto, ho estratto con acido tricloroacetico (TCA) al 25% le 
proteine dal mezzo di coltura delle HEK293T in condizioni normali o dopo stress 
ossidativo. 
Analisi mediante SDS-PAGE ed immunoblot mi hanno permesso di concludere che la 
secrezione di YB-1, che si verifica anche in condizioni fisiologiche, incrementa 
significativamente in seguito a stress ossidativo. 
Le bande elettroforetiche dell’estratto in TCA, immunoreattive all’anticorpo diretto 
contro YB-1, sono state escisse manualmente, processate e sottoposte ad analisi per 
Spettrometria di Massa per verificarne l’identità. Anticorpi diretti contro le proteine 
citoplasmatiche GAPDH e RHN1, sono stati utilizzati per dimostrare che il rilascio di 
YB-1 fosse specifico e non ascrivibile a danno cellulare. Le due proteine, infatti, sono 
espresse in quantità paragonabili a quelle di YB-1 nel citoplasma e non sono secrete 
nel mezzo di coltura sia in condizioni normali sia in seguito a stress ossidativo. 
Le analisi di spettrometria di massa, hanno rivelato la presenza di peptidi che coprono 
l’intera sequenza della proteina, alcuni di questi con modifiche post-traduzionali, tra 
cui l’acetilazione, in accordo con quanto riportato in letteratura e cioè che YB-1 subisce 
modifiche post-traduzionali per poter essere indirizzata ai sistemi di secrezione. 
Questa parte del progetto è stata condotta in collaborazione con il gruppo della 
Prof.ssa Angela Amoresano dell’Università degli Studi di Napoli Federico II. 
La secrezione della proteina in condizioni fisiologiche, ma anche e soprattutto in 
risposta a stress cellulare, pone l’interrogativo sulle funzioni svolte dalla proteina una 
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volta secreta nel mezzo extracellulare. 
 
2. Produzione di un clone stabile per seguire la secrezione e l’acquisizione della 
proteina 
 
Per investigare sulle funzioni della proteina secreta si è proceduto alla creazione di 
una linea cellulare che esprimesse stabilmente la proteina di fusione YB-1-GFP. 
Una volta caratterizzata, la linea cellulare stabile avrebbe potuto rappresentare un utile 
sensore di stress cellulare, in vitro.  
L’impiego di linee cellulari di mammifero che esprimono stabilmente un prodotto genico 
(cloni stabili), costituiscono una risorsa permanente e riutilizzabile, che consente  di 
superare alcune problematiche della espressione transitoria di prodotti genici esogeni 
come l’omogeneità dei livelli di espressione intracellulare e la necessità di dover ri-
trasfettare le cellule ad ogni esperimento. 
La produzione di linee stabili prevede la selezione con antibiotico delle cellule che 
esprimono il plasmide con il gene. Nel mio caso la linea cellulare HEK293T trasfettata 
in transiente mediante lipofezione con il plasmide pcDNA6/V5-HisA-YB-1-GFP è stata 
selezionata con blasticidina. 
L’intera procedura è stata anche eseguita per un clone controllo esprimente in maniera 
stabile la sola GFP. I livelli di espressione della YB-1 endogena e esogena sono stati 
analizzati mediante SDS-PAGE. La proteina di fusione è espressa ad elevati livelli nel 
clone stabile e non influenza i livelli di espressione della proteina endogena.  
Attraverso microscopia a fluorescenza in time lapse ho eseguito esperimenti per 
monitorare, sfruttando il segnale della GFP, la secrezione della proteina e 
l’acquisizione della stessa da parte di cellule HaCaT, 
che non secernono YB-1 né in condizioni fisiologiche né in condizioni di stress. Dati 
preliminari suggerivano un accumulo della proteina YB-1 taggata sulla membrana 
esterna delle cellule riceventi. L’ulteriore caratterizzazione delle proprietà del clone 
stabile ha però messo in evidenza un comportamento anomalo del clone in risposta a 
stimoli di stress. I granuli assemblati dalla YB-1-GFP avevano morfologia e dimensioni 
alterate somigliando ad autofagosomi piuttosto che a granuli da stress. Inoltre, il clone 
presentava un considerevole aumento della mortalità cellulare in risposta allo stress 
ossidativo che facilitava il rilascio passivo della proteina nel mezzo. Si è deciso quindi 
di abbandonare l’utilizzo di questo clone stabile.  
Ulteriori tentativi sono stati eseguiti con altri costrutti aventi tag di più piccole 
dimensioni come YB-1-myc, che si è rivelato essere promettente dal punto di vista 
applicativo. 
 
 
Produzione di YB-1 extracellulare (exYB-1) 
 
Confermata la secrezione specifica della proteina YB-1, l’attenzione è stata focalizzata 
sulla sua potenziale funzione di segnalazione paracrina in risposta allo stress 
ossidativo. Per poter analizzare a fondo questi fenomeni si è proceduto alla produzione 
e purificazione di due forme della proteina YB-1: (1) YB-1 ricombinante (rYB-1) 
prodotta in batteri e (2) YB-1 dal mezzo di coltura delle cellule HEK293T (CCM-YB-1). 
L’attività delle due forme è stata confrontata mediante diversi saggi funzionali. 
Entrambe le procedure di espressione della proteina ricombinante e di purificazione 
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della frazione arricchita della YB-1 nel mezzo di coltura sono state eseguite in 
collaborazione con il laboratorio del Dr. Elio Pizzo dell’Università degli Studi di Napoli 
Federico II. 
 
1. Produzione di YB-1 ricombinante (rYB-1) 
 
La proteina YB-1 umana ricombinante è stata prodotta in E.Coli. La scelta di E.Coli per 
la produzione di YB-1 è da ricercarsi nel fatto che si tratta di un ospite relativamente 
semplice da manipolare e propagare e la cui genetica è ben nota. L’induzione 
dell’espressione di YB-1 dal vettore plasmidico è stata effettuata con aggiunta di IPTG 
(isopropil-1-tio-d-galattopiranoside). 
Il cDNA codificante la proteina umana YB-1 è stato ottenuto mediante PCR dal vettore 
umano pEX-A2. Il cDNA ottenuto, opportunamente purificato è stato inserito nel vettore 
pET22b (+). L’inserimento è stato effettuato a monte di una sequenza di istidine (His-
tag), mediante digestione enzimatica con gli enzimi NdeI e HindIII, per facilitare i 
successivi passaggi di purificazione.  
Il vettore di espressione così ottenuto è stato utilizzato per trasformare ceppi di 
Escherichia Coli competenti BL21 (DE3).  
Analisi di western blot hanno dato conferma che la proteina YB-1 veniva espressa in 
maniera inducibile e che si accumulava a seguito di induzione con IPTG nella frazione 
citosolica solubile. La frazione solubile è stata, quindi, separata dai corpi di inclusione 
ed i prodotti ottenuti sono stati purificati mediante cromatografia di affinità (IMAC) 
seguita da cromatografia a fase inversa. Le frazioni YB-1 positive, analizzate mediante 
WB, sono state dializzate e la loro identità controllata mediante analisi di Spettrometria 
di Massa. 
 
2. Purificazione di YB-1 dal mezzo di coltura (CCM-YB-1) 
 
Parallelamente alla produzione della proteina ricombinante è stata preparata una 
frazione arricchita della proteina YB-1 secreta dalle cellule HEK293T in coltura. 
Terreni di coltura di cellule HEK293T (conditioning culture media – CCM) privi di siero 
sono stati estratti con ammonio solfato (salting out). In particolare sono state ottenute 
3 frazioni a concentrazioni crescenti di ammonio solfato (30, 70 e 100%). 
Le tre frazioni sono state analizzate mediante SDS-PAGE ed immunoblot con 
anticorpo diretto contro la proteina YB-1. L’estrazione più efficace è stata quella al 70% 
di ammonio solfato. Analisi di spettrometria di massa hanno confermato l’arricchimento 
di YB-1 nelle frazioni estratte con ammonio solfato. 
 
 
Analisi funzionale della YB-1 extracellulare (exYB-1) 
 
Per comprendere le funzioni della proteina YB-1 secreta dalle cellule HEK293T su 
cellule riceventi, la proteina ricombinante rYB-1 e la CCM-YB-1 sono state addizionate 
al terreno di coltura di cellule HaCaT per ottenere una concentrazione di 5.0, 7.5 e 10 
µg/ml.  
L’utilizzo dei cheratinociti umani immortalizzati (HaCaT) come cellule riceventi non è 
stato dettato solo dal fatto che le cellule HaCaT non secernono la proteina, ma anche 
dalla considerazione che esse rappresentano un buon modello cellulare per lo studio 
del tessuto cutaneo nel cui differenziamento YB-1 svolge un ruolo rilevante. Entrambe 
le proteine hanno causato una riduzione del tasso proliferativo delle cellule, in maniera 
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dose-dipendente. 
Per verificare se l’effetto di rallentamento della proliferazione fosse dipendente dal 
contesto cellulare, la stessa tipologia di esperimento è stata eseguita sulle cellule di 
adenocarcinoma colon-rettale umano CaCo2 e sulle stesse cellule secretrici 
HEK293T. Anche in questo caso è stato osservato un blocco della proliferazione 
cellulare.  
Interessante notare che la CCM-YB-1, se paragonata alla rYB-1, mostrava un effetto 
molto più pronunciato su tutte e tre le linee cellulari. 
Analisi al citofluorimetro di flusso hanno rivelato che le cellule trattate con la YB-1 
extracellulare (rYB-1 e CCMYB-1) mostravano un incremento di cellule nella fase 
G2/M del ciclo cellulare. L’analisi dei livelli di espressione dei marcatori del ciclo 
cellulare p21WAF e di DNp63a in cellule HaCaT trattate e non con la YB-1 
extracellulare ha confermato quanto osservato per citofluorimetria.  
Dati di letteratura suggeriscono un possibile ruolo di YB-1 nel controllo dei processi 
infiammatori. Questo mi ha indotto a valutare un possibile coinvolgimento del pathway 
di NF-kB in risposta alla YB-1 secreta. Un sistema reporter GFP sotto il controllo del 
promotore attivato dal fattore trascrizionale NF-kB è stato trasfettato in cellule HaCaT 
in maniera transiente. Il trattamento con rYB-1 e CCM-YB1 è stato in grado di indurre 
il sistema reporter in cellule HaCaT. Ho anche osservato in seguito al trattamento un 
incremento dei livelli di TNFa sia a livello di trascritto che di proteina. Sebbene 
preliminari, questi dati mi sono parsi incoraggianti. Ulteriori studi potranno far luce sul 
ruolo della proteina YB-1 secreta nei processi infiammatori. Questo aspetto potrebbe 
avere potenzialità applicative nel settore farmacologico del controllo 
dell’infiammazione. 
 
Trasferimento conoscenze su Danio rerio (KIT) 
 
Ho trascorso parte del mio PhD presso il laboratorio del Prof. Dr. N. S. Foulkes 
dell’Istituto di Tossicologia e Genetica (ITG) del Karlsruher Institut fur Technologies 
(KIT), Eggstein-Leopoldshafen, Germania, dove ho effettuato esperimenti volti a 
comprendere il ruolo di YB-1 quale stress sensor nel modello zebrafish. YB-1 potrebbe 
rappresentare un marcatore di stress negli organismi acquatici che sono soggetti a 
grossi cambiamenti climatici e ambientali. L’impiego dello zebrafish come organismo 
modello è dovuto non solo alla facilità di allevamento degli individui e alla nota 
trasparenza della progenie, ma anche alla semplicità di manipolazione genetica e 
cellulare e alla possibilità di allestire screening genetici su larga scala, cosa più 
impegnativa sia a livello economico che a livello etico se si considerano gli organismi 
convenzionali come topi e ratti.  
Il gruppo di ricerca presso il quale ho svolto parte del mio progetto di dottorato, aveva 
precedentemente dimostrato che la distribuzione subcellulare della proteina YB-1 in 
zebrafish (zfYB-1) è regolata dal ritmo circadiano. 
La zfYB-1 ha una identità di sequenza del 69% con la proteina YB-1 umana, e, come 
questa, è composta da tre domini: dominio N-terminale ricco in alanina e prolina; 
dominio centrale Cold Shock; dominio c-terminale costituito da amminoacidi carichi 
negativamente e positivamente. 
Gli anticorpi contro la YB-1 umana riconoscono zfYB-1 grazie ad una regione N-
terminale estremamente conservata.  
Sorprendentemente, ho osservato che le cellule di zebrafish, al contrario delle cellule 
di mammifero, non assemblano granuli da stress YB-1 positivi in condizioni di stress 
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ossidativo anche se l’attivazione dei geni della risposta allo stress indicavano 
chiaramente che le cellule di zebrafish sono sensibili a questo tipo di stress. 
Una possibile spiegazione è da ricercare nel fatto che zebrafish è un animale abituato 
a gestire variazioni ambientali anche piuttosto repentine come cambi di salinità, 
concentrazione di nutrienti, ecc., ed è possibile dunque che sia dotato di vie alternative 
di risposta allo stress.  
Al contrario, uno stress fisico come lo shock termico, portava alla formazione di 
aggregati YB-1 positivi, visualizzati per immunofluorescenza e microscopia confocale. 
La conferma che gli aggregati ottenuti fossero Granuli da Stress è stata ottenuta 
mediante trattamenti con cicloesimmide, un inibitore della formazione dei granuli, ed 
esperimenti di immunofluorescenza e microscopia confocale con anticorpi diretti 
contro G3BP1, marker canonico dei Granuli da Stress. 
Il silenziamento di zfYB-1 mediante RNA interference ha confermato il ruolo cruciale 
di questa proteina nell’assemblaggio dei granuli da stress.  
Simili analisi eseguite su pinne caudali di esemplari di zebrafish (Tübingen) hanno 
confermato i dati precedentemente ottenuti in un contesto tessutale. In particolare il 
numero dei granuli era maggiore se il campionamento delle pinne caudali avveniva 
nelle ore di luce, sottolineando come la luce fosse di per sé fonte di danno ossidativo. 
 
Applicazioni di YB-1 come stress sensor 
 
La capacità di YB-1 di accumularsi nel nucleo in seguito a danno genomico ed il suo 
ruolo nei granuli da stress, ne sottolineano l’importanza come marcatore dello stress 
cellulare. Ho potuto osservare che il trattamento di cellule di carcinoma squamoso 
cutaneo (SCC) con estratti della corteccia della pianta Uncaria Tomentosa, induce 
morte cellulare. L’estratto di Uncaria Tomentosa induce nelle cellule di carcinoma 
squamoso un incremento dei valori di ROS. Nel contempo inibisce l’accumulo della 
forma da 37 kDa di YB-1 fortemente implicata nei processi di riparo del danno 
genomico. È stata formulata l’ipotesi che l’azione accoppiata di un agente pro-
ossidante ed un potenziale inibitore del proteasoma 20 S contenuti nell’estratto 
vegetale possa spiegare l’efficacia dell’estratto su questo tipo di cellule cancerose.  
Esperimenti simili con Argento Colloidale ed altri fitoestratti sono tutt’ora in corso. 
 
Collaborazioni  
 
Durante il mio percorso di dottorato ho avuto la possibilità di svolgere piccole parti in 
altri progetti in collaborazione con docenti e ricercatori dell’Università degli Studi di 
Napoli Federico II. 
In particolare, ho contributo allo studio delle proprietà antiossidanti delle spore del 
ceppo SF185 di Bacillus Megaterium su cellule umane, con il gruppo della Prof.ssa 
Isticato, ed ho contribuito nella messa a punto di un nuovo approccio metodologico per 
la quantificazione del Wound Healing in collaborazione con il Prof. Caserta 
Presso l’Istituto di Tossicologia e Genetica (ITG) presso il quale ho svolto il mio periodo 
all’estero ho contribuito allo studio della perdita del sistema di riparo del DNA mediato 
da fotoriattivazione nel pesce P. Andruzzii. 
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ABSTRACT 
 
Cell signalling is the complex network of connections between cells and inside the 
single cell. Protein trafficking is deeply involved in cell signalling. Different proteins are 
ordered in clusters of receptors of extracellular signals, transducers, sensors and 
biological response effectors. Together, they are arranged in molecular pathways that 
are relevant for maintenance of cell homeostasis. 
Protein secretion is a relevant component of eukaryotic cell signalling. 
The prototype cold-shock Y-box binding protein 1 (YB-1) is a multifunctional protein 
which regulates a variety of fundamental biological processes. Recently YB-1 has been 
found in human extracellular fluids and shown to be secreted by different cell types.  
This PhD project is focused on YB-1 protein secretion to investigate on its role as a 
potential paracrine signal to elicit changes or responses in nearby cells, altering their 
behaviour.  
During the first part of the project I focused on stimuli and conditions triggering YB-1 
secretion. Low amounts of extracellular YB-1 are released by HEK293T cells in 
physiological condition. Interestingly, I found that YB-1 secretion was enhanced 
following oxidative insults. Secreted YB-1 protein was purified and analysed by mass 
spectrometry to confirm its identity.  In parallel, I verified the assembly of YB-1 in stress 
granules (SGs), cytoplasmic foci where untranslated mRNAs are sorted or processed 
for reinitiation, degradation, or packaging into mRNPs. 
To understand the mechanism beneath YB-1 secretion and uptake by receiving cells, 
I tried several experimental approaches; among them the production and 
characterization of a stable HEK293T cell line expressing a YB-1-GFP fusion protein. 
The properties of this cell line as a stress biosensor were evaluated.  
The second part of the project was devoted to the production of purified recombinant 
human YB-1 (rYB-1) in bacterial host. In parallel I produced enriched fractions of YB-
1 from HEK293T cell culture medium (CCM-YB-1). I found that both CCM-YB-1 and 
rYB-1 have anti-proliferative activity on receiving cells. Both forms of YB-1 protein were 
effective on different recipient cell lines, including HaCaT cells. In particular, inhibition 
of human keratinocytes proliferation by extracellular YB-1 was associated to a G2/M 
cell cycle arrest, induction of p21WAF and reduction of DNp63a protein level. The 
obtained results suggest that sustained release of full length YB-1 protein or YB-1 
derived peptides, by stress stimuli acts as paracrine/autocrine signal stimulating cell 
cycle arrest. 
Finally, I spent six months of my PhD at the Institute of Toxicology and Genetics (ITG-
KIT), in Karlsruhe, Germany, where I had the opportunity to study the behaviour of the 
evolutionarily conserved YB-1 in zebrafish (Danio rerio), one of the most versatile 
genetic models for environmental studies. Unexpectedly, I found that zebrafish cells 
assemble YB-1 positive aggregates only in response to heat, but not oxidative stress 
or copper treatment. YB-1-positive aggregates were confirmed as SGs as they 
contained the G3BP1 protein, a well assessed SG marker in mammalian. I found that 
zfYB-1 gene silencing compromised cell viability under heat shock, but not in normal 
conditions highlighting the essential role played by YB-1 in cell survival following heat 
shock. My findings point to a fundamental role of YB-1 as a valuable biomarker for 
thermal stress.   
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CHAPTER I    
 
1. Cell signalling and biotechnological applications 
 
Cell signalling is at the basis of cellular homeostasis and has to be intended as a 
complex network of connections between cells and inside the single cell. Simplifying, 
signalling machineries act as highly dynamic two-components system, composed by a 
sensor, which sense the internal or external change, and an effector, which execute 
the best response to the variation experienced. 
All cells communicate with each other and with the surroundings. 
Eukaryotic cell communication takes places basically thanks to the trafficking and 
exchange of soluble molecules, proteins, lipids and also through mechanical contacts 
(Figure 1). Understanding how the signalling circuitry of eukaryotic cells can be 
engineered to construct cells, or part of them with designed behaviours is of deep 
interest of biotech industries. Targeted immunosuppression or design of anti-cancer 
cells are indeed good examples of how manipulation and reprogramming of cellular 
signalling systems can be applied [1].  
Signalling can adopt different mechanisms, protein secretion among them plays a 
major role. Accordingly, the analysis of protein secretory pathways has been the focus 
of many research fields throughout the years.  
Although they have a sophisticated information processing capacity, bacterial systems 
are already widely applied as production platforms of secreted proteins because they 
are less complex than eukaryotic cells [2]. There are countless examples in literature 
of engineering of microbial and yeast secretion machineries to refine recombinant 
protein expression or to create Protein Delivery Systems for mammalian cells [3]. For 
instance, Protein Transduction Domains (PTDs) or Cell Penetrating Peptides (CPPs), 
short amino-acids sequences that added to specific cargos facilitate their delivery into 
recipient cells, have opened new frontiers in the control of intracellular cell functions 
by macromolecules [4]. Recently, the study and application of eukaryotic secretion 
itself has gained interest; in particular great progresses have been made in expanding 
the categories of characterized biological components that can be used for cell signal 
manipulation. 
This PhD project was focused on YB-1 protein secretion to investigate on its role as a 
potential paracrine signal to elicit changes or responses in nearby cells, altering their 
behaviour. 
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Figure 1. Representation of eukaryotic cells signalling. 
Eukaryotic cell signalling can be summarized in four passages: 1. the synthesis and production of 
different type of signal molecules; 2. the transport until the target cell and the uptake of the signal by 
this one; 3. the transduction of signals; 4. the trigger one or more cellular responses which led to an 
effect. 
 
 
2. Protein secretion 
 
Trafficking and secretion of soluble proteins containing typical N-terminal signal 
peptide in eukaryotes has been extensively studied. These proteins follow what is 
usually referred to as the Conventional Protein Secretion (CPS) pathway [5]. 
This trafficking route is a linear movement of cargoes, which traverse distinct 
organelles in a membrane-bound way [6]; starting from the rough endoplasmic 
reticulum (RER), where newly synthetized proteins are concentrated in transport 
vesicles which travel along the cell to the Golgi Apparatus (GA), then to the trans-Golgi 
network (TGN) and then fuse with the plasma membrane [7].?
A first definition of the collection of proteins secreted through CPS was secretome; 
nowadays the definition encompasses proteins shed from the cell surface and 
intracellular proteins released through non-classical (or unconventional) secretion 
pathway or exosomes. 
Less, indeed, is known about Unconventional Protein Secretion, also known as 
ER/Golgi-independent protein secretion [8] although it was discovered more than 10 
years ago (Figure 2). 
  
11 
 
 
 
Figure 2. Representation of Conventional and Unconventional Protein secretion. 
Two different major mechanisms of protein secretion in eukaryotic cells. 
 
Beyond solving a fundamental problem in current cell biology, the molecular analysis 
of these processes is of major importance as these export routes are taken by viral 
proteins, angiogenic growth factors, inflammatory cytokines and components of the 
extracellular matrix. These factors can regulate cell differentiation, proliferation, 
apoptosis, parasite infection and inflammatory processes, being of tremendous 
interest of biotechnological industries. 
 
 
3. YB-1 protein  
 
3.1 Structure and functions 
YB-1 (Y-box binding protein 1) is a member of the evolutionarily conserved cold shock 
domain (CSD) proteins and was first identified as a DNA/RNA binding protein [9] 
involved in the control of gene expression both at transcriptional and translational level 
[10,11].  
Human YB-1 is made up of three domains: A/P rich N- terminal domain (amino acids 
1-51); a highly conserved CSD domain (amino acids 52-129) and a large C-terminus 
(amino acids 130-324) [12] (Figure 3).The Cold Shock Domain is composed by five  
β-barrel strands connected by a long flexible loop; it contains the RNA binding motifs 
RNP1 and RNP2, which mediate the interaction with nucleic acids, both specific and 
unspecific [10]. The Alanine/Proline domain is involved in protein-protein interaction 
and, according to the literature, enhances and stabilizes the CTD specific binding with 
RNAs. The CTD domain includes alternating basic and acid clusters and is implicated 
in DNA/RNA binding and protein-protein interaction.  
Except the CSD, which owns a precise secondary structure, the protein shows no 
ordered three-dimensional structure (Figure 3); this gives YB-1 the possibility to 
modulate its structure gaining different fixed organizations through the interaction with 
several distinct partners [13]. 
YB-1 subcellular localization is finely regulated. Specific nuclear localization (NLS) and 
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cytoplasmic retention signals (CRS), all localized in the CTD domain, contribute and 
direct the multifunctional tasking of YB-1 [14]. 
Combining its structural flexibility and the possibility to move from a cellular district to 
another, derives that YB-1 is involved in the control of several biological processes 
including cell proliferation, migration, DNA damage, RNA sorting and many others.  
In normal resting cells, YB-1 localizes to cytoplasm where it is a major component of 
P-body and messenger ribonucleoproteins (mRNPs) acting, predominantly, as a RNA 
binding protein [15; 16]. Furthermore, YB-1 activates translation of specific transcripts 
via its ability to bind UTRs of target mRNAs (low YB-1/mRNA ratio); at high YB-
1/mRNA ratio, instead, it functions as a component of translationally inactive mRNPs, 
and directly blocks the initiation of translation inhibiting mRNA degradation [17].  
YB-1 is also able to bind specific miRNAs, snoRNAs and tRNA-derived fragments and 
regulate the expression of miRNA biogenesis and processing machinery [18]. This 
function of YB-1 is particularly attractive because of the interest on microRNA 
(miRNA)-based technology for therapeutic applications. In this regard RNA-binding 
proteins and microvesicle-dependent trafficking systems are actively studied to set up 
miRNAs-loaded systems which can be delivered into recipient cells simultaneously 
regulating multiple target genes or signalling pathways [19].  
Mitogens and stress stimuli can trigger YB-1 nuclear translocation where it acts as a 
transcription factor, at the G1-S transition of the cell cycle, for instance [20,21].?
Moreover, IR-induced DNA damage activates the DNA-repair activity of YB-1 in the 
nuclear compartment.  
Recent studies link YB-1 to the cellular response to oxidative stress and DNA repair 
mechanisms, leading to the concept of YB-1 as a stress sensor. Indeed, following 
acute oxidative stress, YB-1 localizes to cytoplasmic Stress Granules (SGs), organelle-
like structures devoid of membranes, engaged in mRNA sorting and pro-survival 
translational reprogramming [22,23].  
In particular, YB-1 is recruited in TIA-containing Stress Granules (SGs) where it 
functions as a component of translationally inactive mRNPs to directly block 
translational initiation of highly expressed transcripts [24]. 
 
 
 
Figure 3. Schematic representation of human YB-1 protein. 
YB-1 is composed by three domains; only the CSD has a 3-dimensional structure. 
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3.2 YB-1 as Stress Granules (SGs) nucleator 
Stress caused by environmental insults or disease can disrupt cellular, tissue and 
organ homeostasis. Stress-induced DNA damage may culminate in cell or even 
organismal death [25]. Eukaryotes respond to detrimental conditions by activating a 
set of conserved processes that aim to re-establish cellular homeostasis. This 
multifaceted response is critical for cell survival [25]. It is characterized by stress-
dependent changes in the transcriptome and down-regulation of global translation [26]. 
At the same time, the production of molecular chaperones is enhanced to promote the 
refolding or degradation of damaged proteins [27].  
After exposure to distinct environmental insults, such as oxidative stress, 
hypothermia or extreme heat, eukaryotic cells relocate proteins and messenger RNA 
into transient, dynamic structures known as Stress Granules (SGs). Stress granules, 
directly respond to the protein synthesis status of cells; contain mRNAs, small 
ribosomal subunits and factors such as G3BP1 and YB-1 as their core components 
[28].  
Stress granules are dynamic cytosolic aggregates composed by ribonucleoproteins 
that are induced during cellular stress when protein synthesis is inhibited [29].? In 
response to environmental stress such as oxidative stress or heat shock, cells respond 
by shutting down overall protein synthesis. This results in the disassembly of 
polyribosomes, leading to stalled initiation complexes that are dynamically recruited to 
cytoplasmic foci called, hence, stress granules. Stress granules biology is very 
complex; they somehow evolve from Processing Bodies (PBs) which are linked to 
exosomes, by sharing proteins and RNAs [29,30].?Following this concept, it has been 
proposed a model wherein mRNAs released from polysomes during stress are routed 
to SGs for triage, sorting, and mRNP remodelling, after which certain transcripts are 
selectively exported to associated PBs for degradation, while other transcripts, 
specifically those deadenylated, are degraded by a the 3′–5′ exonucleases present in 
the exosomes [31].?
YB-1 performs a role in SGs formation, in particular in sodium arsenite response, by 
activating translation of HSP70 and G3BP1 protein, which is a well characterized SGs 
nucleator and recruiting tiRNAs generated by angiogenin cleavage [24]. 
 
?
3.3 YB-1 secretion?
A newly identified YB-1 feature is its ability to be secreted in cell culture media and 
human body fluids [32]. YB-1 secretion is particularly active in association with 
malignancies, bacterial infections and inflammatory diseases [33]. 
The precise molecular mechanisms through which YB-1 is secreted is still under 
investigation, but it is generally accepted that YB-1 is secreted through non canonical 
pathways [34] and there are evidences about different proteins and molecular 
machineries involved. One of the more recently mechanism proposed, indicates that 
YB-1 is secreted via exosome vesicles following a specific ubiquitination process [35]; 
this seems to be in contrast with other mechanisms proposed so far, for instance 
acetylation-dependent secretion [36]. 
In exosomes YB-1 is believed to sort RNA by type and quantity in a cell specific manner 
[37].  
Moreover, it is still not clear if YB-1 protein is secreted as a sum of multiple fragments 
and what are the effects of secreted YB-1 on distinct target cells. As a matter of fact, 
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bioinformatic analysis of YB-1 amino acid sequence predict that it may represent a 
precursor for bioactive paracrine molecules; interactions between secreted YB-1 and 
some extracellular receptor domains, for instance Notch 3, have been proposed [38].?
Due to its simultaneous presence in P-bodies, Stress Granules (SGs) and exosomes 
YB-1 is thought to function as a regulator of peptides/RNAs trafficking in and outside 
the cell.  
 
 
4. Aim of the work 
 
In the last decade and half the scientific community has investigated numerous 
features of the YB-1 protein, ranging from its involvement in mRNA control in the 
cytoplasm, leading to its function as transcription factor in the nucleus. 
Different authors have pointed out the extraordinary versatility of the protein, which is 
mostly based on its molecular structure. Until a few years ago YB-1 was considered a 
relevant passive player of such processes. More recently, with the discoveries that YB-
1 is involved in vesicles trafficking routes, for example loading cargos on vesicles or 
participating in their formation and release, a new approach has emerged, the one that 
considers YB-1 an active player.  
It is not exaggerated to intend YB-1 as molecular supervisor of (some) cellular 
processes.  
Accordingly, the idea behind this PhD project was to evaluate the rationality of this 
concept, focusing on YB-1 response to stress.  
As reported above, based on its structural organization, YB-1 is predicted to be a 
potential precursor of signal peptides, and considering its ability to respond to stress 
by assembling SGs, I speculated that YB-1 can act as a sensitive stress sensor being 
secreted to propagate stress signals and by so inducing adaptive response in 
neighbouring cells.  
Starting from this hypothesis I have explored in detail YB-1 response to stress stimuli 
and, finally, I concentrated my studies on the potential role of YB-1 as paracrine 
signalling molecule on receiving cells. 
YB-1 roles and functions are currently being investigated not only in mammals, but 
also in other organisms such as fish. In zebrafish YB-1 is involved in circadian rhythm 
and DNA damage response.  
For those reasons I have also conducted comparative studies on mammalian and 
zebrafish cells to evaluate the sensitivity and relevance of YB-1 as an environmental 
stress biomarker and a water toxicity biosensor in fish for aquaculture optimization.  
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CHAPTER II 
 
 
1. HEK293T cell line characterization 
Human embryonic kidney 293T (HEK293T) cell line is a popular, heterologous 
expression system for producing recombinant proteins in mammalian cells [39]; it is 
also widely used for production of secreted proteins [40].  
For these reasons it has been chosen as a good cell model system to analyse YB-1 
response to stress. 
First, I analysed YB-1 subcellular distribution in normal conditions: I set up 
immunofluorescence experiments in HEK293T using anti-YB-1 antibodies raised 
against the region 1 to 100 of YB-1 protein (abcam 12148). Given that HEK293T 
adhesion to glass/plastic surfaces was weak, plates and slips for immunofluorescence 
were treated with Poly-D-lysine 0.1mg/ml (Sigma-Aldrich, St Louis) before seeding 
cells. Poly-D-lysine increases HEK293T adhesion to plating surfaces by increasing 
electrostatic interaction between negatively-charged ions of cell membrane and culture 
surface. 
In normal condition, immunofluorescence and confocal microscopy revealed that YB-
1 was abundant and almost exclusively cytoplasmic. Interestingly, I observed small 
cytoplasmic aggregates that appeared to be randomly distributed throughout the cell 
(Figure 4, white arrows).  
 
 
 
Figure 4. Confocal immunofluorescence of HEK293T stained with a-YB-1 (green), nuclei are stained 
with DAPI (blue); arrows indicate YB-1 aggregates. 
 
Knowing that YB-1 has been found in P-bodies in many mammalian cell lines, for 
example in Hep-2 and Hela cells [15,41], I evaluated the possibility that also HEK293T 
have YB-1 positive P-bodies.  
Therefore, I performed double immunofluorescence with antibodies against YB-1 
(abcam) and GW182 (Santa Cruz Biotechnology), and as shown in Figure 5, YB-1 and 
GW182 co-localize in cytoplasmic aggregates, confirming that they are P-bodies, or at 
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least GW bodies, which are often associated with the P-bodies of higher eukaryotic 
organisms [42]. 
 
 
 
Figure 5. YB-1 co-localizes with GW182. 
Confocal immunofluorescence of HEK293T stained with a-GW182 (green) and a-YB-1 (red), nuclei 
are stained with DAPI (blue); white, yellow and red arrows indicate respectively, YB-1, GW182 and 
YB-1/GW182 aggregates. 
 
 
 
1.1 HEK293T response to stress  
Once defined the subcellular distribution of YB-1 protein in normal conditions I treated 
cells with different stressors. 
Following heat shock or treatment with 250 µM sodium arsenite (Na Ars) or 500 µM 
hydrogen peroxide (H2O2), YB-1 was found to co-localize with PABP1, a canonical SGs 
marker [43], in cytoplasmic stress granules (Figure 6). Interestingly, SGs size and 
overall number per cell were different depending on the type of stimulus applied 
confirming previous finding indicating stress-specific differences in composition and 
assembly of stress granules [44]. 
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Figure 6. YB-1 co-localizes with PABP1 under stress conditions. 
a) confocal immunofluorescence of un-treated (control) HEK293T and treated with different stressors, 
stained with a-YB-1 (green) and a-PABP1 (red), nuclei are stained with DAPI (blue); yellow arrows 
indicate YB-1 positive P-bodies; withe arrows indicate YB-1 and PABP1 positive stress granules; b) (left 
panel) size of granules and (right panel) number of granules after treatments compared to control; 
statistical analysis was performed using 1-way ANOVA followed by Dunnett’s multiple comparisons test. 
Levels of significance are indicated (***p<0.001, *p = 0.001; see also Appendix II, table 1). 
 
 
Next, I immunoprecipitated YB-1 protein from extracts of untreated or sodium arsenite 
treated HEK293T cells. As show in Figure 7 PABP1 was detectable in YB-1 
immunocomplexes exclusively from cells treated with arsenite thereby indicating that 
YB-1 and PABP1 association occurs predominantly in SGs (Figure 7). 
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Figure 7. YB-1 and PABP1 physically interact under sodium arsenite stimulation. 
Co-immunoprecipitation of HEK293T total protein extracts treated (+) or not (-) with 250 µM Na Ars for 
30’; extracts were immunoprecipitated for YB-1 and immunorevealed for PABP1. YB-1 physically 
interacts with PABP1 only in the presence of Na Ars. Input samples immunorevealed with a-PABP1 and 
a-YB-1 are shown. 
 
 
To assess the relevance of YB-1 in SGs assembly, I depleted HEK293T cells of YB-1 
using a specific siRNA pool against endogenous YB-1 mRNA (siYB1). By immunoblot 
and densitometric analysis I found that the expression level of YB-1 protein was 
reduced to 55% of control (Figure 8a). 
YB-1 knock-down consistently impaired the assembly of arsenite-induced PABP1-
positive stress granules by reducing their size and number (Figure 8b and c). 
Interestingly, in YB-1 depleted cells, PABP1 showed a more nuclear localization both 
in resting condition and under stress stimuli (Figure 8c) suggesting that YB-1 can 
influence PABP1 subcellular distribution.  
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Figure 8. Silencing of YB-1 affects PABP1 positive SGs formation. 
a) western blot of total extract from control (siNC) or 100 nM YB-1 silenced (siYB-1) HEK293T; the 
degree of reduction of YB-1 protein levels in YB-1 siRNA-treated cells compared with control is indicated 
beneath each band in the western blot (where the relative unit 1.0 represents YB-1 levels in cells 
transfected with the control siRNA). β-tubulin was used as loading control. Each panel is assembled 
from cropped western blotting images. b) (left panel) size of granules and (right panel) number of 
granules in YB-1 silenced cells treated with Na Ars compared to siNC (control) cells; statistical analysis 
was performed using unpaired t-test with Welch’s correction (**p = 0.010 and *p = 0.02; see also 
Appendix II, table 1). c) confocal immunofluorescence of control (siNC) and silenced (siYB-1) HEK293T 
cells, treated or not with 250 µM Na Ars for 30’, stained with a-YB-1 (green) and a-PABP1 (red), nuclei 
are stained with DAPI (blue). 
 
 
1.2 YB-1 secretion under stress stimuli. 
Despite the apparent enrichment of YB-1 in SGs, I observed a significant reduction of 
intracellular YB-1 protein level in total extracts of Na Ars and H2O2-treated HEK293T 
(Figure 9a and b). The observed decrease of YB-1 was not caused by cell death and 
subsequent leakage of cell contents as the level of GAPDH and actinin proteins, used 
as control, remained unaffected (Figure 9a and b). By immunoblot analysis of nuclear 
and cytoplasmic subcellular fractions I found that the reduction of YB-1 protein level 
induced by sodium arsenite was exclusively at the expense of the cytoplasmic pool, 
while nuclear YB-1 was totally unaffected (Figure 9c).  
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Figure 9. Sodium arsenite and hydrogen peroxide treatments affect cytoplasmic pool of YB-1. 
Western blot of total protein extracts from HEK293T treated with 250 µM Na Ars (a) or 500 µM H2O2 (b) 
for 30’ and 60’; GAPDH and actinin were used as loading control. The degree of reduction of YB-1 
protein levels in treated cells compared with controls is indicated beneath each band in the western blot 
(where the relative unit 1.0 represents YB-1 levels in control cells). c) western blot of total extract and 
nuclear/cytoplasmic fractionation of Na Ars treated and untreated HEK293T. GAPDH and PARP were 
used as loading control for cytoplasm and nucleus respectively. 
Each panel is assembled from cropped western blotting images. 
 
 
Moreover, after 30’ and 60’ treatment with 250 µM sodium arsenite or 500 µM hydrogen 
peroxide, cell viability was only slightly reduced (90% and 94%, respectively) 
compared to control cells and the increase of trypan blue positive cells was negligible 
(Figure 10a and b), further indicating that extracellular accumulation of YB-1 was not 
due to cell injury. 
Thus, I hypothesized that oxidative stress would enhance YB-1 protein secretion.  
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Figure 10. Sodium arsenite and hydrogen peroxide treatments do not affect cell viability. 
Cell viability assay (a) and Trypan blue (b) of HEK293T cells treated with 250 µM Na Ars and 500 µM 
H2O2 for 30’ and 60’, ns indicate no statistically significance (ordinary 1-way ANOVA and Dunnett’s 
multiple comparison; ns means no statistical significance; see also Appendix II, table 1). 
 
 
 
1.3 TCA precipitation  
To detect YB-1 protein in culture medium I performed trichloroacetic acid precipitation 
(TCA ppt). TCA precipitation is a cost effective and easy to perform method to 
concentrate proteins from culture medium; if added to an aqueous solution TCA 
causes aggregation and precipitation of proteins [45]. I performed TCA ppt on culture 
media of HEK293T treated cells with sodium arsenite at different time intervals (from 
30’ to 240’).   
Briefly, media were collected, centrifuged and filtered with 0.22 µm device to eliminate 
cells eventually present. Processed media were then extracted with TCA 25% (1:1) 
(see Appendix I Materials and Methods) and then subjected to immunoblot. 
As shown in Figure 11, a 50 kDa YB-1 positive signal was detected in all samples; in 
particular, the amount of secreted YB-1 protein significantly peaked after 60’ of 
treatment. Conversely, the ribonuclease inhibitor (RNH1), a not secreted protein 
whose abundance in HEK293T cytoplasm is comparable to that of YB-1 [46] was 
barely detectable (Figure 11, lower panel).  
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Figure 11. YB-1 is secreted after sodium arsenite stimulation. 
Western blot of TCA precipitated supernatants of HEK293T cells. YB-1 secretion peaked at 60’ after Na 
Ars treatment; RNH1 was used to as negative control of cell lysis. 
 
Moreover, I transfected HEK293T cells with Myc-YB-1 expression plasmid and treated 
them with Na Ars 250 µM for 30’, 60’ and 120’. Immunoblotting of TCA-precipitated 
CCM media showed the presence of Myc-tagged YB-1 only in arsenite-stimulated cells 
thus indicating that stressed cells can also secrete transfected YB-1 (Figure 12). 
 
 
Figure 12. Transfected myc-YB-1 can be secreted by cells. 
Western blot of TCA-precipitated CCM of HEK293T cells transfected with Myc-YB-1 and treated or not 
with 250 µM Na Ars for 30’ up to 120’. The presence of Myc-tagged YB-1 only in arsenite-stimulated 
cells indicates that stressed cells can also secrete transfected YB-1. 
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2. HEK293T YB1-GFP stable clone 
Once defined the presence of a connection between cellular stress and YB-1 secretion 
I sought to generate a stable pool of cells constitutively expressing YB-1 as a GFP 
fusion protein to easily follow secretion and eventually uptake by receiving cells. 
Stable cell lines represent a permanent resource that can be stored under cryogenic 
conditions for long periods of time, retrieved, and cultured to provide a consistent and 
reliable level of sustained gene expression [47]. 
HEK293T stable clones can be generated to produce high quantity of recombinant 
proteins. Therefore, I transiently transfected HEK293T cells with YB-1-GFP cDNA 
cloned in pcDNA6/V5-His, a vector derived from pcDNATM3.1(+) (Invitrogen). Cells 
(5.0x105) were seeded in order to reach 80% confluence the day after; lipofection was 
performed using pcDNA6/V5-HisA-YB-1-GFP and peGFP-C1 empty vector as control 
[48]. 48 hours after transfection cells were analysed by immunoblot to evaluate the 
level of YB-1-GFP exogenous expression. Transfected YB-1-GFP was highly 
expressed in HEK293T cells (Figure 13a). Direct fluorescence, acquired by Nikon 
Eclipse 800 microscope, showed a prevalent cytoplasmic localization for YB-1-GFP 
(Figure 13b).  
 
 
 
 
 
Figure 13. YB-1-GFP fusion protein is cytoplasmic. 
a) western blot of total extract from HEK293T transfected with mock (Ctrl) and pcDNA6/V5-HisA-YB-1-
GFP (transf); GAPDH was used as loading control. b) direct eGFP fluorescence acquisition images. 
 
The next step was to produce a pool of clones of HEK293T stably expressing YB-1-
GFP or GFP alone. YB-1-GFP expressing cells were selected with blasticidin while 
G418 was used for selection of peGFP-C1 stable pool. After 4 weeks, 91% of selected 
cells were GFP positive. It is known that YB-1 is involved in cell proliferation [49], and 
total protein amount is crucial for the correct behaviour of cells; for this reason I 
evaluated the proliferation rate of YB-1-GFP expressing cells, where YB-1 protein 
amount was increased compared to HEK293T. Compared to the parental cell line, YB-
1-GFP expressing cells grew slightly faster, but reach a plateau earlier (Figure 14). 
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Figure 14. HEK293T YB-1-GFP grow faster than HEK293T. 
Cell proliferation profile of HEK293T and HEK293T YB-1-GFP from time 0 (seeding time) to 96 hours 
(2-way ANOVA and Sidak’s multiple comparisons test, P<0.001***; see also Appendix II, table 1). 
 
 
2.1 Lack of functionality of the clone 
To examine YB-1-GFP protein localization under oxidative stress I treated HEK293T 
YB-1-GFP cells with sodium arsenite, hydrogen peroxide (H2O2) and performed heat 
shock. By direct fluorescence acquisition, I observed that YB-1 fusion protein was 
detected in unusual GFP-positive aggregates that were abnormal in both dimension 
and shape (Figure 15). 
 
 
 
Figure 15. HEK293T YB-1-GFP cells form aberrant SGs after oxidative and physical insults. 
Direct eGFP fluorescence acquisition of HEK239T-YB-1-GFP treated with 250 µM sodium arsenite, 
500 µM H2O2 or subjected to heat shock (45°C for 45’); arrows indicate aberrant SGs. 
 
Even though in normal conditions the GFP fusion protein behaved like the endogenous 
one and was localized in the right subcellular compartment, I hypothesized that the 
presence of the huge GFP tag (27 kDa) and the fact that the unstructured YB-1 C-
terminus folds depending on the molecular partner [50], may have caused an incorrect 
folding of YB-1-GFP fusion protein(Figure 16). 
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Figure 16. Putative structure of YB-1-GFP protein.  
The GFP tag could hamper YB-1 correct folding and function (red arrows). 
 
Moreover, as demonstrated by MTT and trypan blue assays (Figure 17a and b) I 
found an increase sensitivity of YB-1-GFP cells to oxidative stress, suggesting that 
the overexpression of YB-1 with an incorrect form, alters cells responsiveness to 
stress stimuli.
 
 
Figure 17. HEK293T YB-1-GFP are more sensitive to hydrogen peroxide. 
MTT assay (a) and trypan blue count (b) of HEK293T and HEK293T YB-1GFP after treatment with the 
indicated concentrations of hydrogen peroxide (2-way ANOVA and Sidak’s multiple comparison test, 
***p<0.001 and**p<0.002; see also Appendix II, table 1).  
  
26 
 
 
Given that HEK293T YB-1-GFP showed an altered stress response I decided do not 
adopt this model for further studies on stress-induced secretion. 
 
 
3. Conclusions 
 
The concept of protein equilibrium for YB-1 is essential. Its deficiency or excess can 
induce pathological conditions or unhealthy situations [13]. 
It is well documented, for example, that mRNAs fate in the cytoplasm is dependent 
also on YB-1/mRNA ratio, which in turn relies on YB-1 expression and amount. The 
quantity, and also the localization of the protein, is definitely important for many 
cellular events to happen. 
For all those reasons it appeared quite interesting and unexpected that the total YB-1 
protein amount decreased after oxidative treatments in HEK293T cells. This was 
astonishing considering also YB-1 relevance in SGs formation.  
One possible explanation was the existence of a mechanism through which cells 
facing stress release YB-1. 
On behalf of the experiments performed, I can postulate that YB-1 secretion is the 
result of an active mechanism and not a passive release.  
These findings could open to the possibility that secreted YB-1 works as molecular 
signal, perhaps for neighbouring cells, to signal the occurring of unhappy and harmful 
situation. 
Ideally, the possibility to have a modified form of the protein could have been very 
useful to simplify the observation of the secretion. I attempted to perform live-cell 
immunofluorescence experiments, using HEK293T YB-1-GFP as YB-1-donor cells, 
but without success. In fact, YB-1-GFP, produced for this purpose, was ineffective, 
because it led to the formation of aberrant SGs, probably for steric issues. Moreover, 
YB-1-GFP fusion protein was not secreted, neither in physiological conditions, nor 
after exposure to oxidative stressors. 
On the contrary, other tagged-YB-1 forms, for example myc-YB-1, were successfully 
secreted after oxidative stimuli. This result was really interesting because underlines 
the fact that cells are able to secrete also non-endogenous form of  YB-1, suggesting 
that YB-1 bears a sort of signal which makes it secretable. 
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CHAPTER III 
 
1. Extracellular YB-1 (exYB-1) 
Once excluded the possibility to use the YB-1-GFP expressing cells to follow the 
secretion and uptake of YB-1 protein, to analyse the effects of extracellular YB-1 on 
receiving cells, I prepared a YB-1 enriched fraction from HEK293T conditioned cell 
culture medium (CCM-YB-1) by ammonium sulphate precipitation followed by HPLC 
purification. Furthermore, I produced a recombinant YB-1 from E. coli, which 
accumulated mainly in bacterial cytosolic fraction.  
The whole procedure of recombinant expression and purification was performed 
in collaboration with Dr. E Pizzo and Dr. A. Bosso of the University of Naples 
Federico II. 
 
 
1. Production of human recombinant YB-1 (rYB-1) in bacterial host 
Human YB-1 cDNA sequence was amplified from pEX-A2 plasmid (Eurofins 
Genomics, Germany) and inserted into the pET22b (+) expression vector  
upstream to a His-Tag sequence to facilitate the purification of the recombinant protein 
(for detailed procedure see Appendix I, Materials and Methods). The expression 
plasmid produced, was used then to transform competent E. coli strain BL21(DE3) 
(New England BioLabs, USA). 
I choose Escherichia coli as host since it facilitates protein expression by its relative 
simplicity, its inexpensive and fast high density cultivation and the well-known genetics. 
Cells were grown at 37 °C to an A600 nm = 0.7, induced with 0.6 mM isopropyl-1-thio-d-
galactopyranoside (IPTG) and grown overnight. 
By Western blot analysis I found that recombinant YB-1 was successfully expressed 
upon induction with IPTG and that it accumulated almost completely in bacterial 
cytosolic fraction (Figure 18), thus avoiding any effort for the redirection from inclusion 
bodies into the soluble cytoplasmic fraction. 
 
 
Figure 18. rYB-1 production. 
Western blot of bacterial lysate revealed with anti-YB-1, before (lane NI not induced) and after induction 
(lane IND induced) with IPTG; the amount of YB-1 protein is relevant in the soluble fraction (lane SF) 
and almost absent in inclusion bodies (lane IB). 
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Bacterial cells were harvested by centrifugation, resuspended in Tris-acetate buffer 
(pH 8.0) and subjected to sonication in presence of protease inhibitors. After three 
washes inclusion bodies were separated from cytosolic soluble fraction.  
Recombinant YB1 was purified performing a two-step procedure composed by an 
immobilized metal ion affinity chromatography (IMAC) followed by a reverse phase 
chromatography.  
Figure 19a shows the affinity chromatography elution profile. Fraction 3,5,7,8,9, and 
11 were loaded on polyacrylamide gel to check the ongoing purification (Figure 19b). 
 
 
Figure 19. Affinity chromatography. 
a) affinity chromatography on HisTrap resin; Rif indicates proteins without his-tag, eluted even before 
the elution buffer; W1-W3 resin washes; 1-20 eluted fractions; 
b) fractions 3-5-7-8-9-11 were loaded on polyacrylamide gel; coomassie stain indicated the presence of 
putative YB-1.   
 
 
Then, I performed a step of purification by HPLC reverse phase chromatography (for 
further details see Appendix I, Materials and Methods). 
 
 
 
Figure 20. Reverse phase chromatography reveals that two YB-1 major forms are purified. 
a) reverse phase chromatography of fractions obtained by the first step of affinity chromatography; two 
different volumes of the prior elution peak were loaded on gel. b) western blot of full purified fractions 
showing 50 kDa and 37 kDa canonical YB-1 bands. 
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As shown in Figure 20a the prior elution peak was observed after 75 minutes of elution; 
aliquots of the elution peak were loaded on polyacrylamide gel to check the process. 
SDS-PAGE revealed a major 50 kDa band that was consistent with previous 
purification steps and with YB-1 molecular weight. Next, I dialysed the positive fraction 
to further purify the protein and performed immunoblot with YB-1 antibodies to finally 
identify the protein (Figure 20b). 
 
 
1.2 Production of Culture Medium derived YB-1 (CCM-YB-1) 
Conditioned culture medium (CCM) was prepared by seeding HEK293T cells on Poly-
D-lysine pre-treated wells in order to minimize cell detachment; the day after the culture 
medium was collected, and centrifuged to discard any cells and debris that may be 
present; medium was then sterilized by filtration.  
Media were subjected to three subsequent steps of ammonium sulphate (Sigma-
Aldrich, St Louis) precipitation, 30%, 70% and 100%, determining proteins salting out. 
At each step, media were centrifuged and protein precipitated were analysed by SDS-
PAGE and immunoblot. 
YB-1 positive forms were extracted mostly with 70% of ammonium sulphate. As shown 
in Figure 21, both 50 and 37 kDa form of YB-1 were detectable in the majority of protein 
enriched fractions. Moreover, I was also able to detect smaller YB-1-derived peptide 
bands. 
 
 
Figure 21. 70% Ammonium sulphate extracted fraction are the most promising. 
Western blot of different CCMs (from 1 to 4) extracted with 70% of ammonium sulphate and 
immunorevealed with YB-1. Different signals were detected depending on the samples. In sample 1 
only a 37 kDa band was visible; in samples 2 and 3, 37 and 50 kDa bands were detectable; in lane 4 
only a huge 50 kDa form was detectable; GAPDH and RNH1 were used to ensure the absence of 
cytoplasmic protein due to cell lysis. A total protein extract sample is also shown. 
 
As shown in Figure 21, YB-1 pattern in enriched fractions from different CCM samples 
was different. Given that the 37 kDa form is associated to DNA damage, I postulated 
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that a higher prevalence of the 37 kDa fragment may be either linked to more damaged 
cells or to spontaneous limited YB-1 proteolysis [51]. This interpretation could be 
consistent with the fact that YB-1 secretion is a very dynamic phenomenon, not just a 
release of proteins by cells. On the other hand, hence, the presence of a huge 50 kDa 
band in lane 4 could be connected to more healthy cells. 
 
 
1.3 Mass Spectrometry analysis  
To finally confirm the identity of purified YB-1 proteins, I resolved CCM-YB-1 and rYB-
1 in a polyacrylamide gel, stained it with colloidal coomassie and excided the YB-1 
positive bands for Mass Spectrometry analysis. This part of the project was done in 
collaboration with Prof. A. Amoresano from University of Naples Federico II. 
Each band was subjected to in-situ tryptic digestion and peptides eluted from the gel 
were analysed by LTQ-Orbitrap mass spectrometer. By matching MS and MSMS data 
obtained from the mass spectrometer and peptide sequence databases by Mascot 
search engine, a high sequence coverage of 79% for R1 band (rYB-1 band 1 in Figure 
22), 78% for R2 (rYB-1 band 2 in Figure 22), 60% for S1 and 29% for S2 (CCM-YB-1 
band 1 and 2 respectively, in Figure 22), with an error lower than 10 ppm. A list of 
peptides with relative score, sequence and modifications allowed me to 
unambiguously identify the YB-1 protein with a high sequence coverage and protein 
score (Appendix II, Table 2).  
 
 
 
 
Figure 22. Band excision. 
Image of polyacrylamide gel stained with colloidal coomassie blue. Excised YB-1 putative bands are 
indicated: bands R1 and R2 (recombinant YB-1); band S1 and S2 (Na Ars treated CCM-derived 
sample). 
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2. Functional analysis of exYB-1 
 
2.1 Extracellular YB-1 exerts anti-proliferative effects on receiving cell 
We have previously demonstrated that intracellular YB-1 is implicated in keratinocyte 
proliferation and survival to oxidative stress [51,52].  
To get an insight into the function of secreted YB-1 I evaluated the proliferative 
response of HaCaT cells to the addition of recombinant YB-1 and purified YB-1 from 
HEK293T cell culture medium (CCM-YB-1).  
YB-1 is normally released in the culture medium by HEK293T cells but not by HaCaT 
or CaCo2 cells even though all these cell lines express high level of endogenous YB-
1. This may depend on a particular pathway constitutively activated in HEK293T cells 
or may rely on specific post-translational modifications occurring in HEK293T and 
possibly other cell contexts facilitating YB-1 extracellular release. 
HaCaT cells were incubated for the indicated time with increasing amounts (5.0, 7.5 
and 10 µg/ml) of rYB-1 protein, CCM-YB-1 or Bovine Serum Albumin (BSA) as control 
in serum supplemented culture medium. As shown in Figure 23 (panels a and b), 
treatment with CCM-YB-1 or rYB-1 reduced the rate of proliferation of HaCaT cells 
while equivalent amounts of BSA were ineffective (Figure 23c).  
 
 
 
Figure 23. Extracellular YB-1 affects HaCaT cell proliferation. 
Cell proliferation profile of HaCaT cells incubated with indicated concentrations of CCM-YB-1 (a), rYB-
1 (b) or BSA (c); statistical analysis was performed using 2-way ANOVA followed by Dunnett’s 
multiple comparisons test. Levels of significance are indicated (***p<0.001, ns indicates no statistical 
significance; see also Appendix II, table 1). d) crystal violet assay of HaCaT cells treated with 7.5 
µg/ml of CCM-YB-1, rYB-1, BSA or left untreated (Ctrl); (bars) optical absorbance at 595 nm is 
reported on the y-axis; (image) representative colorimetric evaluation. Statistical analysis was 
performed using 1-way ANOVA followed by Dunnett’s multiple comparisons test. Levels of 
significance are indicated (***p<0.001; see also Appendix II, table 1). 
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This effect was not cell type specific since it was also observed using HEK293T and 
CaCo2 as receiving cells (Figure 24).  
Remarkably, compared to rYB-1, CCM-YB-1 exerted a stronger inhibitory effect on all 
cell lines tested (Figures 23-24a and b). 
This was confirmed by Crystal Violet Assay (CVA) where HaCaT cells treated with 7.5 
µg/ml of CCM-YB-1 for 48 hours showed a 47% reduction in viable cells compared to 
a 11% reduction obtained with the same amount of rYB-1 (Figure 23d).  
 
 
 
 
Figure 24. Extracellular YB-1 affects HEK293T and CaCo2 cell proliferation. 
Cell proliferation profile of HEK293T (a) and CaCo2 (b) incubated with indicated concentrations of 
CCM-YB1 (upper panels) and rYB-1 (lower panels). Statistical analysis was performed using 2-way 
ANOVA followed by Dunnett’s multiple comparisons test (***p<0.001, **p = 0.003, *p = 0.03, ns 
indicates no statistical significance; see also Appendix II, table 1).  
 
 
 
Flow cytometry analysis of HaCaT cells treated with extracellular YB-1 revealed that 
cell proliferation slowdown was due to a G2/M cell cycle arrest (Figure 25a). 
Finally, to explore the molecular mechanism underlying inhibition of cell proliferation 
by extracellular YB-1, I analysed by quantitative PCR the mRNA level of p21waf 
and Dnp63a in rYB-1 or CCM-YB-1 treated HaCaT cells. p21WAF is a relevant cell 
cycle marker that induces G1 and G2/M cell cycle arrest by inhibiting the kinase activity 
of CDK-cyclin complexes [53] while DNp63a maintains the proliferative capacity of 
keratinocytes [54]. p21waf was strongly induced by both rYB-1 and CCM-YB-1 while 
Dnp63a was significantly downregulated only by treatment with CCM-YB-1 (Figure 25b 
upper and lower panels). By western blot analysis we also confirmed reduction of 
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DNp63a and induction of p21WAF at protein level (Figure 25 c and d). Moreover, 
according to the observed cell cycle arrest the level of cyclin A2 and cyclin D1 were 
also reduced (Figure 25c). 
 
 
 
 
Figure 25. exYB-1 induced G2/M phase arrest. 
a) cell cycle profile of HaCaT cells treated with 7.5 µg/ml of CCM-YB-1, rYB-1, BSA or left untreated 
for 48 hours. Statistical analysis was performed using 2-way ANOVA followed by Dunnett’s multiple 
comparisons test. Levels of significance are indicated (***p<0.001, *p = 0.01; see also Appendix II 
table 1). b) RT-qPCR analysis of p21waf and Dnp63a in HaCaT cells treated with 7.5 µg/ml of CCM-
YB-1, rYB-1, BSA or left untreated (Ctrl) for 48 hours. Statistical analysis was performed using 1-way 
ANOVA followed by Dunnett’s multiple comparisons test. Levels of significance are indicated 
(***p<0.001, *p = 0.01; see also Appendix II table 1). c-d) western blot analysis of total extracts of 
HaCaT cell treated with rYB-1 and CCM-YB1 and revealed with the indicated antibodies. GAPDH and 
β-tubulin were used as loading control.  
 
 
2.2 Extracellular YB-1 induces TNFa  
YB-1 has been previously described as a mediator of inflammatory processes [34,55]; 
I explored the possibility of a cross-talk between secreted YB-1 and the NF-kB 
signalling pathway. Nuclear factor-kB (NF-kB) is a family of highly regulated dimeric 
transcription factors that play crucial roles in inflammatory responses (Nishikori). I first 
examined the activity of the NF-kB promoter in HaCaT cells by transient transfection 
of a NF-kB-driven GFP reporter construct. Cells were first transfected with the reporter 
construct (expressing GFP) and then treated with rYB-1 or CCM-YB1 for 24 hours. 
Western blot analysis of total extracts from YB-1 treated HaCaT cells showed that both 
forms of YB-1 protein were able to induce the NF-kB promoter (Figure 26).  
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Figure 26. rYB-1 and CCM-YB-1 induce NF-kB-driven GFP expression. 
Western blot of total extracts of HaCaT cells transiently transfected with a Mock plasmid or NF-kB-
driven GFP reporter construct. GAPDH was used as loading control. 
 
 
Tumor Necrosis Factor a (TNFa) is one of the most potent physiological inducers of 
the nuclear transcription factor NF-kB [56]. Therefore, I analysed the effect of rYB-1 
and CCM-YB-1 treatments on TNFa protein expression. HaCaT cells were treated with 
increasing amount of rYB-1 and CCM-YB-1. Then, I performed immunoblot on total 
cell extracts. As shown in Figure 27, TNFa was induced in a time-dependent way and 
after 24 hours it was significantly increased in exYB-1 treated cells.  
 
 
 
 
 
Figure 27. CCM-YB-1 and rYB-1 induce TNFa protein. 
Western blot of total protein extract from HEK293T treated with increasing concentrations of CCM-YB-
1 (a) or rYB-1 (b). Actinin was used as loading control. 
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3. Conclusions 
During my PhD I have reported evidences that the extracellular release of YB-1 by 
HEK293T is not the result of a passive mechanism, but follows a rationale. 
In other cell types, such as CaCo2 and HaCaT cells, even if the general YB-1 
behaviour is conserved and the protein is abundant as in HEK293T cells [14,51,52] no 
YB-1 secretion occurs. Moreover, it was previously reported that LPS induces YB-1 
secretion in primary monocytes and in MonoMac-6 (MM6) cells [35] and that YB-1 is 
secreted from macrophages but not dendritic cells [33]. Based on all these 
observations I can reasonably conclude that secretion of YB-1 upon oxidative and 
inflammatory stimuli is cell-type dependent and that enhanced level of YB-1 in the 
extracellular environment is a clear sign of cellular stress. 
The production of a recombinant form of the protein and the purification of a fraction 
from conditioned culture medium, allowed me to have two tools to perform functional 
studies on receiving cells. 
Conditioned culture medium derived YB-1 (CCM-YB-1) represents the protein (or parts 
of it) which is secreted by cultured cells, so all the modifications needed for the 
secretion should be preserved. Instead, recombinant YB-1 (rYB-1), being processed 
in bacteria, is an unmodified form of the protein. Such differences in concept are also 
visible in practice, as indicated by Mass Spectrometry analysis and western blot. 
Referring to the major molecular pathway in which YB-1 is involved [13] I decided to 
verify possible effects on cell proliferation and inflammation. As receiving cells, after 
different preliminary tests, I choose HaCaT cells which offer a well-studied and 
simplified model of the skin [52]. 
Treatments were performed mostly with a fixed concentration of exYB-1 (7.5 µg/ml) as 
indicated in the text, because, among all concentration tested, was the one which gave 
reproducible and consistent results. 
Both extracellular YB-1 forms seem to negatively control cell proliferation inducing a 
G2/M phase arrest. The effect of CCM-YB-1 is stronger compared to that of rYB-1, 
perhaps as a consequence of the post-post-translational modifications as discussed 
above.  
As regards the inflammatory response, this is a really complex field which requires 
great expertise. Classic and alternative inflammation pathway relies on the activity of 
NF-kB proteins, for this reason I decided to test the activity of NF-kB promoter after 
treatments with exYB-1, by monitoring GFP expression, as preliminary experiment.  
Both CCM-YB-1 and rYB-1 had an effect on NF-kB promoter activity and also in this 
case CCM-YB-1 seemed to be more active. 
The induction of TNFa was definitely more intense after treatment with rYB-1 rather 
than CCM-YB-1. Even if the interplay between NF-κB and TNFa is not always clear 
and linear, I can conclude that there is an involvement of inflammatory pathways.  
To summarize, it can be said that treatment with exYB-1 produce effect on cell 
proliferation and trigger inflammation response in immortalized keratinocyte.  
The same effect on cell proliferation was observed also in HEK293T cells, which have 
a complex karyotype, with two or more copies of each chromosome, including three 
copies of the X chromosome, and in CaCo2, cells of human adenocarcinoma. 
Those findings could represent a starting point to verify if secreted YB-1 could work 
not only as signal, but also as effector molecule. 
Further investigations should be extended to un-transformed cell lines, to verify the 
potential role of YB-1 as anti-proliferative agent for cancer cells. 
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CHAPTER V 
 
Collaborations 
 
1. Exploring molecular cell response to oxidative stress 
 
Endogenous reactive oxygen species (ROS) are by-products of the aerobic 
metabolism of cells and have an important signalling role as secondary messengers in 
various physiological processes, including cell growth and development [71]. However, 
the excessive production of ROS as well as the exposure to exogenous ROS, 
originated, for example, from xenobiotics or foods, can cause protein oxidation, lipid 
peroxidation and DNA damages leading to cell damages and a number of health 
disorders. ROS accumulation has been associated with diverse pathogenesis, among 
them, for instance, neurodegenerative diseases, progression of arteriosclerosis and 
inflammatory bowel diseases. 
During my PhD I have contributed to various studies aimed to understand the effects 
of plant extracts and bacterial spores on mammalian cells, monitoring cells response 
to ROS. 
 
1.1 Plant extracts are an important source of bioactive compounds for many 
drug discovery programs 
Plant extracts are an important source of bioactive compounds for many drug 
discovery programs. Given the chemical complexity, however, the identification and 
characterization of bioactive compounds in crude plant extracts still remain a big 
challenge. Moreover, complex mixtures of phytochemicals generally combine the 
advantage of targeting multiple molecular pathways so that a desired biological 
response may be due to a mixture of different bioactive components. 
Uncaria tomentosa (Willd.) DC. (Rubiacee), also known as uña de gato, a plant that 
grows wild in the upper Amazon region of Peru and Cayenne pepper (Capsicum), a 
spicy staple of many foods, have been widely used in folk medicine to treat several 
health conditions including cancer. 
I have contributed to the study of the effects of Uncaria Tomentosa and Capsicum 
annuum fiesta on squamous carcinoma cells and immortalized HaCaT keratinocytes, 
in order to provide molecular evidence supporting its therapeutic use against this type 
of cancer.  
Briefly, we have produced an aqueous extract from Uncaria tomentosa (UT-ex) and 
Capsicum and we have evaluated cell proliferation, apoptosis and the level of reactive 
oxygen species following treatments. UT-ex affected cell cycle progression and 
reduced cell viability in a dose and time-dependent manner. 
We have exploited the activity of the 37 kDa pro-survival YB-1 form, which is involved 
in DNA damage repair interacting with Mre11 and Rad50 complexes, providing  cellular 
protection from oxidative stress [13,20,23].  
Our data indicate that UT-ex-induced cell death can be ascribed, at least in part, to its 
ability both to induce oxidative DNA damage and antagonize the mechanism of DNA 
repair relying upon YB-1 activity. 
C. annuum fiesta, instead, exerts a protective role reducing intracellular ROS levels in 
a dose-dependent manner and stimulating cell viability at low concentrations without 
affecting cell proliferation. 
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See Appendix III, papers 3 and 4. 
 
1.2 Protective and therapeutic effects of Bacillus megaterium spores on gut 
oxidative stress 
A variety of molecules and live bacteria with antioxidant activity have been proposed 
as food additives to avoid ROS accumulation. 
The research group of Prof. Isticato, from University of Naples Federico II, has 
demonstrated that spores of SF185, a human isolate of Bacillus megaterium, have 
intrinsic antioxidant activity and we analyse their effect in vitro and in vitro. 
The antioxidant effects of SF185 spores were tested in vitro on CaCo-2 cells 
measuring the ability of spores to reduce the toxicity of hydrogen peroxide and in vivo 
in a murine model of dextran sodium sulphate (DSS) -induced oxidative stress. 
In vitro, spores have a scavenging action reducing the amount of intracellular ROS and 
so inducing a protected state in cells. Pre-dosing mice with spores before the treatment 
with DSS protects the animals from the chemically-induced damages.  
The consumption of spores-based products could prevent or reduce the damages 
caused by oxidative stress. The human origin of SF185, its strong antioxidant activity, 
and its protective effects both in vitro and in vivo led to propose the spore of this strain 
as a new probiotic for gut health.  
See Appendix III, manuscript 2. 
 
 
2. Studies on D. Rerio and P. Andruzzii 
 
As mentioned before the possibility to analyse YB-1 protein as stress sensor in 
zebrafish come from previous information obtained during my stay at Institute of 
Toxicology and Genetics (ITG-KIT) in Germany, investigating the circadian rhythm in 
zebrafish. 
Moreover, I had the possibility to join another research project regarding the different 
response to DNA damage of blind cavefish P. Andruzzii. 
 
2.1 The tumor-associated YB-1 protein: new player in the circadian control of 
cell proliferation  
In this study, using zebrafish as a vertebrate model system, we show that the nuclear 
localization of the Y-box binding protein 1 (YB-1), a regulator of cyclin expression and 
a hallmark of certain cancers, is robustly regulated by the circadian clock. We implicate 
clock-controlled changes in YB-1 SUMOylation as one of the mechanisms regulating 
its periodic nuclear entry at the beginning of the light phase. Furthermore, we 
demonstrate that YB-1 nuclear protein is able to downregulate cyclin A2 mRNA 
expression in zebrafish via its direct interaction with the cyclin A2 promoter. Thus, by 
acting as a direct target of cyclic posttranslational regulatory mechanisms, YB-1 serves 
as one bridge between the circadian clock and its cell cycle control.  
See Appendix III, paper 5. 
 
2.2 Modulation of DNA Repair Systems in Blind Cavefish during Evolution in 
Constant Darkness 
In a comparative study using zebrafish and the Somalian blind cavefish, Phreatichthys 
andruzzii, we reveal that during evolution for millions of years in continuous 
darkness, photoreactivation DNA repair function has been lost in P. andruzzii. We 
demonstrate that this loss results in part from loss-of-function mutations in pivotal DNA-
  
52 
repair genes. Specifically, C-terminal truncations in P. andruzzii DASH and 6-4 
photolyase render these proteins predominantly cytoplasmic, with consequent loss in 
their functionality. In addition, we reveal a general absence of light-, UV-, and ROS-
induced expression of P. andruzzii DNA-repair genes. This results from a loss of 
function of the D-box enhancer element, which coordinates and enhances DNA repair 
in response to sunlight. Our results point to P. andruzzii being the only species 
described, apart from placental mammals, that lacks the highly evolutionary conserved 
photoreactivation function. We predict that in the DNA repair systems of P. andruzzii, 
we may be witnessing the first stages in a process that previously occurred in the 
ancestors of placental mammals during the Mesozoic era. 
See Appendix III, paper 6. 
 
 
3. A novel approach to quantify Wound Healing closure dynamic 
 
The Wound Healing (WH) assay is widely used to investigate cell migration in vitro, in 
order to reach a better understanding of many physiological and pathological 
phenomena. Several experimental factors, such as uneven cell density among 
different samples, can affect the reproducibility and reliability of this assay, leading to 
a discrepancy in the wound closure kinetics among data sets corresponding to the 
same cell sample. Together with the group of Prof. S. Caserta from University of 
Naples Federico II, we observed a linear relationship between the wound closure 
velocity and cell density, and suggested a novel methodological approach, based on 
transport phenomena concepts, to overcome this source of error on the analysis of the 
Wound Healing assay. In particular, we propose a simple scaling of the experimental 
data, based on the interpretation of the wound closure as a diffusion-reaction process. 
We applied our methodology to the MDA-MB-231 breast cancer cells, whose motility 
was perturbed by silencing or over-expressing genes involved in the control of cell 
migration. Our methodological approach leads to a significant improvement in the 
reproducibility and reliability in the in vitro WH assay. 
See Appendix III, paper 7. 
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CONCLUDING REMARKS 
 
 
YB-1 protein is biotechnologically relevant because is involved in different cellular 
processes both in physiological and in pathological conditions; for this reason the 
spectrum of applications is potentially unlimited. With the proper manipulation the 
protein could be used for many purposes, ranging from pharmaceutical drugs 
production to the creation of biomarkers and biosensors. 
In this PhD project I have evaluated the connections between YB-1 protein secretion 
and cellular stress response in human cells. 
My data point out that YB-1 protein secretion is enhanced as a direct consequence of 
oxidative stress. YB-1 secretion has to be intended as one of the signalling 
processes that cells set up while facing unhealthy or dangerous conditions. 
Cells experience stress as they are put into culture dishes, not only when are treated 
with stress-inducing chemicals or reagents. In vitro system constitutes an 
exemplification of a living organism, but they give the not trivial possibility to 
understand the basis of a specific phenomenon, and in the end, the possibility to 
create applications. 
There is no accordance in literature about the precise mechanism by which YB-1 is 
secreted; as a matter of fact, different publications suggest the involvement of 
different machineries [10,37]. In my experience I have observed that YB-1 can 
undergo different post-translational modifications such as ubiquitination, 
SUMOylation, phosphorylation and acetylation [10,60,51]. Thus, is generally 
accepted that upon different stimuli, YB-1 is modified, processed accordingly and 
secreted. This would be in accordance with Mass Spectrometry data, (see Appendix 
II, table 2), which report modifications on the secreted forms I analysed.  
The most followed hypothesis is the one which states that YB-1 is englobed in 
exosome-like vesicles, which on turn, take contact with plasmatic membrane of 
receiving cells releasing their cargoes. On the other hand, this assumption would be 
a little in contrast with other publications which report that secreted YB-1 is 
internalized after the interaction with a receptor (i.e. Notch3) [34]. 
Understanding the precise secretion mechanism would be really interesting for 
developing proper delivery strategies using YB-1 or YB-1 derived peptides as 
therapeutic agent. 
Beside the not yet completely understood secretion modality, once released the 
protein triggers a response in receiving cells.  
During my investigations, I reported data on YB-1 induced cell cycle arrest in 
receiving cells, when treated with extracellular YB-1.  
An effect on the cell cycle was somehow expected, because it is well known that 
endogenous YB-1 plays a role in controlling cell proliferation [10]. 
It is well reported, in fact, that YB-1 protein over-expression or down-expression can 
alter proliferation rates, inducing either complete cell cycle arrest or an increase of 
duplication rates depending on cell lines and cellular context.  
Although data are still preliminary, I observed also a potential effect on NF-kB 
pathway activation, highlighting that there is not only a single response to exogenous 
YB-1 treatment. 
Moreover, it should be investigated if YB-1 works only as a signal molecule, so after 
secretion and uptake by neighbouring cells other molecules do trigger pathways, or if 
the protein itself directly induces a response. Clues would be indicated by 
understanding how YB-1 is secreted.  
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APPENDIX I  
 
Materials and Methods  
 
Plasmids and chemicals 
The expression construct 5xMyc-YB-1 was previously described [60]. pcDNA 3.1B, 
used as control, was purchased by ThermoFisher Scientific (USA). pcDNA6/V5-His 
derived from pcDNATM3.1(+) (Invitrogen). 
Sodium (meta)arsenite (NaAsO2) (Sigma-Aldrich, St Louis, S7400); hydrogen 
peroxide (Sigma-Aldrich, St Louis, H1009); trichloroacetic acid (TCA) (Sigma-Aldrich, 
St Louis, T4885); Poly-D-lysine (Sigma-Aldrich, St Louis, P7405); cycloheximide 
(Sigma-Aldrich, St Louis, C7698). 
 
Cell culture 
HEK293T, human embryonic kidney cells, HaCaT, spontaneously immortalized 
keratinocytes from adult skin, and Caco-2 human colorectal adenocarcinoma cells, 
were purchased from Cell Line Service (CLS, Germany), cultured in humidified 
incubator at 37°C and 5% CO2, and maintained in DMEM High Glucose (Gibco) 
supplemented with 10% Fetal Bovine Serum (Gibco), 1% L-Glutamine (Gibco) and 
1% Pen-Strep solution (Gibco). 
To increase HEK293T adhesion to glass/plastic surfaces, all plates and slips for 
immunofluorescence were treated with Poly-D-lysine 0.1mg/ml (Sigma-Aldrich, St 
Louis) before seeding cells. 
The zebrafish PAC2 cell line [72] was propagated at 26°C in an atmospheric CO2, 
non-humidified cell culture incubator; cells were cultured in L-15 (Leibovitz) medium 
(Gibco BRL) supplemented with 15% Fetal Bovine Serum (Sigma-Aldrich, St Louis), 
100 units/ml penicillin, 100 µg/ml streptomycin and 50 µg/ml gentamicin (Gibco BRL). 
Cells were routinely checked for mycoplasma contamination, using a mycoplasma 
detention kit (abm, Canada). 
 
Fish care, treatment and ethical statements 
All husbandry and experimental procedures were performed in accordance with 
European Legislation for the Protection of Animals used for Scientific Purposes 
(Directive 2010/63/EU), the German (Animal Protection Law, BGBl. I, 1934, 2010). 
Research was also approved by the Local Government of Baden-Württemberg, 
Karlsruhe, Germany (35-9185.81/G-131/16). General license for fish maintenance 
and breeding: Az.: 35-9185.64.  
Zebrafish (Dario rerio, Tubingen strain) were maintained according to standard 
procedures [73] in a re-circulating water system at 26°C and under 14:10 light:dark 
cycles. For each experiment 6 –12 months old zebrafish males or females were 
used. The caudal fins were amputated using razor blades following anesthesia with 
0.02% w/v MS222 (3- aminobenzoate methanesulfonic acid, Sigma-Aldrich, St 
Louis).  
Stereo-image of caudal fins were acquired using a Zeiss Stemi 305 microscope. 
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Heat Shock treatments in cells and adult zebrafish caudal fins 
Cells cultured in petri dishes were abruptly placed on the surface of a pre-heated 
water bath at the indicated time points and temperatures by floating the Petri dishes 
on a water bath floater (Promega).  
Following heat shock treatment, cells were processed for immunofluorescence 
analysis. For the heat shock recovery experiment, cells were returned to a 26°C 
incubator for the designated time.  
For the analysis of mRNA expression during heat shock treatment, for the time points 
harvested at 3 and 6 hours from the onset of heat shock, the cells were exposed for 
1 hour to heat shock and then returned to a 26 °C incubator for the remainder of the 
time course in order to avoid mortality due to prolonged exposure to the higher 
temperature.  
Fins were gently placed in 2ml Eppendorf filled with complete cell culture medium 
(Leibovitz’s L-15, Gibco BRL) and placed in a pre-warmed water bath at 45°C for the 
designated time or in a cell culture incubator at 26°C as a control.  
 
Immunofluorescence microscopy in zebrafish cells and mammalian cells 
6.0x104 PAC2 cells were seeded on coverslips and maintained in constant darkness 
for the subsequent 48 hours prior to receive the treatment. 3x104 HEK293T cells 
were seeded on Poly-D-lysine pre-treated coverslips, HaCaT and Caco-2 cells were 
seeded on not pre-treated surfaces; the day after cells were treated or left untreated.  
Following treatment, both mammalian and zebrafish cells were gently rinsed with 1X 
PBS and then fixed in PFA 3.7% for 10 and 15’, respectively. After 3 washes with 1X 
PBS (10 minutes each), cells were washed twice with 0.01%Tween-PBS and blocked 
for 1 hour with a 1% BSA-0.01%Tween-PBS solution for PAC2 and with a 3% BSA 
solution for mammalian cells to avoid unspecific binding of antibodies. PAC2 cells 
were then incubated overnight at 4°C with the primary antibodies. Primary antibody 
incubation for mammalian cells was performed for 1 hour in dark at room 
temperature. After incubation with primary antibodies, cells were washed three times 
with 0.01% Tween-PBS (10 minutes each) and incubated with secondary antibodies 
for 45 minutes in darkness. Then, both PAC2 and HaCaT cells were incubated for 5 
minutes in a DAPI solution (1:50000) (Sigma-Aldrich, St Louis) followed by 3 washes 
in 0.01% Tween PBS. Coverslips were immersed in a Dako mounting medium 
(Agilent). 
All images were acquired using a Leica SPE confocal microscopy (63x oil immersion 
objective) or Carl Zeiss LSM 700 (63x oil immersion objective) microscope. Image 
processing and analysis were performed with Fiji (ImageJ) software. 
 
Immunofluorescence microscopy in zebrafish adult caudal fins  
After an overnight fixation of the fin-clips in Carnoy’s solution (60% ethanol, 30% 
chloroform, 10% acetic acid) at 4°C, fins were incubated overnight in 100% Methanol 
and then subjected to sequential rehydration steps of 10’ in 100%, 66% and 33% 
methanol in PBTX (1XPBS, 0.3% Triton X100). At this stage, fins were pre-incubated 
in PBTX plus 1% BSA blocking solution for 3 hours. Then the primary antibody was 
added and the samples were incubated at 4°C overnight. After several washes, 
samples were incubated at 4°C with the secondary fluorescent antibody overnight. 
DAPI staining was used for visualization of nuclei. The samples were mounting on 
glass slides. 
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All images were acquired using a Leica SPE confocal microscopy (63x oil immersion 
objective). Image processing and analysis were performed with Fiji (ImageJ) 
software. 
 
Cell Viability assays   
Cell viability was determined by the crystal violet assay (CVA) method, through a (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide) MTT based assay, or 
through trypan blue count. 
Cells were seeded in 96-well plate for MTT (8x103 cells), in 35mm dishes (2.5x105 
cells) for CVA and in 12-well plates (1.5 x105 cells) for trypan blue. 
The day after plating, cells were treated or not. For crystal violet, dye uptake was 
measured at 570 nm using a spectrophotometer. Cell viability was calculated as dye 
intensity and compared with untreated samples. 
For MTT, the optical absorbance was determined at 570 nm using an iMark 
microplate reader (Bio-Rad, USA). For trypan blue count, after treatment cells were 
gently rinsed with 1X PBS, trypsinized and collected. An aliquot was diluted 1:1 with 
trypan blue (Sigma-Aldrich, St Louis, MO). 
 
Cell cycle analysis 
3 x105 cells were seeded and let grow for 24 hours; then cells were serum starved for 
24 hours to achieve synchronization; the day after cells were treated with 
recombinant YB-1 or CCM-derived-YB-1 or left untreated for 24 hours. Cells were 
then trypsinized, collected in FACS Buffer (1% FBS, 0.25 mM EDTA in PBS) and 
centrifuged at 1200 rpm, 4 minutes, 4°C; for each sample the same number of cells 
(1x105) was processed. The cell pellet was resuspended in methanol, incubated on 
ice for 20 minutes and centrifuged at 1200 rpm, 5 minutes, 4°C. After a wash in 
FACS Buffer PBS, the pellet was incubated in FACS Buffer PBS, containing RNase 
A (Thermo-Fisher Scientific) 100 μg/ml for 20 minutes at RT. Propidium iodide 
(Sigma-Aldrich, St Louis, MO) was then added at a concentration of 50 μg/ml for 30 
minutes at 4°C. Cell cycle analysis was performed on the BD Accuri C6 flow 
cytometer (BD Biosciences).  
 
Cell proliferation analysis  
6 x104 HaCaT and Caco-2 cells were seeded in 12-well plate while HEK293T were 
seeded on pre-treated 12-well; cells were serum starved for 24 hours; after starvation 
recombinant or CCM-derived YB-1 were added at different concentrations. Every 24 
hour cells were gently rinsed with 1X PBS, trypsinized and counted. The count was 
confirmed by Scepter 2.0 analysis (Millipore). 
 
RNA silencing (siRNA) and transfections  
Mammalian cells were transfected using Lipofectamine 2000 (Life Technology) 
according to the manufacturer’s recommendations. Briefly, cells were seeded at 70-
80% confluence (1.5×106) in 100-mm dishes and transiently transfected with different 
concentrations of plasmid (from 800 ng up to 1.5 μg). 
YB-1 transient silencing was carried out with IBONI YB-1siRNA pool (RIBOXX 
GmbH, Germany) and RNAiMAX reagent (Life Technologies, CA, USA), according to 
the manufacturer’s recommendations. Cells were seeded at 70-80% confluence 
(1.5×106) in 100-mm dishes and transiently silenced with IBONI YB1-siRNA at 100 
nM final concentration. 
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All Star Negative Control siRNA, provided by Quiagen (Hilden, Germany), was used 
as negative control.  
PAC2 cells were transfected using Fugene HD (Promega) according to the 
manufacturer’s recommendations. A 4:1 ratio (4 µl of Fugene HD reagent for each µg 
of siRNA) was used. Briefly, cells were seeded at 70-80% confluence (1.5 × 106) in 
100-mm dishes; after 48 hours of incubation in darkness, cells were transiently 
transfected with siRNA (100 nM final concentration). 24 hours after siRNA 
transfection, cells were treated or left untreated. All Star Negative Control siRNA, 
provided by Quiagen (Hilden, Germany), was used as negative control.  
Predesigned siRNAs for YB-1 were purchased from Riboxx (Germany) and listed 
below: 
 
zf YB-1_1 guide 5’-3’  
AUUCUGUCACAUCUCUCCCCC 
passenger  
5’-3’ GGGGGAGAGAUGUGACAGAAUA 
zf YB-1_2 guide 5’-3’  
UUCUCCUUAUCCUCCUCUCCCCC 
 
passenger 5’-3’ 
GGGGGAGAGGAGGAUAAGGAGA 
zf YB-1_3 guide 5’-3’  
UUUGCAAGCUUAGACGAUCCCCC 
passenger 5’-3’ 
GGGGGAGAGGAGGAUAAGGAGAA 
h YB-1(pool) guide 5’-3’ 
UUUAUCUUCUUCAUUGCCGCCCCC 
passenger 5’-3’ 
UUAUUCUUCUUAUGGCAGCCCCC 
h YB-1(pool) guide 5’-3’  
UUCAACAACAUCAAACUCCCCC 
passenger 5’-3’ 
UCAUAUUUCUUCUUGUUGGCCCCC 
 
 
Antibodies  
Primary antibodies: anti-YB-1 raised against the region 1 to 100 of YB-1 protein 
(12148 Abcam); anti-YB-1 raised against amino acids 307-324 of hYB-1 (Sigma-
Aldrich, St Louis, MO, Y0396 C-ter); anti-PABP1 (Sigma-Aldrich, St Louis, MO, clone 
10E10); anti-Myc (Sigma-Aldrich, St Louis, MO, SAB21084786); anti-cyclin D1 
(GT8912, Genetex); anti-cyclin A2 (GT2547, Genetex); anti-GAPDH (6C5 Santa 
Cruz Biotechnology); anti-PARP1 (Cell Signaling); anti-RNH1 (Sigma-Aldrich, St 
Louis, MO 436-450) anti-β-tubulin (H-235, Santa Cruz Biotechnology); anti-actinin 
(AT6/172, Abcam); anti-p21 WAF (1D21 Cell Signaling); anti-DNp63a (4A4) (sc-8431 
Santa Cruz Biotechnology); anti-vinculin (Sigma-Aldrich, St Louis, MO, V9131); anti-
G3BP1 (611127 BD transduction Laboratories, BD Biosciences); anti-Histone H3 
(9715 Cell Signaling). 
Secondary fluorescent antibodies: Alexa Fluor 488 anti-rabbit (ThermoFisher 
Scientific); Alexa Fluor 647 anti-goat (ThermoFisher Scientific); Cy3 anti-mouse 
(Jackson ImmunoResearch); DAPI (Sigma-Aldrich, St Louis, MO D9542). 
 
Immunoblot analysis 
For total protein extraction cells were seeded at 1.5×106 in 100-mm petri dishes. 
After 48 hours the cells were harvested in Lysis Buffer (50 mM Tris-HCl pH 7.5, 5 
mM EDTA, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate) with the addition 
of 1 mM phenylmethylsulfonyl fluoride and protease inhibitor cocktail (Sigma-Aldrich, 
  
63 
St Louis, MO). Cells were dislodged with a scraper and left on ice for 30’. Then 
extracts were clarified by centrifugation at 13200 rpm for 30’ at 4°C.  
For nuclear-cytoplasmic fractionation, cells were seeded 1.5×106 in 100-mm dishes. 
24 hours after seeding, cell lysates were fractionated to obtain cytoplasmic and 
nuclear fractions as previously reported [24]. The amount of protein in the samples 
was determined by the Bio-Rad protein assay (Bio-Rad, Milan, Italy).  
After the addition of Laemmli buffer (Sigma-Aldrich, St Louis, MO) the samples were 
boiled at 100°C for 5 min and resolved by SDS- polyacrylamide gel electrophoresis 
(SDS-PAGE). About 10μg of nuclear and 30μg of cytoplasmic or total extracts (1:3 
rate) were separated by SDS-PAGE. 
The proteins were then transferred to a polyvinylidene difluoride membrane (PDVF, 
Millipore) using a Mini trans-blot apparatus (Bio-Rad, Milan, Italy) according to the 
manufacturer’s instructions. The PVDF membrane was blocked in 5% w/v milk buffer 
(5% w/v non-fat dried milk, 50 mM Tris, 200 mM NaCl, 0.2% Tween 20) and 
incubated overnight at 4°C with primary antibodies diluted in 5% w/v milk or bovine 
serum albumin (BSA) buffer according to the manufacturer’s instructions. Following 
three washes with TTBS (Tris-buffered saline, 0.1 % Tween), the blots were 
incubated for 1 hour at RT with HRP-conjugated secondary antibodies (Sigma-
Aldrich, St Louis, MO). Proteins were visualized by an enhanced chemiluminescence 
method (ECL, Bio-rad) and analysed by Quantity One W software of ChemiDoc TM 
XRS system (Bio-Rad, Milan, Italy). 
 
Co-immunoprecipitation. 
For co-immunoprecipitations (Co-IP) 2×106 HEK293T cells were seeded in Poly-D-
lysine pre-treated 100-mm dishes; the day after cells were treated with Na Ars 
(Sigma-Aldrich, St Louis) 250 µM for 30 minutes; cells extracts were incubated with 
an anti-PABP1 antibody (Sigma-Aldrich, St Louis, MO), 3 μg for 1mg of protein 
extract overnight at 4 °C. The day after Dynabeads Protein G (Invitrogen) were 
added to samples for 4 hrs at 4°C in rotation. Immunoglobulin G (IgG) 3 μg for 1mg 
of protein extract was used as a negative control. Immunocomplexes were resolved 
with SDS-PAGE; immunoblot was performed with anti-YB-1 antibody (bcam).  
 
Trichloroacetic acid precipitation 
HEK293T cells were grown as previously described; 24 hours after seeding cells 
were gently rinsed twice with 1xPBS, and serum starved for 2 hours. After 
treatments, the cell culture medium was filtered through 0.22 µm filters to remove 
floating cells and debris. Scepter 2.0 (Merck, Millipore) was used to determine if cells 
were still present in the collected medium. TCA (Trichloroacetic acid, Sigma-Aldrich, 
St Louis) 25% was added to culture medium in 1:1 ratio, tubes were placed on ice for 
30 min. Samples were then centrifuged at maximum speed at 4°C for 30 min.?
Supernatant was discarded and cold acetone 100% (200 μl per sample), was added 
to tubes, samples were then centrifuged at maximum speed, for 15 minutes, at 4°C. 
This passage was done twice. Acetone was gentle removed and 200uL of diethyl 
ether was added to tubes for 15 minutes on ice. After a centrifuge at maximum speed 
at 4°C for 15 minutes, samples were placed on the block heater in order to evaporate 
diethyl ether. After addition of sample buffer. Samples were denatured in sample 
buffer (Sigma-Aldrich, St Louis, USA) and loaded on the gel. 
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Quantitative Real Time-PCR  
3x105 cells were seeded and let grow for 24 hours; the day after were treated with 
rYB-1 or CCM-YB-1 or left untreated. 
For RT-PCR cells analysis total RNA was isolated using the RNA Extraction Kit from 
Qiagen (Hilden, Germany) according to the manufacturer’s instructions. RNA (2-5μg) 
was treated with DNAse I (Promega, Madison USA) and used to generate reverse 
transcribed cDNA using SuperScript III (Life Technologies, CA, USA), according to 
the manufacturer’s instructions. Real Time PCR with SYBR green (Promega) 
detection was performed with a 7500 RT-PCR Thermo Cycler (Applied Biosystem, 
Foster City, USA. 
Expression levels were normalized using g6pd mRNA expression. Expression levels 
were normalized using zf β-actin and gapdh mRNA expression for zebrafish PAC2 
and human HaCaT cells, respectively. The relative levels of mRNA were calculated 
using the 2−ΔΔCT method. For each gene, primer sequences are presented below: 
 
 
zf β -actin F: GCCTGACGGACAGGTCAT R: ACCGCAAGATTCCATACCC  
zf yb-1 F: TACCCACCATACTTCGTGCG R: GCGGTAGTTGAAGTTGCGAC 
hyYb-1 F: CGCAGTGTAGGAGATGGAGAG R: GAACACCACCAGGACCTGTAA 
zf hsp70 F: AGAGCATTACCCTGATGAAGC R: TAAGTGGTGAAGGTCTGGGTCT 
zfcry1a F: TCCGCTGTGTGTACATCCTC R: CAAACACTGCAGCAAAAACC 
Zfcry5 F: ATGAGCCATAACACCATTCA R TTATCTCTTTGCCTTCTTCTG:  
zf c-fos F: GCTCCATCTCAGTCCCAGAG R: AGAGTGGGCTCCAGATCAGA 
zf junB F: GCTTCGTCAAGGCTCTGGAT R: GTATGTGGGACGGCAGGTAG 
zf junD F: TTACACGAACTTGAGCGCCT R: CGGTTACGCAGCTTCTTCCT 
zf gapdh F: CGACCACTTTGTCAAGCTCA R: TTCCTCTTGTGCTCTTGCTG 
h p21waf F: GCTAAGGTTTACCTGGGGTCTTA R: GTGGCTCTGATTGGCTTTCTG  
h Dnp63a F: GGTTGGCAAAATCCTGGAG  R: GGTTCGTGTACTGTGGCTCA 
h gapdh F: ACCCAGAAGACTGTGGATGG R: TTCTAGACGGCAGGTCAGGT 
 
 
Preparation of bacterial expression vector pET22b(+)/YB-1 
Human YB-1 cDNA sequence was amplified with a PCR reaction from recombinant 
vector pEX-A2 (Eurofins Genomics, Edersberg, Germany ).PCR has been carried out 
using following primers: forward 5’- CCCATATGAGCAGCGAGGCCGAGACCC-3’; 
reverse 5’- GGAAGCTTGCCTCGGGAGCGGGAA-3’. Bold and underlined 
sequences refer to restriction sites (NdeI and HindIII), designed to permit the 
insertion of YB-1 coding sequence upstream to a His-Tag sequence to facilitate the 
purification of the recombinant protein. The PCR reaction was carried out in a total 
volume of 50 μl containing 60 ng of each primer, 20 ng of template, 
deoxyribonucleotides (dNTPs) containing 0.2 mM of each dNTP, 5 μl 10Χ Taq buffer 
and 1.5 units of Taq DNA polymerase (EuroClone, Milan, Italy). PCR was performed 
under the following conditions: an initial denaturation step at 98°C for 5 minutes, 
followed by 38 cycles of 30 seconds at 98 °C, 1 minute at 65 °C, and 2 minute at 72 
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°C. PCR products were then isolated by electrophoresis on 1% agarose gel, and 
purified using the Product Purification Kit (Roche Applied Science, Monza, Italy). 
Purified DNA, treated with NdeI and HindIII restriction enzymes, was inserted into the 
pET22b (+) expression vector by ligation reaction catalysed by T4 DNA ligase 
(ThermoFisher Scientific). All cloned, purified DNAs were certified through 
sequencing (Eurofins Genomics Edersberg, Germany) before processing. The 
recombinant expression plasmid, was used then to transform competent E. coli strain 
BL21(DE3) (New England BioLabs, Ipswich, Massachusetts, United States). 
 
Recombinant YB-1 protein preparation 
The expression plasmid pET22b(+)/YB-1 was used to transform competent E. coli 
strain BL21(DE3) cells. Cells were grown at 37 °C to an A600 nm = 0.7, and then 
induced with 0.6 mM isopropyl-1-thio-d-galactopyranoside (IPTG) and grown 
overnight. The expression level of recombinant YB-1 (rYB-1) was estimated 
performing a western blot on two bacterial aliquots collected before the addiction of 
IPTG and after 16 hrs respectively. Bacterial cells were then harvested by 
centrifugation (7000 rpm, 4°C, 15 min), re-suspended in 100 mM Tris acetate buffer 
(pH 8.0) and subjected to sonication in presence of protease inhibitors. Cell debris 
and precipitated proteins were removed by centrifugation (17500 g, 1 hour) whereas 
the supernatant was subjected to at least three washes in 100 mM Tris acetate pH 
8.0 and finally centrifuged to separate inclusion bodies and cytosolic soluble fraction, 
the latter containing rYB-1.  
 
Chromatographic procedures 
rYB1 was purified performing a two-step procedure composed by an affinity 
chromatography followed by a reverse phase chromatography.  
Affinity chromatography was carried out on HisTrap resin (GE Healthcare) 
equilibrated with 100 mM Tris acetate pH 8.0 containing 20 mM imidazole. Elution 
was carried out by using 100 mM Tris acetate pH 8.0 containing 500 mM imidazole 
and spectrophotometrically monitored at 280 nm. Reverse phase chromatography 
was performed on a HPLC device Series 200 (Perkin Elmer, Waltham, 
Massachusetts, United States) by using a C4 column (Dr. Maisch GmbH, 
Ammerbuch-Entringen Germany), 0.1% TFA in 5% acetonitrile as buffer A and 0.1% 
TFA in 95% acetonitrile as buffer B. Elution was performed by setting a linear 
gradient 5-95% buffer B in 60 min and spectrophotometrically monitored at 278 nm. 
 
Protein separation by SDS-PAGE and in situ digestion 
Proteins precipitated from culture medium were separated by 12% SDS-PAGE, 
under reducing conditions. Proteins were visualized by colloidal Coomassie brilliant 
blue and the immunopositive bands were excised, also depending on the 
visualization of bands at expected molecular weight. Each band was subjected to in 
situ digestion protocol by reducing proteins by 10 mM DTT and alkylation with 55 mM 
iodoacetamide, according to the established protocol. Finally, each dry gel piece was 
rehydrated in 40 μL of 10 mM ammonium bicarbonate solution containing 200 ng of 
Trypsin Gold, Mass Spectrometry grade (Promega, Madison, USA), and incubated at 
37 °C overnight. The trypsinolysis was stopped with 0.1% formic acid (FA), and 
tryptic peptides were eluted, vacuum dried, and dissolved in 0.1% formic acid for 
LC−MS/MS analysis. 
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LTQ-Orbitrap analysis 
Peptides were separated on a 1.7-μm BEH C18 column (Waters Corporation, USA) 
at a flow rate of 280 nL/min by using as mobile phase solution A: 95% water, 5% 
Acetonitrile, 0.1% acetic acid; solution B: 95% Acetonitrile, 5% water, 0.1% acetic 
acid. Peptide elution was achieved along a linear gradient of B from 20% to 90% over 
53 min. MS and MS/MS data were acquired on an Orbitrap LTQ XL high-
performance liquid chromatography MS system (Thermo-Scientific, Waltham, MA, 
USA) equipped with an electrospray source (ESI). The full scan precursor MS 
spectra (400−1600 m/z) were acquired in the Velos-Orbitrap analyser with a 
resolution of r = 60000. This was followed by data dependent MS/MS fragmentation 
in centroid mode of the most intense ion from the survey scan using collision-induced 
dissociation (CID) in the linear ion trap: normalized collision energy 35%; activation Q 
0.25; electrospray voltage 1.4 kV; capillary temperature 200 °C; and isolation width 
2.00. The targeted ions were dynamically excluded for 30 s, and this MS/MS scan 
event was repeated for the top 20 peaks in the MS survey scan. The five most 
intense doubly and triply charged peptide ions were selected and fragmented. The 
resulting MS data were processed by MS Converter General User Interface software 
(ProteoWizard) to generate peak lists for protein identifications. Database searches 
were carried out on the Mascot Deamon version 4.1 by Matrix Science (London, UK). 
The SwissProt database (release January 2017, 547599 sequences; 195014757 
residues) was employed (settings: two missed cleavages; carbamidomethyl (C) as 
fixed modification and Oxidation (M), Phospho (ST), Phospho (Y), Acetyl (K), Gln-
>pyro-Glu (N-term Q), Glu->pyro-Glu (N-term E) as variable modifications; peptide 
tolerance of 10 ppm and fragment mass tolerance of ± 0.6 Da). 
 
Statistical Analysis ?
Statistical analyses were performed using GraphPad Prism7 (GraphPad Software 
Inc). Statistical significance of difference in measured variables between control and 
treated groups was determined by t-test or analysis of variance (ANOVA) followed by 
Tukey’s or Dunnett’s multiple comparisons post-test. To report p-values, the NEJM 
(New England Journal of Medicine) decimal format was used; differences were 
considered statistically significant at *P<0.033, **P<0.002 and ***P<0.001.  
Detailed statistical information are shown in Appendix II, Table 1. 
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APPENDIX II  
Supplementary material 
Table 1. Statistical analysis. 
Figure/experiment Test method Significance n 
Figure 6b - Granules size (left panel) 1 way ANOVA, α = 0.05 F = 21.12; P <0.001*** 5 
Ctrl. vs Na Ars Dunnett's multiple 
comparisons test 
P <0.001***   
Ctrl. vs H2O2 - P <0.001***   
Ctrl. vs Heat Shock - P = 0.01*   
Figure 6b - Granules per cell (right panel) 1 way ANOVA, α = 0.05 F = 31.3; P <0.001*** 3 
Na Ars vs. Ctrl. Dunnett's multiple 
comparisons test 
P = 0.03*   
H2O2 vs. Ctrl. - P <0.001***   
Heat Shock vs. Ctrl. - P <0.001***   
Figure 8b - Granules size (left panel) Unpaired t-test  
with Welch's correction 
F = 1.397; P = 0.02* 20 
siYB-1 vs. siNC (control) Two-tailed, α = 0.05     
Figure 8b - Granules per cell (right panel) Unpaired t-test  
with Welch's correction 
F = 1.254; P = 0.01** 6 
siYB-1 vs. siNC (control) Two-tailed, α = 0.05     
Figure 10a - MTT assay 30' 1 way ANOVA, α = 0.05 F = 1.409; P = 0.27 ns 6 
Ctrl. vs. 250 µM Na Ars Dunnett's multiple 
comparisons test 
P = 0.90 ns   
Ctr. vs. 500 µM H2O2 - P = 0.22 ns   
Figure 10a - MTT assay 60' 1 way ANOVA, α = 0.05 F = 1.198; P = 0.33 ns 6 
Ctrl. vs. 250 µM Na Ars Dunnett's multiple 
comparisons test 
P = 0.45 ns   
Ctr. vs. 500 µM H2O2 - P = 0.26 ns   
Figure 10b - Trypan blue 30' 1 way ANOVA, α = 0.05 F = 1.079; P = 0.40 ns 3 
Ctrl. vs. 250 µM Na Ars Dunnett's multiple 
comparisons test 
P = 0.57 ns   
Ctr. vs. 500 µM H2O2 - P = 0.32 ns   
Figure 10b - Trypan blue 60' 1 way ANOVA, α = 0.05 F = 0.2497; P = 0.79 
ns 
3 
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Ctrl. vs. 250 µM Na Ars Dunnett's multiple 
comparisons test 
P = 0.82 ns   
Ctr. vs. 500 µM H2O2 - P = 0.74 ns   
Figure 14 - HEK293T/HEK239T YB-1-GFP 
proliferation curve 
2 way ANOVA, α = 0.05  6 
Time (h)  F = 1031; P <0.001***   
Cell line  F = 0.3737; P =0.54 ns   
Interaction (Time vs. Cell line)  F = 67.97; P <0.001***   
HEK293T vs. HEK293T YB-1-GFP Sidak's multiple comparison 
test 
   
0 h - P >0.99 ns   
24 h - P = 0.25 ns   
48 h - P <0.001***   
72 h - P <0.001***   
96 h - P <0.001***   
Figure 17a - HEK293T/HEK239T YB-1-GFP  
MTT assay 
2 way ANOVA, α = 0.05  6 
Treatment (H2O2)  F = 1136; P <0.001***   
Cell line  F = 43.62; P <0.001***   
Interaction (Treatment vs. Cell line)  F = 4.174; P = 0.003**   
HEK293T vs. HEK293T YB-1-GFP Sidak's multiple comparison 
test 
   
Ctrl. - P >0.99 ns   
H2O2 0.5 mM - P = 0.010**   
H2O2 1 mM - P = 0.71 ns   
H2O2 2.5 mM - P = 0.29 ns   
H2O2 5 mM - P <0.001***   
H2O2 7.5 mM - P = 0.002**   
Figure 17b - HEK293T/HEK239T YB-1-GFP 
 Trypan Blue 
2 way ANOVA, α = 0.05  6 
Treatment (H2O2)  F = 695.1; P <0.001***   
Cell line  F = 493.3; P <0.001***   
Interaction (Treatment vs. Cell line)  F = 47.13; P <0.001***   
HEK293T vs. HEK293T YB-1-GFP Sidak's multiple comparison 
test 
   
Ctrl. - P >0.99 ns   
H2O2 0.5 mM - P <0.001***   
H2O2 1 mM - P <0.001***   
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H2O2 2.5 mM - P <0.001***   
H2O2 5 mM - P <0.001***   
H2O2 7.5 mM - P <0.001***   
Figure 23a - HaCaT proliferation curve 2 way ANOVA, α = 0.05  3 
Time (h)  F = 3.56; P = 0.04*   
Treatment (CCM-YB-1)  F = 46; P <0.001***   
Interaction (Time vs. CCM-YB-1)  F = 11.63; P <0.001***   
Ctrl. vs. 5 µg/ml Dunnett's multiple 
comparisons test 
P <0.001***   
Ctrl. vs. 7.5 µg/ml - P <0.001***   
Ctrl. vs. 10 µg/ml - P <0.001***   
Figure 23b - HaCaT proliferation curve 2 way ANOVA, α = 0.05  3 
Time (h)  F = 7.866; P = 0.002**   
Treatment (rYB-1)  F = 18.34; P<0.001***   
Interaction (Time vs. rYB-1)  F = 6.075; P<0.001***   
Ctrl. vs. 5 µg/ml Dunnett's multiple 
comparisons test 
P <0.001***   
Ctrl. vs. 7.5 µg/ml - P <0.001***   
Ctrl. vs. 10 µg/ml - P <0.001***  
 
  
    
 
Figure 23c - HaCaT proliferation curve 2 way ANOVA, α = 0.05  3 
Time (h)  F = 286.9; P 
<0.001*** 
  
Treatment (BSA)  F = 0.3106; P = 0.82 
ns 
  
Interaction (Time vs. BSA)  F = 0.3227; P = 0.92 
ns 
  
Ctrl. vs. 5 µg/ml Dunnett's multiple comparisons 
test 
P = 0.96 ns   
Ctrl. vs. 7.5 µg/ml - P >0.99 ns   
Ctrl. vs. 10 µg/ml - P = 0.91 ns   
Figure 23d - Crystal Violet Assay (48) 1 way ANOVA, α = 0.05 F = 400.9; P 
<0.001*** 
3 
Ctrl. vs. BSA 7.5 µg/ml Dunnett's multiple comparisons 
test 
P = 0.10 ns   
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Ctrl. vs. rYB-1 7.5 µg/ml - P <0.001***   
Ctrl. vs. CCM-YB-1 7.5 µg/ml - P <0.001***   
Figure 24a - HEK293T prol. curve (upper 
panel) 
2 way ANOVA, α = 0.05  3 
Time (h)  F = 188.8; P 
<0.001*** 
  
Treatment (rYB-1)  F = 6.809; P = 
0.002** 
  
Interaction (Time vs rYB-1)  F = 2.314; P = 0.07 
ns 
  
Ctrl. vs. 5 µg/ml Dunnett's multiple comparisons 
test 
P = 0.03*   
Ctrl. vs. 7.5 µg/ml - P = 0.01*   
Ctrl. vs. 10 µg/ml - P <0.001***   
Figure 24a - HEK293T prol. curve  
(lower panel) 
2 way ANOVA, α = 0.05  3 
Time (h)  F = 3.273; P = 0.06 
ns 
  
Treatment (CCM-YB-1)  F = 52.45; P 
<0.001*** 
  
Interaction (Time vs CCM-YB-1)  F = 13.72; P 
<0.001*** 
  
Ctrl. vs. 5 µg/ml Dunnett's multiple comparisons 
test 
P <0.001***   
Ctrl. vs. 7.5 µg/ml - P <0.001***   
Ctrl. vs. 10 µg/ml - P <0.001***   
Figure 24b - CaCo2 prol. curve (upper 
panel) 
2 way ANOVA, α = 0.05  3 
Time (h)  F = 118.8; P 
<0.001*** 
  
Treatment (rYB-1)  F = 5.012; P = 
0.008** 
  
Interaction (Time vs rYB-1)  F = 4.796; P = 
0.002** 
  
Ctrl. vs. 5 µg/ml Dunnett's multiple comparisons 
test 
P = 0.20 ns   
Ctrl. vs. 7.5 µg/ml - P = 0.003**   
Ctrl. vs. 10 µg/ml - P = 0.03*   
Figure 24b - CaCo2 prol. curve (lower panel) 2 way ANOVA, α = 0.05  3 
Time (h)  F = 2.775; P = 0.08 
ns 
  
Treatment (CCM-YB-1)  F = 27.54; P 
<0.001*** 
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Interaction (Time vs CCM-YB-1)  F = 6.682; P 
<0.001*** 
  
Ctrl. vs. 5 µg/ml Dunnett's multiple comparisons 
test 
P <0.001***   
Ctrl. vs. 7.5 µg/ml - P <0.001***   
Ctrl. vs. 10 µg/ml - P <0.001***   
Figure 25a - HaCaT cell cycle distribution 
(48h) 
2 way ANOVA, α = 0.05  3 
Cell phase   F = 1025; P <0.001***   
Treatment   F = 0.02836; P = 0.97 
ns 
  
Interaction (Cell phase vs. Treatment)  F = 257.4; P 
<0.001*** 
  
G1 - Ctrl. vs. rYB-1 7.5 µg/ml Dunnett's multiple comparisons 
test 
P = 0.89 ns   
G1 - Ctrl. vs. CCM-YB-1 7.5 µg/ml - P <0.001***   
S - Ctrl. vs. rYB-1 7.5 µg/ml - P <0.001***   
S - Ctrl. vs. CCM-YB-1 7.5 µg/ml - P = 0.01*   
G2 - Ctrl. vs. rYB-1 7.5 µg/ml - P <0.001***   
G2 - Ctrl. vs. CCM-YB-1 7.5 µg/ml - P <0.001***   
Figure 25b - RT-qPCR p21waf (upper panel) 1 way ANOVA, α = 0.05 F = 50.98; P 
<0.001*** 
3 
Ctrl. vs. BSA 7.5 µg/ml Dunnett's multiple comparisons 
test 
P = 0.71 ns   
Ctrl. vs. rYB-1 7.5 µg/ml - P = 0.03*   
Ctrl. vs. CCM-YB-1 7.5 µg/ml - P <0.001***   
Figure 25b - RT-qPCR ΔNp63α (lower 
panel) 
1 way ANOVA, α = 0.05 F = 210.6; P 
<0.001*** 
3 
Ctrl. vs. BSA 7.5 µg/ml Dunnett's multiple comparisons 
test 
P = 0.23 ns   
Ctrl. vs. rYB-1 7.5 µg/ml - P = 0.07 ns   
Ctrl. vs. CCM-YB-1 7.5 µg/ml - P <0.001***   
Figure 30a – PAC2 MTT assay 1 way ANOVA, α = 0.05 F = 0.7438; P = 0.57 
ns 
6 
Ctrl 26°C vs. 45°C 30' Dunnett's multiple comparison 
test 
P >0.99 ns   
Ctrl 26°C vs. 45°C 45' - P = 0.95 ns   
Ctrl 26°C vs. 45°C 60' - P = 0.73 ns   
Ctrl 26°C vs. 45°C 90' - P = 0.46 ns   
Figure 30b – RT-qPCR (zf hsp70) 2-way ANOVA, α = 0.05  3 
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Interaction  F = 54.61; P 
<0.001*** 
  
Time (h)  F = 345.2; P 
<0.001*** 
  
Temperature °C  F = 186; P <0.001***   
0' - 26°C vs. 37°C Dunnett's multiple comparison 
test 
P >0.99 ns   
0' - 26°C vs. 42°C - P = 0.96 ns   
0' - 26°C vs. 45°C - P = 0.96 ns   
30' - 26°C vs. 37°C - P <0.001***   
30' - 26°C vs. 42°C - P <0.001***   
30' - 26°C vs. 45°C - P = 0.005**   
1h' - 26°C vs. 37°C - P <0.001***   
1h' - 26°C vs. 42°C - P <0.001***   
1h' - 26°C vs. 45°C - P <0.001***   
Figure 30c – RT-qPCR (zf yb-1) 2-way ANOVA, α = 0.05  3 
Interaction  F = 16.54; P 
<0.001*** 
  
Time (h)  F = 25.61; P 
<0.001*** 
  
Temperature °C  F = 90.44; P 
<0.001*** 
  
26°C vs. 45°C Sidak's multiple comparison 
test 
   
0' - P >0.99 ns   
30' - P = 0.45 ns   
1h - P = 0.1 ns   
3h - P <0.001***   
6h - P <0.001***   
Figure 30d – RT-qPCR (h yb-1)  2-way ANOVA, α = 0.05  3 
Interaction  F = 2.995; P <0.04*   
Time (h)  F = 2.792; P <0.05 ns   
Temperature °C  F = 14.53; P <0.001**   
37°C vs. 45°C Sidak's multiple comparison 
test 
   
0' - P = 0.92 ns   
30' - P = 0.01*   
1h - P = 0.03*   
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3h - P = 0.38 ns   
6h - P = 0.82 ns   
Figure 31b – Aggregate size (µm)  Unpaired t-test with Welch's 
correction 
P = 0.007** 3 
  Two-tailed, α = 0.05     
Figure 32c – Aggregate size (µm) 1 way ANOVA, α = 0.05 F = 52.54; P 
<0.001*** 
3 
26°C vs. 37°C Dunnett's multiple comparisons 
test 
P >0.99 ns   
26°C  vs. 40°C - P >0.99 ns   
26°C  vs. 42°C - P = 0.50 ns   
26°C  vs. 45°C - P <0.001***   
Figure 33c – left part (white bars) 1 way ANOVA, α = 0.05 F = 87.27; P 
<0.001*** 
3 
Ctrl 26°C vs 45°C 30' Dunnett's multiple comparisons 
test 
P = 0.30 ns   
Ctrl 26°C vs 45°C 45' - P <0.001***   
Ctrl 26°C vs 45°C 60' - P <0.001***   
Ctrl 26°C vs 45°C 90' - P <0.001***   
Figure 33c – right part (black bars) 1 way ANOVA, α = 0.05 F = 45.77; P 
<0.001*** 
3 
Ctrl 45°C 45' vs Rec 26°C 15' Dunnett's multiple comparison 
test 
P <0.001***   
Ctrl 45°C 45' vs Rec 26°C 30' - P <0.001***   
Ctrl 45°C 45' vs Rec 26°C 60' - P <0.001***   
Figure 35d – Aggregate size (µm)  1 way ANOVA, α = 0.05 F = 157.7; P 
<0.001*** 
3 
Ctrl 45°C 45' vs Rec 26°C 15' Dunnett's multiple comparisons 
test 
P <0.001***   
Ctrl 45°C 45' vs Rec 26°C 30' - P <0.001***   
Ctrl 45°C 45' vs Rec 26°C 60' - P <0.001***   
Figure 35c – Aggregate size (µm)  1 way ANOVA, α = 0.05 F = 60.78; P 
<0.001*** 
3 
Ctrl vs. CHX  Tukey's multiple comparison 
test 
P = 0.46 ns   
Ctrl vs. HS 45°C 45' - P <0.001***   
Ctrl vs. CHX + HS - P = 0.005**   
CHX vs. HS 45°C 45' - P = 0.002**   
CHX 20 µg/mL vs. CHX + HS - P = 0.01*   
HS 45°C 45' vs. CHX + HS - P = 0.05*   
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Figure 36c – MTT assay 1 way ANOVA, α = 0.05 F = 17.19; P 
<0.001*** 
3 
Ctrl 26°C vs. siYB-1 26°C Tukey's multiple comparison 
test 
P = 0.38 ns   
Ctrl 26°C vs. Ctrl 45°C - P = 0.85 ns   
Ctrl 26°C vs. siYB-1 45°C  - P <0.001***   
siYB-1 26°C vs. Ctrl 45°C - P = 0.84 ns   
siYB-1 26°C vs. siYB-1 45°C - P <0.001***   
Ctrl 45°C vs. siYB-1 45°C  - P <0.001***   
Figure 38b – RT-qPCR (zf c-fos) 1 way ANOVA, α = 0.05 F = 13.24; P 
<0.001*** 
3 
0 vs. 30' Dunnett's multiple comparison 
test 
P = 0.01*   
0 vs. 1h - P = 0.02*   
0 vs. 3h - P = 0.46 ns   
0 vs. 6h - P = 0.42 ns   
0 vs. 9h - P = 0.33 ns   
Figure 38b – RT-qPCR (zf jun-B) 1 way ANOVA, α = 0.05 F = 93.63; P 
<0.001*** 
3 
0 vs. 30' Dunnett's multiple comparison 
test 
P <0.001***   
0 vs. 1h - P <0.001***   
0 vs. 3h - P = 0.54 ns   
0 vs. 6h - P = 0.91 ns   
0 vs. 9h - P >0.99 ns   
Figure 38b – RT-qPCR (zf jun-D) 1 way ANOVA, α = 0.05 F = 114.9; P 
<0.001*** 
3 
0 vs. 30' Dunnett's multiple comparison 
test 
P <0.001***   
0 vs. 1h - P <0.001***   
0 vs. 3h - P = 0.01*   
0 vs. 6h - P = 0.02*   
0 vs. 9h - P = 0.04*   
Figure 38b – RT-qPCR (zf cry1a) 1 way ANOVA, α = 0.05 F = 90.13; P 
<0.001*** 
3 
0 vs. 30' Dunnett's multiple comparison 
test 
P = 0.99 ns   
0 vs. 1h - P <0.001***   
0 vs. 3h - P <0.001***   
0 vs. 6h - P <0.001***   
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Figure 38b – RT-qPCR (zf cry5) 1 way ANOVA, α = 0.05 F = 16.53; P 
<0.001*** 
3 
0 vs. 30' Dunnett's multiple comparison 
test 
P = 0.85 ns   
0 vs. 1h - P = 0.002**   
0 vs. 3h - P = 0.001**   
0 vs. 6h - P <0.001***   
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Table 2. MSMs analysis or rYB-1 and CCM-YB-1. 
Peptides with relative score, sequence and modifications obtained after MS and 
MSMS analysis on YB-1 putative bands. Rec1 and Rec2 correspond to rYB-1; S1 
and S2 correspond to CCM-YB-1 (see Figure 22 in the text).
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Introduction
Y-box binding protein1 (YB-1) is a member of the evolution-arily conserved cold shock domain (CSD) proteins and was first identified as a DNA/RNA binding protein [1] involved in the control 
of gene expression at both transcriptional and translational level [2-4]. Given its multiple cellular functions, YB-1 is involved in the 
control of severalbiological processes including cell proliferation 
and migration. To properly perform its functions, YB-1 subcellu-lar localization has to be finely regulated. Specific nuclear export (NES), nuclear localization (NLS) and cytoplasmic retention signals (CRS) contribute and direct the multifunctional tasking of YB-1 [5]. 
In normal resting cells, YB-1 localizes to cytoplasm where it is a 
majorcomponent of P-bodies and messenger ribonucleoproteins (mRNPs) [6]. Recent studies link YB-1 tothe cellular response tooxidative stress and DNA repair mechanisms. Indeed, following 
acute oxidative stress, YB-1 localizes to cytoplasmic Stress Granules 
(SGs), organelle-likestructures devoid of membranes engagedin mRNA sorting and pro-survival translational reprogramming [7,8]. 
In particular, YB-1 is recruited in TIA-containing Stress Granules 
(SGs) where it functions as a component of translationally inactive mRNPs todirectly block translational initiation of highly expressed [9]. Following DNA damage, YB-1 translocates to the nucleus an-dassociates with DNA repair protein complexes. Here we report the characterization of a stable pool of HEK293T cellsconstitutively ex 
 
pressing YB-1 as a GFP fusion protein enabling sensitiveanalysis of 
YB-subcellular localization by confocal microscopy.
Methodology
Cell Culture: HEK293T, human embryonic kidney cells were purchased from Cell LineService (CLS, Germany). Cells were cul-tured in humidified incubator at 37°C and 5% CO
2
 and maintained in DMEM High Glucose (Gibco) supplemented with10% Fetal Bo-vine Serum (Gibco), 1% L-Glutammine (Gibco) and 1% Pen-Strep-solution (Gibco). For HEK293T YB-1-GFP and HEK293T GFP, blas-ticidin(Sigma-Aldrich, St Louis, MO) and G418(Sigma-Aldrich, St Louis, MO)antibiotics were added in the medium to a final concen-tration of 5μg/ml.
Plasmids: The expression construct pcDNA6V5/HIS-A-YB-1-GFP derived from pcDNATM3.1(+) (Invitrogen); pcDNA 3.1HIS-C was purchased from Thermo Fischer Scientific (USA). peGFP-C1 was purchased from Clontech(USA).
Transfections: Cells were transfected using Lipofectamine 2000 (Life Technology) according to the manufacturer’s instruc-tions. Briefly, cells were seeded at 70-80% confluence (1.5 × 106) in 
100mm dishes and transiently transfected with different concen-trations of plasmid (from 800ng upto 1,5μg).
AbstractUsing fluorescent proteins as imaging probes is a wide spread and versatile technique in microscopy. GFP tagged proteins can be used 
to track and examine real time localization, interactions and translocation of proteins of interest as well as to investigate several aspects 
of cell biology. The Y-box binding protein 1 (YB-1) is a pleiotropic protein involved in a widenumber of cellular processes and a substantial 
amount of knowledge on YB-1 localization and function was produced using YB-1-GFP constructs. Recently, it has been shown that YB-1 plays a 
critical role in cell stress response, playing an important role in the formation of stress granules (SG). To deeply investigate on this subject, we produced a stable HEK293T cell line constitutively expressing YB-1-GFP. In physiological conditions YB-1-GFP expressing cells behaved like the parental cells and YB-1-GFP protein properly localized to the cytoplasmic compartment. However, upon oxidative insult we observed a strong reduction in cell viability along with the occurrence of unusual GFP positive aggregates. Taken together, our findings suggest tocritically revise 
existing insights obtained with YB-1-GFP construct and, morein general, to beware and be critical in interpreting data obtained withfunctionally 
uncharacterized GFP fusion proteins.
Keywords: GFP; Stress Granules; Oxidative Stress; Stable Cell Line
Abbreviations: CSD: Cold Shock Domain; NES: Specific Nuclear Export; NLS: Nuclear Localization; CRS: Cytoplasmic Retention Signals; SG: Stress Granules; RNP: Ribonucleoproteins; CLS: Cell Line Service; mRNPs: Messenger Ribonucleoproteins
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Generation of YB1-GFP Stable Clones: HEK293T cells were 
tested for their sensitivity to blasticidin in order to determine the 
best concentration for a correct selection. Concentrations of 2,5, 8, 
10 and 12mg/ml were tested. Controls start to die from the day af-
ter the addition of the higher blasticidin concentration up to 3 days 
for the lower antibiotic concentration. The concentration chosen for selection was 5mg/ml. HEK293T cells were seeded in 100mm dishes (Corning) and let grow to reach 80% confluence. Cells were transfected by lipofectamine with pcDNA6/V5-HISA encoding hu-
man YB-1-GFP bearing the gene for blasticidin resistance or with pcDNA3.1/His C control plasmid. After 48 hours from transfection, blasticidin was added to plates at a final concentration of 5mg/ml. Aspreviously observed, pcDNA3.1/His C transfected cells start to 
die after 3 daysof selection. After one week of selection cells were 
tripsynized and replated and after two weeks of selection stable 
clones were obtained.
nflrescence icrscǣ 3x104 HEK293T, HEK293T GFP and HEK293T YB-1-GFP cells were seeded onpoly-D-lysine 
pre-treated coverslips (12mm thickness); the day after, cells were treated or not with H
2
O
2
 (Sigma-Aldrich, St Louis, MO). At the end 
of treatment cells were gently rinsed with 1X PBS before adding PFA at 3,4% for 10 minutes to fix cells; after 3 washes with 1X PBS cells were permeabilized by adding 0.5% Triton X-100-PBS for five 
minutes; then, after 3 washes with 1X PBS, cells were blocked to avoid unspecific binding of antibodies with a 3% BSA solution for 
20 minutes. Primary antibodies were added for 1hour (dilution range1:200); after incubation, three washes with 0.05% Tween PBS were performed; then Alexa Fluor 488 (Life Technologies) and Cy3 (Jackson Immuno Research, USA) secondary antibodies were add-ed for 45 minutes in dark; after 3 washes in 0.05% Tween PBS cov-er-slips were immersed in a glycerol PBS solution and fixed. Direct eGFP signal was acquired without the addiction of fluorescent dyes. Images were acquired using a Carl Zeiss LSM700 equipped with an axio Observer Z1 or with a Nikon TE Eclipse 2000. Image process-
ing and analysis were performed with Fiji (ImageJ) software.
Cell Viability Assay: Cell viability was determined by the MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay (Sigma-Aldrich, St Louis, MO) as previously described [10]. 
Cells were seeded in 96-well plate at the cell density of 2 x103; the day after cells were treated or not with H
2
O
2
. After treatment, cell 
medium was substituted with DMEM without phenol-red (GIBCO) 
and without supplements; MTT solution was added to cells to pro-
duce formazan crystals. After 2hrs MTT solution was substituted by 
acidic isopropanol to solubilize theformazan crystals. The optical 
absorbancewas determined at 570nm using an iMark microplate reader (Bio-Rad, USA). The experiments were carriedout intripli-
cate for each experimental point and reported as percentage of the 
untreated control set at 1.0.
Trypan Blue Assay: Cells were seeded on poly-D-lysine 
pre-treated 12 well plates at 2,5 x105. The day after plating, cells 
were treated or not; after treatment cells weregently rinsed with 1X PBS, trypsinized andcollected. An aliquot was diluted 1:1 with trypan blue (Sigma-Aldrich, St Louis, MO). The experiments were 
carried out in triplicate for each experimental point.
Cell Proliferation Analysis: Cells were seeded on poly-D-ly-
sine pre-treated 12-well plates at 2,5 x105. Every 24 hours cells 
were gently rinsed with 1X PBS, trypsinized and counted in a Burk-er chamber. The count was confirmed with analysis by a Scepter 
2.0(Millipore). The experiments were carried out in triplicate for 
each experimental point.
Immunoblot Analysis: Cells were seeded at 60% confluence (1.5 × 106) in 100mm plates; the day after, plates were gently rinsed with 1X PBS, and collected in Lysis Buffer (50mM Tris-HCl pH 7.5, 5mM EDTA, 150mMNaCl, 1% NP-40, 1Mm phenylmethylsulphon-yl fluoride, 0.5% sodium deoxycholate, and protease inhibitors). 
Cells were then left on ice for 30 minutes, and crude extracts were 
obtained following centrifugation at 13200rpm for 30 minutes at 4°C. Theamount of protein in the samples was determined by the 
Bio-Rad protein assay (Bio-Rad, Milan, Italy). After the addition of Laemmli buffer (Sigma Chemical Co, St. Louis, MO, USA) the samples were boiled at 100°C for 5min and resolved by SDS- polyacrylamide 
gel electrophoresis (SDS-PAGE). The proteins werethen transferred to a polyvinylidene difluoride membrane (PDVF, Millipore) using a 
Mini trans-blot apparatus (Bio-Rad, Milan, Italy) according to the manufacturer’s instructions. The PVDF membrane was blocked in 5%w/v milkbuffer (5%w/v non-fat dried milk, 50mMTris, 200mM NaCl, 0.2% Tween 20) and incubated with primary antibodies di-luted in 5% w/v milk or bovine serum albumin (BSA) buffer over-night at 4°C. The blots, washed three timeswith TTBS (Tris-buff-eredsaline, 0.1%Tween), were incubated for 1 hour atRT with HRP-conjugated secondary antibodies (SigmaAldrich). Proteins were visualized by an enhanced chemi luminescence method (ECL, GE-Healthcare) and analyzed by Quantity One W software of Chem-
iDoc TM XRS system (Bio-Rad, Milan, Italy).
Primary Antibodies: Anti-YB-1 (Abcam, UK); anti-PABP (Sig-ma-Aldrich, St Louis, MO); anti-GAPDH(Santa Cruz Biotechnology, USA) (Table 1).
Table 1: Statistical analysis.
Panel Experiment Test Method Siinificance n
Panel c (proliferation 
curve)
Cell line vs. time 2 way ANOVA Time(h)
Cell line 
Interaction Sidak’s multiple comparison 
test
F =1031; p<0,00*** F=0,3737; p=0,54 ns 
F=67,97; p<0,001***
6
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HEK293T vs. HEK293T 
YB-1-GFP
0 h - P>0,99 ns24h - P=0,25 ns48h - P<0.001***
72h - P<0,001***
96h - P<0,001***
Panel E (Trypan blue count)
2-way ANOVA Time(h) 
Cell line 
Interaction Sidak’s multiple comparison 
test
F=695,1; P<0,001*** F=493,3; P<0,001*** F=47,13; P<0,001*** 3
HEK293T vs. HEK293T 
YB-1-GFP
Control - P>0,99 nsHydrogen Peroxide 0,5 mM - P<0,001***Hydrogen Peroxide 1 mM - P<0,001***Hydrogen Peroxide 2,5 mM - P<0,001***Hydrogen Peroxide 5 mM - P<0,001***Hydrogen Peroxide 7,5 mM - P<0,001***
Panel F (MTT assay)
2-way ANOVA Time(h) 
Cell line 
Interaction Sidak’s multiple comparison 
test
F=1136; P <0,001*** F=43,62; P<0,001*** F=4,174; P=0,003*** 6
HEK293T vs. HEK293T 
YB-1-GFP
Control - p>0,99 nsHydrogen Peroxide 0,5 mM - P=0,010**Hydrogen Peroxide 1 mM - P=0,71 nsHydrogen Peroxide 2,5 mM - P=0,29 nsHydrogen Peroxide 5 mM - P<0,001***Hydrogen Peroxide 7,5 mM P<0,002***
 
Statistical analyses were performed using GraphPad Prism7 (GraphPad Software Inc). Statistical significance of difference in meas-
ured variables between control and treated groups was determined by the two-way analysis of variance (ANOVA) followed by 
Sidak’s multiple comparisons post-test. Difference were considered significant at P < 0.033 (*), P < 0.002 (**) and P< 0.001 (***).
Conclusion
Stable cell lines represent a permanent resource that can be 
stored under cryogenic conditions for long periods of time, re-
trieved, and cultured to provide a consistent and reliable level of 
sustained gene expression. To explore the role of YB-1 localization 
upon stress stimuli we sought to generate a stable pool of cells 
constitutively expressing YB-1as a GFP fusion protein. Preliminar-ily, we transiently transfected HEK293T cells with YB-1-GFP cDNA cloned in pcDNA6/V5-His, a vector derived from pcDNATM3.1(+) (Invitrogen). 5.0x105 cells were seeded in order to reach 80% con-fluence the day after; lipofection was performed using pcDNA6/V5-HisA-YB-1GFP and peGFP-C1 empty vector as control [10]. 48hours 
after transfection cells were analyzed by immuno blot to evaluate 
the level of YB-1-GFP fusion GFP exogenous expression. Transfect-ed YB-1-GFP was highly expressed inHEK293T cells (Figure 1). Direct fluorescence, acquired by Nikon Eclipse 800 microscope, 
showed a prevalent cytoplasmic localization for YB1-GFP (Figure 
2). Moreover, viability of YB-1-GFP cells, as assessed by MTT assay, was undistinguishable from HEK293T parental cells and cells ex-pressing GFP alone (data not shown). Next, we produced pools of clones of HEK293T stably expressing YB-1-GFP or GFP alone. YB-1-GFP expressing cells were selected by blasticid in while G418 was used for selection of peGFP-C1 stable pool. After 4 weeks, 91% of selected cells were GFP positive. Next, we analyzed the prolifera-
tion rate of YB-1-GFP expressing pool. Compared to the parental 
cell line, YB-1-GFP expressing cells grew slightly faster (Figure 3). 
To examine YB-1 protein localization under oxidative stress we treated HEK293T YB-1-GFP cells with hydrogen peroxide (H2O2). Byimmunofluorescence, we could observe typical stress granules 
(SGs) in control and GFP expressing cells, using a canonical SGs marker, PABP-1 Figure 4 left panel. Unexpectedly, YB-1 fusion pro-
tein was detected in unusual GFP positive aggregates that were ab-
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normal in both dimension and shape (Figure5 right panel arrows). 
Remarkably, although YB-1-GFP cells grew faster than control cells, 
their sensitivity to oxidative stress was increased as demonstrated 
by MTT and try pan blue assays (Figure 6). Taken together, our data 
show that, even though the GFP fusion protein behaved like the 
endogenous one and is localized in the right sub cellular compart-
ment, the presence of the huge GFP tag causes a lack in functionali-
ty that can be observed only in particular experimental conditions. 
Therefore, insights obtained so far with YB-1-GFP construct should 
be critically revised and, more in general, we should beware and be 
careful in interpreting data obtained with functionally uncharacter-
ized GFP fusion proteins.
Figure 1: Western blot of total extracts from HEK293T YB-1-GFP and control (untransfected) HEK293T cells, showing the full 
length endogenous 50 kDa YB-1 band and the YB-1-GFP bands (66-90 kDa); GAPDH was used as loading control.
Figure 2: Direct eGFP fluorescence of HEK293T YB-1-GFP and HEK293T GFP in physiological conditions; images were 
acquired using a Nikon TE Eclipse 2000 (20x objective).
Figure 3: Cell proliferation profile of HEK293T and HEK293T YB-1-GFP from time 0 (seeding time) to 96 hours (2-way ANOVA 
P<0,001***, for post-hoc tests see Table 1).
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Figure 4: (left panel) confocal immunofluorescence of HEK293T treated with 0,5 mM hydrogen peroxide (H2O2) for 1 hour; PABP (red) and YB-1 (green) mark Stress Granules; (right panel) direct eGFP fluorescence of HEK293T, HEK293T GFP and 
HEK293T YB-1GFP treated with 0,5 mM hydrogen peroxide (H2O2) for 1 hour; images acquired using a Carl Zeiss LSM 700 (40x oil objective) (left panel) and Nikon TE Eclipse 2000 (20x objective) (right panel).
Figure 5: Cell viability assay (MTT) of HEK293T and HEK293T YB-1-GFP cells treated with indicated concentrations of 
hydrogen peroxide (H2O2) for 1 hour (2-way ANOVA P<0,001***, for post-hoc tests see Table 1).
Figure 6: Trypan blue count; representation of the increasing number of dead cells afterhydrogen peroxide (H2O2) treatments (2-way ANOVA P<0,001***, for post-hoc tests see Table 1).
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Abstract: The prototype cold-shock Y-box binding protein 1 (YB-1) is a multifunctional protein that
regulates a variety of fundamental biological processes including cell proliferation and migration,
DNA damage, matrix protein synthesis and chemotaxis. The plethora of functions assigned to YB-1
is strictly dependent on its subcellular localization. In resting cells, YB-1 localizes to cytoplasm where
it is a component of messenger ribonucleoprotein particles. Under stress conditions, YB-1 contributes
to the formation of stress granules (SGs), cytoplasmic foci where untranslated messenger RNAs
(mRNAs) are sorted or processed for reinitiation, degradation, or packaging into ribonucleoprotein
particles (mRNPs). Following DNA damage, YB-1 translocates to the nucleus and participates in
DNA repair thereby enhancing cell survival. Recent data show that YB-1 can also be secreted and
YB-1-derived polypeptides are found in plasma of patients with sepsis and malignancies. Here we
show that in response to oxidative insults, YB-1 assembly in SGs is associated with an enhancement
of YB-1 protein secretion. An enriched fraction of extracellular YB-1 (exYB-1) significantly inhibited
proliferation of receiving cells and such inhibition was associated to a G2/M cell cycle arrest, induction
of p21WAF and reduction of ∆Np63α protein level. All together, these data show that acute oxidative
stress causes sustained release of YB-1 as a paracrine/autocrine signal that stimulate cell cycle arrest.
Keywords: cold shock proteins; stress granules; oxidative stress; protein secretion
1. Introduction
Oxidative stress is linked to a number of chronic diseases including diabetes, neurodegenerative
and cardiovascular diseases, cancer, and aging [1]. The cold-shock Y-box binding protein 1 (YB-1) is
involved in stress response [2] and chronic inflammation [3–5]. YB-1 is a member of the evolutionarily
conserved cold shock domain (CSD) proteins and was first identified as a DNA binding protein
interacting with the Y-box motif present in the major histocompatibility complex class II gene [6].
YB-1 binds to DNA and RNA [7] and it is involved in the transcriptional and translational control of
many biological processes including cell proliferation and migration [8–11]. Moreover, YB-1 protein is
upregulated in many types of human cancers including, breast, prostate, ovarian and melanoma [12,13].
Human YB-1 contains 324 amino acids [14]. Its structure can be subdivided into three domains
namely N-terminal, cold shock (CS) and C-terminal domain. The short N-terminal domain, named
A/P, contains 1–51 residues and is rich in alanine and proline. The central part of YB-1 is a CS
Genes 2018, 9, 513; doi:10.3390/genes9100513 www.mdpi.com/journal/genes
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domain conserved from bacteria to human (52–129 residues) [9]. The long C-terminal domain (130–324
residues) contains positive and negative charged clusters of amino acids.
Accumulating evidence links YB-1 to the cell response to oxidative stress [2] and DNA
damage [15–17]. More specifically, following acute oxidative stress, YB-1 localizes to cytoplasmic
stress granules (SGs) where it participates in a pro-survival mRNA translational reprogramming [2].
Cytosolic YB-1 can also be found in P-bodies [18], TIA-containing SGs, but its precise role in these
cytoplasmic structures remains to be defined [2,19–21].
Following DNA damage, YB-1 translocates to the nucleus to oversee DNA damage repair
mechanisms [16,17]. Indeed, genotoxic stress triggers a limited cleavage of YB-1 by the 20S proteasome
with the consequent accumulation of a 36 kDa truncated form of YB-1 (amino acids 1–219) in the
nucleus [22]. Truncated YB-1 associates with Mre11 and Rad50 in DNA repair complexes [16]. Nuclear
shuttling of YB-1 also takes place during cancer growth and upon activation of pro-survival signaling
cascades such as PI3K/AKT, RSK, Ras/MAPK and PKC and is triggered by phosphorylation at serine
102 of YB-1 [23–27].
Recent data show that YB-1 can also be secreted after cytokine challenge by mesangial and
immune cells [28] and is increased in sera from sepsis and tumor patients [29–31]. Here, we focused
our studies on secreted YB-1 and found that oxidative stress enhances YB-1 secretion. Finally, using
extracellular YB-1 (exYB-1) we provide some evidence of a role of exYB-1 as an autocrine/paracrine
signal inducing cell cycle arrest.
2. Materials and Methods
2.1. Plasmids and Chemicals
The expression construct 5xMyc-YB-1 was previously described [32]. Plasmid pcDNA 3.1B, used
as a control, was purchased by Thermo-Fisher Scientific (Waltham, MA, USA).
Sodium (meta)arsenite (NaAsO2) (S7400 Sigma-Aldrich, Saint Louis, MO, USA); hydrogen
peroxide (H1009 Sigma-Aldrich, Saint Louis, MO, USA) were used to perform oxidative stress.
Trichloroacetic acid (TCA) (T4885 Sigma-Aldrich, Saint Louis, MO, USA) was used to extract proteins
from cell culture medium.
2.2. Cell Culture
Human embryonic kidney cells (HEK293T), spontaneously immortalized keratinocytes from
adult skin (HaCaT), and human colorectal adenocarcinoma cells (CaCo-2), were purchased from Cell
Line Service (CLS, Eppelheim, Germany) and grown as previously described [33].
To increase HEK293T adhesion to glass/plastic surfaces, plates and slips for immunofluorescence
were treated with poly-D-lysine 0.1 mg/mL (P7405, Sigma-Aldrich, Saint Louis, MO, USA) before
seeding cells.
2.3. Immunofluorescence Microscopy
Confocal immunofluorescence was performed as previously described [34]. All images were
acquired using a Carl Zeiss LSM700 (63⇥ oil immersion objective). Image processing and analysis
were performed with Fiji (ImageJ version 2.0) software.
2.4. Cell Viability Assays
Cell viability was determined by the crystal violet assay (CVA) method, through a (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide) MTT based assay, or through trypan blue
count as previously described [35].
Cells were seeded in 96-well plate for MTT (8 ⇥ 103 cells), in 35 mm dishes (2.5 ⇥ 105 cells) for
CVA and in 12-well plates (1.5 ⇥ 105 cells) for trypan blue.
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The day after plating, cells were treated or not. For crystal violet, dye uptake was measured at
570 nm using a Beckman Coulter spectrophotometer (DU730). Cell viability was calculated as dye
intensity and compared with untreated samples.
For MTT, the optical absorbance was determined at 570 nm using an iMark microplate reader
(Bio-Rad, Hercules, CA, USA). For trypan blue count, after treatment cells were gently rinsed with 1⇥
Phosphate-buffered saline (PBS), trypsinized and collected. An aliquot was diluted 1:1 with trypan
blue (Sigma-Aldrich, Saint Louis, MO, USA).
2.5. Cell Cycle Analysis
A total of 3 ⇥ 105 cells were seeded and let grow for 24 h; then, cells were serum starved for
24 h to achieve synchronization; the day after, cells were treated with recombinant YB-1 (rYB-1) or
Conditioned Culture Medium derived YB-1 (CCM-YB-1) or left untreated for 24 h. Cells were then
trypsinized, collected in PBS with the addition of 1% FBS, 0.25 mM ethylenediaminetetraaacetic acid
(EDTA) in PBS and centrifuged at 1200 rpm, 4 min, 4  C; for each sample the same number of cells
(1 ⇥ 105) was processed. The cell pellet was resuspended in methanol, incubated on ice for 20 min and
centrifuged at 1200 rpm, 5 min, 4  C. After a wash in PBS, the pellet was incubated in PBS, containing
RNase A (Thermo-Fisher Scientific) 100 µg/mL for 20 min at RT. Propidium iodide (Sigma-Aldrich,
Saint Louis, MO, USA) was then added at a concentration of 50 µg/mL for 30 min at 4  C. Cell cycle
analysis was performed on the BD Accuri C6 flow cytometer (BD Biosciences, San Jose, CA, USA).
2.6. Cell Proliferation Analysis
A total of 6 ⇥ 104 HaCaT and CaCo-2 cells were seeded in 12-well plate, while HEK293T were
seeded on pre-treated 12-well; cells were serum starved for 24 h; after starvation, recombinant or
CCM-YB-1 were added at different concentrations. Every 24 h cells were gently rinsed with 1⇥ PBS,
trypsinized and counted. The count was confirmed by Scepter 2.0 analysis (Millipore, Burlington, MI,
USA) as previously described [36].
2.7. Transfections
Cells were transfected using Lipofectamine 2000 (Life Technologies, Carlsbad, CA, USA) according
to the manufacturer’s recommendations. Briefly, cells were seeded at 70–80% confluence (1.5 ⇥ 106) in
100-mm dishes and transiently transfected with different concentrations of plasmid (from 800 ng up to
1.5 µg).
YB-1 transient silencing was carried out with IBONI YB-1 small interfering (siRNA) pool
(RIBOXX GmbH, Radebeul, Germany) and RNAiMAX reagent (Life Technologies, Carlsbad, CA, USA),
according to the manufacturer’s recommendations. Cells were seeded at 70–80% confluence (1.5 ⇥ 106)
in 100-mm dishes and transiently silenced with IBONI YB1-siRNA at 100 nM final concentration.
All Star Negative Control siRNA, provided by Quiagen (Hilden, Germany), was used as negative
control. YB-1 guide sequences:
50-UUUAUCUUCUUCAUUGCCGCCCCC-30; 50-UUAUUCUUCUUAUGGCAGCCCCC-30;
50-UUCAACAACAUCAAACUCCCCC-30; 50-UCAUAUUUCUUCUUGUUGGCCCCC-30.
2.8. Antibodies
Primary antibodies: anti-YB-1 raised against the region 1 to 100 of YB-1 protein (12148 Abcam,
Cambridge, UK); anti-PABP1 (poly(A)-binding-proteiin 1) (clone 10E10, Sigma-Aldrich); anti-Myc
(SAB21084786, Sigma-Aldrich, Saint Louis, MI, USA); anti-cyclin D1 (GT8912, Genetex, Irvine,
CA, USA); anti-cyclin A2 (GT2547, Genetex, Irvine, CA, USA); anti-GAPDH (6C5 Santa Cruz
Biotechnology, Dallas, TX, USA); anti-PARP1 (Cell Signalling, Danvers, MA, USA); anti-RNH1 (436–450,
Sigma-Aldrich, Saint Louis, MO, USA) anti-β-tubulin (H-235, Santa Cruz Biotechnology, Dallas, TX,
USA); anti-actinin (AT6/172, Abcam, Cambridge, UK); anti-p21 WAF (1D21 Cell Signaling, Danvers,
MA, USA); anti-∆Np63α (4A4) (sc-8431 Santa Cruz Biotechnology, Dallas, TX, USA).
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Secondary fluorescent antibodies: Alexa Fluor 488 anti-rabbit (Thermo-Fisher Scientific, Waltham,
MA, USA); Cy3 anti-mouse (Jackson ImmunoResearch, Cambridge, UK); DAPI (Sigma-Aldrich, Saint
Louis, MO, USA).
2.9. Immunoblot Analysis
Immunoblots were performed as previously described [37,38].
For total protein extraction and nuclear-cytoplasmic fractionation, cells were seeded at 60%
confluence (1.5 ⇥ 106 cells) in 100-mm dishes. Then, 24 h after seeding, cells were treated or left
untreated; cell lysates were fractionated to obtain total, cytoplasmic and nuclear fractions as previously
described [38]. About 20 µg of total extract, 10 µg of nuclear and 30 µg of cytoplasmic extracts (1:3 rate)
were separated by SDS-PAGE and subjected to immunoblot.
Proteins were visualized by enhanced chemiluminescence (ECL, GE-Healthcare, Chicago, IL, USA)
and ChemiDoc TM XRS system and analyzed by Quantity One W software (Bio-Rad, Milan, Italy).
2.10. Co-Immunoprecipitation
For co-immunoprecipitations (Co-IP) 2 ⇥ 106 HEK293T cells were seeded in poly-D-lysine
pre-treated 100-mm dishes; the day after cells were treated with sodium arsenite (Na Ars)
(Sigma-Aldrich, Saint Louis, MO, USA) 250 µM for 30 min; cells extracts were incubated with an
anti-PABP1 antibody (Sigma-Aldrich, Saint Louis, MO, USA), 3 µg for 1 mg of protein extract overnight
at 4  C. The day after, Dynabeads Protein G (Invitrogen, Carlsbad, CA, USA) were added to samples
for 4 h, at 4  C in rotation. Immunoglobulin G (IgG) 3 µg for 1 mg of protein extract was used as
a negative control. Immunocomplexes were resolved with SDS-PAGE; immunoblot was performed
with anti-YB-1 antibody (Abcam, Cambridge, UK).
2.11. Trichloroacetic Acid Precipitation
HEK293T cells were grown as previously described; Then, 24 h after seeding cells were gently
rinsed twice with 1⇥ PBS, and serum starved for 2 h. After treatments, cell culture medium was filtered
through 0.22 µm filters to remove floating cells and debris. Scepter 2.0 (Millipore, Burlington, MA,
USA) was used to determine if cells were still present in the collected medium. Trichloroacetic acid
25% was added to culture medium in 1:1 ratio, tubes were placed on ice for 30 min. Samples were then
centrifuged at maximum speed at 4  C for 30 min. Supernatant was discarded and cold acetone 100%
was added to tubes (200 µL per sample), samples were then centrifuged at maximum speed, for 15 min,
at 4  C. This passage was done twice. Acetone was gentle removed and 200 µL of diethyl ether was
added to tubes for 15 min on ice. After a centrifuge at maximum speed at 4  C for 15 min, samples were
placed on the block heater in order to evaporate diethyl ether. After addition of sample buffer. Samples
were denatured in sample buffer (Sigma Chemical Co, St. Louis, MO, USA) and loaded on the gel.
2.12. Quantitative Real Time-PCR
A total of 3 ⇥ 105 cells was seeded and let grow for 24 h; the day after, they were treated with
recombinant YB-1 (rYB-1) or CCM-YB-1 for 24 h or left untreated.
For real time (RT)-PCR cells analysis, total RNA was isolated using the RNA Extraction Kit
from Qiagen (Hilden, Germany) according to the manufacturer’s instructions. RNA (2–5 µg) was
treated with DNAse I (Promega, Madison, WI, USA) and used to generate reverse transcribed cDNA
using SuperScript III (Life Technologies, CA, USA), according to the manufacturer’s instructions.
RT-PCR with SYBR green (Promega) detection was performed with a 7500 RT-PCR Thermo Cycler
(Applied Biosystem, Foster City, Carlsbad, CA, USA). The relative quantification in gene expression
was determined using the 2 ∆∆Ct method.
Expression levels were normalized using g6pd mRNA expression.
For each gene, primer sequences are presented in Supplementary Materials Table S3.
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2.13. Statistical Analysis
Statistical analyses were performed using GraphPad Prism (version7.0, GraphPad Software Inc.,
San Diego, CA, USA).
Statistical significance of the difference in measured variables between control and treated groups
was determined by t-test or analysis of variance (ANOVA) followed by Tukey’s or Dunnett’s multiple
comparisons post-test. Difference were considered significant at p < 0.033 (*), p < 0.002 (**) and
p < 0.001 (***). To report p-values, the New England Journal of Medicine (NEJM) decimal format was
used; differences were considered statistically significant at * p < 0.033, ** p < 0.002 and *** p < 0.001.
Detailed statistical information is shown in Table S2.
3. Results
3.1. YB-1 Is Recruited in Stress Granules under Diverse Stress Stimuli
It is documented that the functions played by YB-1 are strictly dependent on its subcellular
localization [16,39,40]. Thus, we examined YB-1 subcellular localization in human HEK293T cells in
resting conditions and following treatment with Na Ars, a well-known inducer of oxidative stress and
translational arrest [41,42]. By double immunofluorescence labelling and confocal microscopy using
antibodies against YB-1 and PABP1, another specific SGs marker [43], we found that YB-1 and PABP1
were evenly distributed in the cytoplasm in resting conditions (Figure 1a, control). However, following
heat shock or treatment with Na Ars or hydrogen peroxide, YB-1 was found to co-localize with PABP1
in cytoplasmic stress granules (Figure 1a). Interestingly, the size and overall number of SGs per cell
were different depending on the type of stimulus applied (Figure 1b, upper and lower panels), thus
confirming previous findings indicating stress-specific differences in composition and assembly of
stress granules [44].
 
 
μ μ
α α
Figure 1. Y-box-binding protein 1 (YB-1) and Poly(A)-binding protein 1 (PABP1) co-localize and interact
in stress granules (SGs) under stress conditions. (a) Confocal immunofluorescence of un-treated (control)
HEK293T, and treated with 250 µM sodium arsenite (Na Ars) for 30’, 500 µM H2O2 for 1 h or subjected
to heat shock at 45  C for 1 h, stained with α-YB-1 (green) and α-PABP1 (red); yellow and white arrows
indicate P-bodies and stress granules respectively; (b) (Upper panel) size and number (lower panel)
of SGs after treatments compared to control; statistical analysis was performed using 1-way ANOVA
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followed by Dunnett’s multiple comparisons test. Levels of significance are indicated (*** p < 0.001,
* p = 0.001, see also Supplementary Materials Table S2); (c) Co-immunoprecipitation of HEK293T total
protein extracts treated (+) or not ( ) with 250 µM Na Ars for 30’; extracts were immunoprecipitated
for YB-1 and immunorevealed for PABP1. Input samples immunorevealed with α-PABP1 and α-YB-1
are shown. Each panel is assembled from cropped Western blotting images (see original Western blot
file for the original images).
Next, we immunoprecipitated YB-1 protein from extracts of HEK293T cells left untreated
( ) or treated with 250 µM Na Ars (+). As shown in Figure 1c, PABP1 was detectable in YB-1
immunocomplexes exclusively from Na Ars treated cells, indicating that YB-1 and PABP1 association
occurs predominantly in SGs.
To determine the relevance of YB-1 in SGs assembly, we depleted HEK293T cells of YB-1 using
a specific siRNA pool against endogenous YB-1 mRNA (siYB1). By immunoblot and densitometric
analysis we found that the expression level of YB-1 protein was reduced to 55% of control (Figure 2a).
However, YB-1 knock-down consistently impaired the assembly of arsenite-induced PABP1-positive
stress granules by reducing their size and number (Figure 2b, upper and lower panels and Figure 2c).
Interestingly, in YB-1 depleted cells, PABP1 was located into the nucleus both in resting and under
stress condition (Figure 2c), thus suggesting that YB-1 may act as a cytoplasmic anchor for PABP1.
 
− μ
α α
−
μ
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μ
α α
 
Figure 2. Silencing of YB-1 affects PABP1 positive SGs formation. (a) Western blot of total extract from
control (siNC) or 100 nM YB-1 silenced (siYB-1) HEK293T; the degree of reduction of YB-1 protein
levels in YB-1 siRNA-treated cells compared with control is indicated beneath each band in the Western
blot (where the relative unit 1.0 represents YB-1 levels in cells transfected with the control siRNA).
β-tubulin was used as loading control. Each panel is assembled from cropped Western blotting images
(see original Western blot file for the original images); (b) (Upper panel) size and number (lower
panel) of stress granules (SGs) in YB-1 silenced cells treated with Na Ars compared to siNC (control)
cells; statistical analysis was performed using unpaired t-test with Welch’s correction (** p = 0.010 and
* p = 0.02 see Supplementary Materials Table S2); (c) Confocal immunofluorescence of control (siNC)
and silenced (siYB-1) HEK293T cells, treated or not with 250 µM Na Ars for 30’, stained with α-YB-1
(green) and α-PABP1 (red), nuclei are stained with DAPI (blue).
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3.2. Arsenite-Induced Oxidative Stress Promotes YB-1 Secretion
We performed Western blotting analysis to reveal YB-1 protein in total extracts of Na Ars and
H2O2-treated HEK293T cells. Despite the apparent enrichment of YB-1 in SGs, we found a significant
reduction of the level of intracellular YB-1 protein (Figure 3a,b). By immunoblot analysis of HEK293T
nuclear and cytoplasmic fractions we found that the reduction of YB-1 protein level induced by Na
Ars was exclusively at the expense of the cytoplasmic pool, while nuclear YB-1 was totally unaffected
(Figure 3c). YB-1 was previously found to be secreted [45,46] therefore we hypothesize that the decrease
of cytoplasmic YB-1 was due to oxidative stress-enhanced YB-1 secretion. To prove this hypothesis,
we treated HEK293T cells with Na Ars and precipitated the supernatant by TCA at different time points
(from 30’ to 240’). Trichloroacetic acid-precipitated fractions were then subjected to immunoblot and
revealed with antibodies against YB-1 and Ribonuclaese/Angiogenin Inhibitor 1 (RNH1) a not secreted
cytoplasmic ribonuclease inhibitor abundantly expressed in HEK293T [47]. As shown in Figure 3d,
in the 240’ time course the amount of secreted YB-1 protein upon Na Ars treatment significantly
increased and peaked after 60’. RNH1 signal was barely detectable ensuring that the increase of exYB-1
was not due to cell death and passive release (Figure 3d, lane 3, lower panel). Moreover, after 30’ and 60’
treatment with 250 µM Na Ars or 500 µM hydrogen peroxide, cell viability was only slightly reduced
(90% and 94%, respectively) compared to control cells and the increase of trypan blue positive cells
was negligible (Figure S1a,b, respectively). These data further indicate that extracellular accumulation
of YB-1 was not due to cell injury.
 
μ μ
 
μ μ
μ
Figure 3. Na Ars induced oxidative stress promotes YB-1 secretion. Western blot of total protein extracts
from HEK293T treated with 250 µM Na Ars (a) or 500 µM H2O2 (b) for 30’ and 60’; glyceraldehyde
3-phosphate dehydrogenase (GAPDH) and actinin were used as loading control. The degree of
reduction of YB-1 protein levels in treated cells compared with controls is indicated beneath each band
in the Western blot (where the relative unit 1.0 represents YB-1 levels in control cells); (c) Western
blot of total extract and nuclear/cytoplasmic fractionation of Na Ars treated and untreated HEK293T.
GAPDH and PARP were used as loading control for cytoplasm and nucleus, respectively; (d) Western
blot of TCA precipitated supernatants of HEK293T cells. Ribonuclease/Angiogenin Inhibitor 1 (RNH1)
was used as negative control of cell lysis. Each panel is assembled from cropped Western blotting
images (see original Western blot file for the original images).
Genes 2018, 9, 513 8 of 16
Similar results were obtained from Western blot analysis of supernatants from HEK293T cells
transfected with Myc-YB-1 expression plasmid and treated with Na Ars 250 µM for 30’, 60’ and 120’.
Immunoblotting of TCA-precipitated CCM media showed the presence of Myc-tagged YB-1 only in
arsenite-stimulated cells thus indicating that stressed cells can also secrete transfected YB-1 (Figure S2).
3.3. Extracellular YB-1 Exerts Anti-Proliferative Effects on Receiving Cells
To analyze the effects of exYB-1on receiving cells we prepared a YB-1 enriched fraction from
HEK293T conditioned cell culture medium (CCM-YB-1) by ammonium sulphate precipitation followed
by high performance liquid chromatography (HPLC) purification. Furthermore, we produced
a recombinant YB-1 from Escherichia coli, that was accumulated mainly in bacterial cytosolic fraction.
CCM-YB-1 and rYB-1 were analyzed by SDS-PAGE and YB-1 immunopositive bands were manually
excised as reported in Figure S3. Each band was subjected to in situ tryptic digestion and peptides
eluted from the gel were analyzed by LTQ-Orbitrap mass spectrometer (Thermo-Scientific, Waltham,
MA, USA) (see Appendix A). By matching MS and MSMS data obtained from the mass spectrometer
and peptide sequence databases by Mascot search engine, a high number of identified peptides was
obtained with an error lower than 10 ppm. We obtained a high sequence coverage of 79% for R1
band (rYB-1 band 1 in Figure S3), 78% for R2 (rYB-1 band 2 in Figure S3), 60% for S1 and 29% for S2
(CCM-YB-1 band 1 and 2 respectively, in Figure S3). A list of peptides with relative score, sequence
and modification allowed to unambiguously identify the YB-1 protein with a high sequence coverage
and protein score (Table S1).
We have previously demonstrated that intracellular YB-1 is implicated in keratinocytes
proliferation and survival to oxidative stress [40,48]. To get an insight into the function of secreted
YB-1 we evaluated the proliferative response of HaCaT cells to the addition of rYB-1 or HPLC-purified
YB-1 from HEK293T cell culture medium (CCM-YB-1).
HaCaT cells were then incubated for the indicated time with increasing amounts (5.0, 7.5
and 10 µg/mL) of rYB-1 protein, CCM-YB-1 or Bovine Serum Albumin (BSA) as control in serum
supplemented culture medium. As shown in Figure 4a,b, treatment with CCM-YB-1 or rYB-1 reduced
the rate of proliferation of HaCaT cells while equivalent amounts of BSA were ineffective (Figure 4c).
This effect was not cell type specific since it was also observed using HEK293T and CaCo2 as receiving
cells (Figure S4). Remarkably, compared to rYB-1, CCM-YB-1 exerted a stronger inhibitory effect on
all cell lines tested (Figure 4a,b; Figure S4). This was confirmed by Crystal Violet Assay (CVA) where
HaCaT cells treated with 7.5 µg/mL of CCM-YB-1 for 48 h showed a 47% reduction in viable cells
compared to a 11% reduction obtained with the same amount of rYB-1 (Figure 4d).
The effect on the rate of cell proliferation caused by CCM-YB-1 and rYB-1 was associated to
a G2/M phase cell cycle arrest, as indicated by flow cytometry analysis of HaCaT cells treated
with exYB-1 (Figure 5a). Finally, to explore the molecular mechanism underlying inhibition of cell
proliferation by exYB-1we analyzed by quantitative PCR the mRNA level of p21waf and ∆np63α in
rYB-1 or CCM-YB-1 treated HaCaT cells. p21WAF is a relevant cell cycle marker that induces G1
and G2/M cell cycle arrest by inhibiting the kinase activity of Cyclin-dependent kinase (CDK)-cyclin
complexes [49] while ∆Np63α maintains the proliferative capacity of keratinocytes [50]. p21waf was
strongly induced by both rYB-1 and CCM-YB-1 while ∆np63α was significantly downregulated only
by treatment with CCM-YB-1 (Figure 5a,b). By Western blot analysis we also confirmed reduction of
∆Np63α and induction of p21WAF at protein level (Figure 5c,d). Moreover, according to the observed
cell cycle arrest the level of cyclin A2 and cyclin D1 were also reduced (Figure 5c).
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Figure 4. Extracellular YB-1 (exYB-1) affects HaCaT cell proliferation. Cell proliferation profile of
HaCaT cells incubated with indicated concentrations of CCM-YB-1 (a), rYB-1 (b) or Bovine Serum
Albumin (BSA) (c); statistical analysis was performed using 2-way ANOVA followed by Dunnett’s
multiple comparisons test. Levels of significance are indicated (*** p < 0.001, see also Supplementary
Materials Table S2); (d) Crystal violet assay of HaCaT cells treated with 7.5 µg/mL of CCM-YB-1,
rYB-1, BSA or left untreated (Control; (bars) optical absorbance at 595 nm is reported on the y-axis;
(image) representative colorimetric evaluation. Statistical analysis was performed using 1-way ANOVA
followed by Dunnett’s multiple comparisons test. Levels of significance are indicated (*** p < 0.001, see
also Supplementary Materials Table S2).
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Figure 5. Extracellular YB-1 induced G2/M phase arrest. (a) Cell cycle profile of HaCaT cells treated
with 7.5 µg/mL of CCM-YB-1, rYB-1, BSA or left untreated for 48 h. Statistical analysis was performed
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using 2-way ANOVA followed by Dunnett’s multiple comparisons test. Levels of significance are
indicated (*** p < 0.001, * p = 0.01, see also Supplementary Materials Table S2); (b) RT-qPCR analysis of
p21waf and ∆np63α in HaCaT cells treated with 7.5 µg/mL of CCM-YB-1, rYB-1, BSA or left untreated
(Control for 48 h. Statistical analysis was performed using 1-way ANOVA followed by Dunnett’s
multiple comparisons test. Levels of significance are indicated (*** p < 0.001, * p = 0.01, see also
Supplementary Materials Table S2); (c,d) Western blot analysis of total extracts of HaCaT cell treated
with rYB-1 and CCM-YB1 and revealed with the indicated antibodies. GAPDH and β-tubulin were
used as loading control. Each panel is assembled from cropped Western blotting images (see original
Western blot file for the original images).
4. Discussion
Although YB-1 was originally identified as a transcription factor belonging to the Y-box binding
family, a number of works provide evidence that YB-1 possesses additional functions, independent of
its DNA binding activity [7,9,39]. Based on more recent literature, a possible regulatory role of YB-1 in
inflammation and stress response has started to emerge [4].
The goal of our study was to investigate the function of YB-1 protein under stress conditions.
In unstressed cells, YB-1 was diffusely distributed throughout the cytoplasm. Upon addition Na
Ars, H2O2 and heat shock at 45
 C, we observed YB-1 protein association to SGs, which constitute
a canonical cellular response to stress. In HEK293T cells, YB-1 almost complete co-localizes with the
SGs marker PABP1; the co-localization was accompanied by the physical interaction between the two
proteins, only in stress conditions.
Moreover, we show that YB-1 silencing impairs the assembly of PABP-1 positive SGs under
stress conditions, thus confirming that YB-1 plays a pivotal role in the aggregation of SG components.
Interestingly, we also found that PABP1 was mainly nuclear in YB-1 depleted cells, under normal as well
as stress conditions, indicating that YB-1 may retain PABP1 protein in the cytoplasmic compartment.
This observation raises the question of whether YB-1 silencing, by altering PABP1 localization, also
influences the metabolism of PABP1-associated transcripts.
Involvement of YB-1 in SGs formation has potential pathological relevance in vivo, given that SGs
formation in cancer cells might protect them against stress-induced cell damage and death [2]. Indeed,
because of metabolic and signaling aberrations, cancer cells exhibit elevated ROS levels that can
promote tumor formation and progression by inducing DNA mutations and pro-oncogenic signaling
pathways [51]. By impairing SGs assembly, YB-1 depletion may weaken the antioxidant capacity
of tumor cells, thus sensitizing them to necrosis/apoptosis and may have a therapeutic impact in
cancer chemotherapy.
In the process of characterization of YB-1 response to cellular stresses, we observed a decrease
of total amount of the protein after Na Ars or hydrogen peroxide treatments. This result sounded
unexpected, considering the relevance of YB-1 in SGs.
Remarkably, the decrease of YB-1 protein level was at the expenses of cytoplasmic YB-1, while
nuclear YB-1 was totally unaffected.
However, considering that YB-1 is normally released in the culture medium by HEK293T cells [28],
we speculated that stress stimuli may function as enhancers of YB-1 protein secretion.
Interestingly, we found a significant increase of exYB-1 level during Na Ars treatment; such
increase was clearly detectable after 30 min and peaked at 60 min of treatment. After 4 h of treatment
the level of exYB-1 was reduced probably because of protein degradation. It should be noticed that
non-specific YB-1 release due to cell death was excluded by cell viability assays (viability of treated
cells >95%) and the lack of comparable RNH1 release, a highly abundant cytoplasmic protein.
YB-1 secretion after cell stimulation is not unprecedented. Recently, YB-1 was found to be
secreted by Lipopolysaccharide (LPS)-stimulated human monocytes and mesangial cells and acts as an
extracellular mitogen by interacting with Notch-3 receptor [45]. YB-1 has been isolated in extracellular
vesicles and postulated to play a role in sorting small noncoding RNAs into a subpopulation of
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exosomes [52]. However, it has to be noted, that in previous manuscripts neither YB-1 positive SGs
formation nor reduction of intracellular YB-1 was observed in stimulated cells [45].
Extracellular occurrence of YB-1 raises the question of its functional relevance. So far, the
functional role of exYB-1and the pathological implications of secreted YB-1 are largely unknown. Data
from other laboratories indicated that exYB-1may be involved in tumor progression since addition of
recombinant YB-1 to cancer cell lines revealed pro-mitogenic effects [45].
Intriguingly, we found that exYB-1exerts an anti-proliferative effect on receiving HaCaT, HEK293T,
and CaCo-2 cells. Remarkably, YB-1 is normally released in the culture medium by HEK293T cells but
not by HaCaT or CaCo2 cells even though all these cell lines express high levels of endogenous YB-1.
This may depend on a particular pathway constitutively activated in HEK293T cells or rely on specific
posttranslational modifications occurring in HEK293T and possibly other cell contexts facilitating YB-1
extracellular release.
Treatment of HaCaT cells with exYB-1induced a G2/M cell cycle arrest associated with p21WAF
induction and ∆Np63α reduction. The effect of CCM-YB-1 was more pronounced compared to that of
the rYB-1. We can speculate that specific posttranslational modifications, such as ubiquitination and/or
sumoylation, occurring in mammalian cells can explain the different effects showed by CCM-YB1 and
rYB-1 proteins on receiving cells. Alternatively, bacterially synthesized rYB-1 may have a different
protein folding that partially affect its functions.
It has been reported that intracellular YB-1 activates Notch signalling [53] and acts as a mediator
of signals transmitted via the EGFR-RAS-MAPK [54] enhancing ∆Np63α level in keratinocytes.
Therefore, we postulate that exYB-1may either activate Notch or repress EGFR pathways, thus reducing
∆Np63α level which is known to support the proliferative potential of normal and transformed
keratinocytes [55].
We can presume that upon severe tissue-injury, exYB-1can signal to neighboring cells that a cell
cycle arrest is required to allow cells to recover from stress and/or avoid the propagation of genetic
lesions and repair them. However, further studies are needed to define the molecular mechanisms by
which YB-1 can signal and regulate this response in receiving cells and the exact cellular source and
targets in patients with malignant disorders.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4425/9/10/513/s1,
Figure S1: YB-1 presence in the cell medium is not due to cell death and lysis, Figure S2: Transfected myc-YB-1
can be secreted by cells, Figure S3: Band excision, Figure S4: Extracellular YB-1 affects HEK293T and CaCo2 cell
proliferation. Table S1: MSMs analysis or rYB-1 and CCM-YB-1, Table S2: Statistical analysis, Table S3: RT-qPCR
assay PCR primers.
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Appendix A.
Appendix A.1. Preparation of Bacterial Expression Vector pET22b(+)/YB-1
Recombinant vector pEX-A2 containing human YB-1 cDNA sequence (purchased from Eurofins
Genomics, Edersberg, Germany), has been used as template for a PCR reaction.
PCR has been carried out using following primers: forward
50-CCCATATGAGCAGCGAGGCCGAGACCC-30; reverse 50-GGAAGCTTGCCTCGGGAGCGGGAA-30.
Bold and underlined sequences refer to restriction sites (NdeI and HindIII), designed to permit the
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insertion of YB-1 coding sequence upstream to a His-Tag sequence to facilitate the purification of
the recombinant protein. The PCR reaction was carried out in a total volume of 50 µL containing
60 ng of each primer, 20 ng of template, deoxyribonucleotides (dNTPs) containing 0.2 mM of each
dNTP, 5 µL 10⇥ Taq buffer and 1.5 units of Taq DNA polymerase (EuroClone, Milan, Italy). PCR was
performed under the following conditions: An initial denaturation step at 98  C for 5 min, followed
by 38 cycles of 30 s at 98  C, 1 min at 65  C, and 2 min at 72  C. PCR products were then isolated by
electrophoresis on 1% agarose gel, and purified using the Product Purification Kit (Roche Applied
Science, Monza, Italy). Purified DNA, treated with NdeI and HindIII restriction enzymes, was inserted
into the pET22b (+) expression vector by ligation reaction catalyzed by T4 DNA ligase (Thermo Fisher
Scientific, Waltham, MA, USA). All cloned, purified DNAs were certified through sequencing (Eurofins
Genomics, Edersberg, Germany) before processing. The recombinant expression plasmid was used
then to transform competent E. coli strain BL21(DE3) (New England BioLabs, Ipswich, MA, USA).
Appendix A.2. Recombinant YB-1 Protein Preparation
The expression plasmid pET22b(+)/YB-1 was used to transform competent E. coli strain
BL21(DE3) cells. Cells were grown at 37  C to an A600 nm = 0.7, and then induced with 0.6 mM
isopropyl-1-thio-D-galactopyranoside (IPTG) and grown overnight. The expression level of rYB-1
was estimated performing a Western blot on two bacterial aliquots collected before the addiction of
IPTG and after 16 h respectively. Bacterial cells were then harvested by centrifugation (7000 rpm, 4  C,
15 min), re-suspended in 100 mM Tris acetate buffer (pH 8.0) and subjected to sonication in presence of
protease inhibitors. Cell debris and precipitated proteins were removed by centrifugation (17,500⇥ g,
1 h) whereas the supernatant was subjected to at least three washes in 100 mM Tris acetate pH 8.0 and
finally centrifuged to separate inclusion bodies and cytosolic soluble fraction, the latter containing
rYB-1. Recombinant YB1 was purified performing a two-step procedure composed by an affinity
chromatography followed by a reverse phase chromatography.
Appendix A.3. Chromatographic Procedures
Affinity chromatography was carried out on HisTrap resin (GE Healthcare, Chicago, IL, USA)
equilibrated with 100 mM Tris acetate pH 8.0 containing 20 mM imidazole. Elution was carried out by
using 100 mM Tris acetate pH 8.0 containing 500 mM imidazole and spectrophotometrically monitored
at 280 nm. Reverse phase chromatography was performed on a HPLC device Series 200 (Perkin Elmer,
Waltham, MA, USA) by using a C4 column (Dr. Maisch GmbH, Ammerbuch-Entringen, Germany),
0.1% TFA in 5% acetonitrile as buffer A and 0.1% TFA in 95% acetonitrile as buffer B. Elution was
performed by setting a linear gradient 5–95% buffer B in 60 min and spectrophotometrically monitored
at 278 nm.
Appendix A.4. Extraction of Human Secreted YB-1 from HEK293T Cell Culture Medium
All culture media, enriched with secreted YB-1, have been processed with three subsequent steps
of protein precipitations by using ammonium sulfate (Sigma Aldrich, Milan, Italy). The concentration
of ammonium sulfate was increased from 0 to 30%, 30% to 70% and, finally until 100%, determining
proteins salting out. Between each step, media were centrifuged 1 h at 14,000 rpm and 4  C to sediment
protein aggregates. All sediments were finally re-suspended in PBS, quantified and then analyzed by
SDS-page and Western blotting.
Appendix A.5. Protein Separation by SDS-PAGE and In Situ Digestion
The proteins precipitated from culture medium were separated by 12% SDS-PAGE, under reducing
conditions. Proteins were visualized by colloidal Coomassie brilliant blue and the immunopositive
bands were excised, also depending on the visualization of bands at expected molecular weight.
Each band was subjected to in situ digestion protocol by reducing proteins by 10 mM DTT and
alkylation with 55 mM iodoacetamide, according to the established protocol. Finally, each dry gel
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piece was rehydrated in 40 µL of 10 mM ammonium bicarbonate solution containing 200 ng of Trypsin
Gold, Mass Spectrometry grade (Promega, Madison, WI, USA), and incubated at 37  C overnight.
The trypsinolysis was stopped with 0.1% formic acid (FA), and tryptic peptides were eluted, vacuum
dried, and dissolved in 0.1% formic acid for LC-MS/MS analysis.
Appendix A.6. LTQ-Orbitrap Analysis
Peptides were separated on a 1.7-µm BEH C18 column (Waters Corporation, Milford, MA, USA)
at a flow rate of 280 nL/min by using as mobile phase solution A: 95% water, 5% acetonitrile, 0.1%
acetic acid; solution B: 95% acetonitrile, 5% water, 0.1% acetic acid. Peptide elution was achieved along
a linear gradient of B from 20% to 90% over 53 min. MS and MS/MS data were acquired on an Orbitrap
LTQ XL high-performance liquid chromatography MS system (Thermo-Scientific, Waltham, MA, USA)
equipped with an electrospray source (ESI). The full scan precursor MS spectra (400–1600 m/z) were
acquired in the Velos-Orbitrap analyzer with a resolution of r = 60,000. This was followed by data
dependent MS/MS fragmentation in centroid mode of the most intense ion from the survey scan using
collision-induced dissociation (CID) in the linear ion trap: Normalized collision energy 35%; activation
Q 0.25; electrospray voltage 1.4 kV; capillary temperature 200  C; and isolation width 2.00. The targeted
ions were dynamically excluded for 30 s, and this MS/MS scan event was repeated for the top 20 peaks
in the MS survey scan. The five most intense double and triple charged peptide ions were selected and
fragmented. The resulting MS data were processed by MS Converter General User Interface software
3.0 (ProteoWizard) to generate peak lists for protein identifications. Database searches were carried out
on the Mascot Deamon version 4.1 by Matrix Science (London, UK). The SwissProt database (release
January 2017, 547,599 sequences; 195,014,757 residues) was employed (settings: two missed cleavages;
carbamidomethyl (C) as fixed modification and Oxidation (M), Phospho (ST), Phospho (Y), Acetyl (K),
Gln->pyro-Glu (N-term Q), Glu->pyro-Glu (N-term E) as variable modifications; peptide tolerance of
10 ppm and fragment mass tolerance of ±0.6 Da).
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Plant extracts are an important source of bioactive compounds for many drug discovery programs.
Given the chemical complexity, however, the identification and characterization of bioactive com-
pounds in crude plant extracts still remain a big challenge. Moreover, complex mixture of phytochem-
icals generally combine the advantage of targeting multiple molecular pathways so that a desired
biological response may be due to a mixture of different bioactive components. Ethno-pharmacology
history and available information about the plant to be studied may help to set specific bio-assays
that can predict the reputed therapeutic activity and facilitate the isolation of the bioactives responsi-
ble for that biological activity. In a collaborative effort, we have analyzed the bioactivities of Cayenne
pepper (Capsicum) a spicy staple of many foods, largely used in folk medicine for its extensive
curative properties. Used either topically or internally, Capsicum may help support healthy bone,
joint and muscle function by reducing inflammation. It is commonly used as a general stimulant
and to heal ulcers, improve circulation and boost immune system. To elucidate the mechanism of
action of Capsicum at cellular level, we have studied the effects of the variety Capsicum annuum
fiesta on immortalized human keratinocytes. We have analyzed cell viability, intracellular ROS lev-
els, stress granules formation and cell cycle distribution demonstrating that C. annuum fiesta exerts
a protective role reducing intracellular ROS levels in a dose-dependent manner and stimulating cell
viability at low concentrations without affecting cell proliferation. Another area of interest in our lab
involves the characterization of Uncaria tomentosa extract (UT-ex) that has been widely used in
folk medicine to treat a variety of health conditions including skin burns and cancer. Cell viability,
intracellular ROS levels and cell cycle distribution were evaluated following treatment of immortal-
ized and transformed keratinocytes cells with UT-ex. All cell lines tested showed dose-dependent
susceptibility to Uncaria cytotoxicity, untransformed HaCaT keratinocytes being, however, less sen-
sitive than squamous carcinoma cells. Interestingly, we found that following UT-ex treatment PARP1
cleavage occurred concomitantly with the reduction of the cleaved form of Y-box binding protein 1
(YB-1), a nuclear prosurvival factor involved in DNA damage repair. Taken together, our observa-
tions suggest that Uncaria induced cell death can be ascribed to its ability to simultaneously induce
oxidative DNA damage and antagonize the mechanism of DNA repair. Our data support the use
of Uncaria extract as adjuvant therapy for treatment of precancerous and early forms of squamous
cell carcinomas.
Keywords: Skin Cancer, ROS, Uncaria tomentosa, Apoptosis, Capsicum annuum fiesta.
1. INTRODUCTION
Given the steady increase in global cancer incidence with
its associated morbidity and mortality, together with the
∗Authors to whom correspondence should be addressed.
healthcare costs of treatment, there is increasing interest in
strategies for cancer prevention. One approach with enor-
mous potential is the administration of phyto-extracts for
chemoprevention. Higher plants are an important source
of a wide array of bioactive compounds since they can
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exert protective effects against the initial phases of car-
cinogenesis as well as in the progression to an invasive
disease.1 Given the chemical complexity, the identifica-
tion and characterization of bioactive compounds in crude
plant extracts still remain a big challenge. On the other
hand, biological effects of a complex mixtures of phyto-
chemicals are hard to predict from chemical analysis of
individual constituents because they usually present the
advantage of targeting the multiple molecular pathways
involved in complex disorders; therefore, a desired biolog-
ical response may be due to a mixture or to a synergy
of different bioactive components in extracts that often
results in a considerable reduction of toxic side effects
that, conversely, could be lost if single constituents are
analyzed.2
Ethno-pharmacology history and available information
about the plant to be studied may help to set specific bio-
assays that can predict the reputed therapeutic activity and
eventually facilitate the isolation of the bioactives respon-
sible for an observed biological activity.
Cancer control may benefit from the potential that
resides in alternative therapies. Ideally, a phytochemi-
cal should possess anti-tumor properties, minimal toxicity
and a defined mechanism of action. The knowl-
edge of the mechanism of action and signaling path-
way/s that are targeted by natural compounds is a
way to understand the molecular mechanisms involved
in cancer progression and indicate novel therapeutic
approaches.
Induction of apoptosis is considered one of the most
important markers of cytotoxicity for antitumor agents.
Some natural compounds including plant metabolites are
able to induce apoptotic pathways that are usually blocked
in cancer cells through various mechanisms.
Another key feature in most chronic diseases, can-
cer included, is the continued oxidative stress; this lead
to chronic inflammation. On the other hand, chronic
inflammation is, in turn, associated with an increased
risk of cancers.3 Interestingly, phytoextracts have often
been described for their extensive antioxidant and anti-
inflammatory activities.4
Skin is an interesting and versatile model to study
the anticancer effects of natural compounds. Skin organ-
otypic cultures as well as immortalized keratinocytes and
skin tumor derived carcinoma cells represent good sim-
plified in vitro models to study potential antitumoral and
antioxidant effects of natural compounds. On the other
hand, in vitro analysis are fundamental steps in the eval-
uation of both the efficacy and eventual toxicity of new
substances.
In line with this, we have previously published that
Aloe arborescens Miller crude leaf extract is able to exert
an antiproliferative effect on several human cancer cell
lines. Furthermore, analyzing several skin markers we
could show that Aloe arborescens extract is able to exert
a pro-differentiative effect on both primary and immortal-
ized human keratinocyte, Proteomic analysis of whole cell
extracts coupled with a cellular biological approach helped
us to reveal the presence of proteins with strong antipro-
liferative and antioxidant activity in the Aloe arborescens
phytoextract, supporting its application as a therapeutical
agent.5
Another area of interest in our laboratory involves the
characterization of Uncaria tomentosa extract (UT-ex) that
has been widely used in folk medicine to treat a vari-
ety of health conditions including skin burns and cancer.
Cell viability, intracellular ROS levels and cell cycle dis-
tribution were evaluated following treatment of immortal-
ized and transformed keratinocytes cells with UT-ex. All
cell lines tested showed dose-dependent susceptibility to
Uncaria cytotoxicity, untransformed HaCaT keratinocytes
being, however, less sensitive than squamous carcinoma
cells. Interestingly, we found that following UT-ex treat-
ment PARP1 cleavage occurred concomitantly with the
reduction of the cleaved form of Y-box binding protein 1
(YB-1), a nuclear prosurvival factor involved in DNA dam-
age repair. Taken together, our observations suggest that
Uncaria induced cell death can be ascribed to its ability to
simultaneously induce oxidative DNA damage and antag-
onize the mechanism of DNA repair. Our data support the
use of Uncaria extract as adjuvant therapy for treatment
of precancerous and early forms of squamous cell carci-
nomas.
In a collaborative effort, we have analyzed the bioac-
tivities of Cayenne pepper (Capsicum) a spicy staple of
many foods, largely used in folk medicine for its exten-
sive curative properties. Used either topically or internally,
Capsicum may help support healthy bone, joint and muscle
function by reducing inflammation. It is commonly used
as a general stimulant and to heal ulcers, improve circula-
tion and boost immune system. One of the most important
actions, although not extensively studied at the molecular
level, appear to be Capsicum annuum anti-inflammatory
activity. To elucidate the mechanism of action of Capsicum
at the molecular and cellular level, we have studied the
effects of the variety Capsicum annuum fiesta on immor-
talized human keratinocytes (HaCat cells). Cell viability
analysis shows that C. annuum Fiesta ethanolic extract is
non toxic in the range of concentrations analyzed (up to
300 !g/ml) instead, it is slightly stimulating cell viability
at low doses (1–10 !g/ml) without affecting cell prolif-
eration. We also observed that C. annuum fiesta exerts a
protective role on HaCat cells functioning as antioxidant.
Infact we observed that C. annuum fiesta can reduce intra-
cellular ROS species of cells subjected to oxidative stress
in a dose-dependent manner. Interestingly, also the number
of cells that respond to an acute oxidative insult with the
formation of Stress Granules (SG) is reduced following
incubation with C. annuum fiesta extracts.
2 J. Nutr. Ecol. Food Res. 4, 1–3, 2017
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A B S T R A C T
Uncaria tomentosa (Willd.) DC. (Rubiacee), also known as uña de gato, is a plant that grows wild in the upper
Amazon region of Peru and has been widely used in folk medicine to treat several health conditions including
cancer. We have produced an aqueous extract from Uncaria tomentosa (UT-ex) and analyzed its effects on
squamous carcinoma cells and immortalized HaCaT keratinocytes. Squamous cell carcinoma (SCC) is an un-
controlled growth of abnormal cells arising in the skin's squamous layer of epidermis. When detected at an early
stage, SCCs are almost curable, however, if left untreated, they can penetrate the underlying tissue and become
disfiguring. We have evaluated cell proliferation, apoptosis and the level of reactive oxygen species following
UT-ex treatment. UT-ex affected cell cycle progression and reduced cell viability in a dose and time-dependent
manner. From a mechanistic point of view, this delay in cell growth coincided with the increase of reactive
oxygen species (ROS). Furthermore, PARP1 cleavage was associated to the reduction of Y-box binding protein 1
(YB-1) 36 kDa, a nuclear prosurvival factor involved in DNA damage repair. These data indicate that UT-ex-
induced cell death can be ascribed, at least in part, to its ability both to induce oxidative DNA damage and
antagonize the mechanism of DNA repair relying upon YB-1 activity. They also show that non metastatic SCCs
are more susceptible to UT-ex treatment than untransformed keratinocytes supporting the use of UT-ex for the
treatment of precancerous and early forms of squamous cell carcinomas. Preliminary chemical investigation of
UT-ex revealed the presence of hydrophilic low-medium molecular weight metabolites with anticancer potential
towards squamous carcinoma cells.
1. Introduction
Squamous cell carcinoma (SCC) is an uncontrolled growth of ab-
normal cells arising in the squamous cells, which compose most of the
skin's upper layers (Sapijaszko et al., 2015). SCCs may occur on any part
of the body, including the mucous membranes and genitals, but are
most common in areas frequently exposed to the sun, such as the neck,
face, balding scalp, arms and legs. Squamous cell carcinomas detected
at an early stage are almost always curable. However, left untreated,
they eventually penetrate the underlying tissues and can become dis-
figuring. A small percentage may even metastasize to local lymph
nodes, distant tissues, and organs and can become fatal. Actinic kera-
toses (AKs) are considered the earliest form of SCC and may be the first
sign of squamous cell carcinoma (Boukamp, 2005); indeed, 40–60% of
squamous cell carcinomas begin as untreated AKs.
Though considerable progress has been made in developing effec-
tive skin cancer treatments, surgery and radiation are still predominant
and it would be beneficial to find new topical treatments for pre-
cancerous skin lesions to prevent their progression.
Nowadays, there is an increased demand for alternative concepts or
approaches to cancer treatment. Compelling evidence from epidemio-
logical and experimental studies highlight the importance of com-
pounds derived from plants, “phytochemicals”, for inhibiting the de-
velopment and spread of tumors in pre-clinical studies.
Uncaria tomentosa (Willd.) DC., from the Rubiaceae family, is a
thorny liana that grows wild in the upper Amazon region of Peru and
http://dx.doi.org/10.1016/j.jep.2017.09.031
Received 14 June 2017; Received in revised form 21 September 2017; Accepted 24 September 2017
⁎ Corresponding authors.
1 These authors contributed equally to this work.
E-mail addresses: francesca.ciani@unina.it (F. Ciani), vcalabro@unina.it (V. Calabrò).
???????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????
????
neighboring countries. In Peru, Uncaria tomentosa, also known as uña de
gato, is believed to have anti-inflammatory and anti-tumoral properties
(Heitzman et al., 2005; Garcia Prado et al., 2007). The boiled extract of
Uncaria tomentosa root/bark has been used over the centuries by the
indigenous civilization of the Amazonian rain forest for the treatment of
fever, rheumatism, arthritis, gastrointestinal disorders, cirrhosis, neu-
rodegenerative diseases, microbial infections, cancer, skin impurities
and inflammation (Keplinger et al., 1998; Ccahuana-Vasquez et al.,
2007).
Many active compounds have been isolated from Uncaria tomentosa
including antioxidants such as tannin, catechins, and procyanidins,
sterols, triterpenes, flavonoids, carboxyl alkyl esters, indol and oxindol
alkaloids (Heitzman et al., 2005; Wagner et al., 1985a). In particular,
alkaloids, the major active components of Uncaria species were ex-
tensively studied for their potential use as anticancer agents and found
to be effective against the proliferation of breast and bladder tumor
lineages (Riva et al., 2001; Kaiser et al., 2013). From a mechanistic
point of view, Uncaria tomentosa was found to affect tumor growth by
inhibiting the Wnt or NF-kB/TNFα signaling pathways (Akesson et al.,
2003; Gurrola-Diaz et al., 2011). Moreover, Uncaria tomentosa aqueous
extract was reported to enhance DNA repair in human skin organ cul-
tures irradiated with UV-B (Mammone et al., 2006) and to abate actinic
keratoses and early squamous cell cancer in hairless mice exposed to
UV-A radiation thereby suggesting its possible application as a product
for skin cancer protection (Mentor et al., 2015).
The aim of the present study was to analyze, the biological effects of
Uncaria tomentosa extract on human immortalized keratinocytes and
squamous carcinoma cells in order to provide molecular evidence
supporting its therapeutic use against this type of cancer.
2. Materials and methods
2.1. Cell culture and reagents
HaCaT, spontaneously immortalized keratinocytes from adult skin,
were purchased from Service Cell Line (CLS, Germany) and cultured as
described (Amoresano et al., 2010); A431, human epidermoid carci-
noma cells were from American Type Culture Collection (ATCC, Man-
assas, VA). Head and neck cancer cell lines SCC011, SCC013 and SC-
C022 were originally derived from tumors in patients affected by
squamous cell carcinoma of the upper aerodigestive tract (Resto et al.,
2008). HaCaT and A431 cell lines were cultured in Dulbecco's Modified
Eagle's Medium (DMEM, Sigma Chemical Co, St. Louis, MO, USA),
while all SCC lines were cultured in Roswell Park Memorial Institute
medium (RPMI 1640 Sigma Chemical Co, St. Louis, MO, USA). All cell
line cultures were supplemented with 10% fetal bovine serum (FBS,
Hyclone Laboratories, Inc., Logan, UT, USA), 1% L-glutamine, and 1%
penicillin-streptomycin (ICN Biomedicals, Inc., Aurora, OH, USA) at
37 °C in humidified atmosphere of 5% CO2.
2.2. Bright-field microscopy
HaCaT, A431, SCC011, SCC013 and SCC022 cells were plated at a
density of 2.5 × 105 per well and treated with the indicated doses of
Uncaria Tomentosa. After 24 h of treatment, images were acquired in
phase-contrast at Nikon Eclipse TE-2000U.
2.3. Antibodies
The primary antibodies GAPDH (6C5), actin (I-19) and actinin (H-2)
were purchased from Santa Cruz Biotechnology, Inc. Santa Cruz, CA,
USA). Primary antibodies YB-1 (ab12148), hnRNPA1 (ab177152) were
from Abcam (Cambridge, UK). PARP1, p21-WAF (12D1), Bax (D2E11)
and H2AX antibodies were from Cell Signaling (Beverly, MA). Anti-
Ubiquitin antibodies were purchased from DAKO (Glostrup, Denmark).
2.4. Extract preparation
The water extract of Uncaria tomentosa bark (UT-ex) used for the
experiments was prepared as follows: 15 g of dried bark were shredded
and boiled for 30 min in 500 ml of bi-distilled H2O, then cooled at room
temperature (RT) and filtered through sterile gauze. The concentration
(w/v) was estimated by the ratio between the weight of the bark, ex-
pressed in grams, and the final volume obtained at the end of the
preparation:
=g g15 /400ml [00.0375 /ml]
UT-ex contains 1.28 mg/ml of proteins as determined by Bradford
assay, 3.08 mg/ml phenols and 4.05 mg/ml carboidrates (2.08 pentoses
and 1.97 hexoses).
The water extract was filtered through a 0.20 µm filter before being
applied to the cells. An aliquot was lyophilized (SAVANT, SC110 Speed
Vac Plus A) and resuspended in the initial volume of sterile H2O in
order to check for loss of properties during the sublimation process
(ReUT-ex).
2.5. Cell viability assay
The effect of Uncaria tomentosa on cell viability was evaluated by
measuring the reduction of 3-(4,5-dimethylthiazol-2) 2,5-diphenylte-
trazolium bromide (MTT) to formazan by mitochondrial dehy-
drogenase. Briefly, 9×103 cells were seeded on 96-well plates and ex-
posed to increasing concentrations of UT-ex (from 0.3 to 10 mg/ml) for
24, 48 and 72 h. MTT/PBS solution (0.5 mg/ml) was then added to the
wells and incubated for 3 h at 37 °C in a humidified atmosphere. The
reaction was stopped by removal of the supernatant followed by dis-
solving the formazan product in acidic isopropanol. Optical density was
measured with an ELISA reader (Bio-Rad) using a 570 nm filter. Under
these conditions, undissolved formazan crystals were not observed. Cell
viability was assessed comparing optical density of the treated samples
compared to the control group.
2.6. Cell growth profile
HaCaT, A431 and SCC022 cells were plated at a density of 2.5 ×
105 per well in a Corning 6 well plate and the counts were performed in
a Neubauer chamber by Trypan Blue dye exclusion. Briefly, 20 μL cell
suspension was diluted 1:1 with 0.4% solution of trypan blue in phos-
phate saline buffer pH 7.2. Cell counting was carried out at 24-hr in-
tervals for 3 days.
2.7. Cell cycle analysis
Cells were seeded at 3× 105 in 35 mm dishes and treated with UT-
ex at 0.3 and 1.5 mg/ml for 24 h. Cells were then trypsinized and wa-
shed by centrifugation (1200 rpm, 4 min, 4 °C) in Phosphate Buffered
Saline (PBS 1x). The cell pellet was resuspended in methanol, incubated
in ice for 20 min and centrifuged at 1200 rpm, 5 min, 4 °C. After a wash
in PBS, the cell pellet was incubated in PBS 1x, containing RNase
100 µg/ml for 20 min at RT. Propidium iodide was then added at a
concentration of 50 µg/ml for 30 min at 4 °C. Cell cycle analysis was
performed on the BD Accury™ C6 flow cytometer (BD Biosciences). Cell
debris and aggregates were excluded from the analysis.
2.8. Western blot and immunoprecipitation analyses
Immunoblots (IB) and immunoprecipitations (Co-IP) were per-
formed as previously described (Calabrò et al., 2004; Di Costanzo et al.,
2011). Uncaria tomentosa treated and untreated cells were harvested in
lysis buffer (50 mM Tris-HCl pH 7.5, 5 mM EDTA, 150 mM NaCl, 1%
NP-40, 1 mM phenylmethylsulfonyl fluoride, 0.5% sodium deox-
ycholate, and protease inhibitors) as previously described (Lo Iacono
F. Ciani et al. ???????????????????????????????????????????????
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et al., 2006). Total cell lysates were incubated on ice for 40 min and
clarified by centrifugation at 13,200 rpm for 15 min at 4 °C. The
amount of protein in the samples was determined by the Bio-Rad pro-
tein assay (Bio-Rad, Milan, Italy). After the addition of Laemmli buffer
(Sigma Chemical Co, St. Louis, MO, USA) the samples were boiled at
100 °C for 5 min and resolved by SDS-polyacrylamide gel electrophor-
esis (SDS-PAGE). The proteins were then transferred to a poly-
vinylidene difluoride membrane (PDVF, Millipore) using a Mini trans-
blot apparatus (Bio-Rad, Milan, Italy) according to manufacturer's in-
structions. The PVDF membrane was blocked in 5% w/v milk buffer
(5% w/v non-fat dried milk, 50 mM Tris, 200 mM NaCl, 0.2% Tween
20) and incubated with primary antibodies diluted in 5% w/v milk or
bovine serum albumin (BSA) buffer for 2 h at RT or overnight at 4 °C.
The blots, washed three times with TTBS (Tris-buffered saline, 0.1%
Tween), were incubated for 1 h at RT with HRP-conjugated secondary
antibodies (Santa-Cruz biotechnology). The proteins were visualized by
an enhanced chemiluminescence method (ECL, GE-Healthcare) and
analyzed by Quantity One W software of ChemiDoc TM XRS system
(Bio-Rad, Milan, Italy). For IP experiments, extracts were pre-cleared
with 30 μL of protein A-agarose (50% slurry; Roche, Manheim, Ger-
many), and incubated overnight at 4 °C with anti-YB-1 (3 μg) or α-
rabbit IgG (3 μg). Whole extracts were separated by SDS-PAGE and
subjected to immunoblot, as previously described.
2.9. Reactive oxygen species (ROS) generation assay
Intracellular ROS generation was measured by flow cytometry using
2!−7! dichlorofluorescein diacetate (DCFDA), a non-fluorescent com-
pound permeable to the cell membrane, which can be oxidized by ROS,
giving a fluorescent compound. In brief, 3× 105 cells were treated with
different concentrations of Uncaria tomentosa (0.3 and 3 mg/ml), the
medium was removed after 24 h and cells were washed with PBS. Fresh
medium with DCFDA (1 mM) was added for 30 min, then DCFDA was
removed by washing in PBS and the cells were harvested. The mea-
surement of ROS was obtained using flow cytometry Accuri C6 (BD-
biosciences, US) and for each sample at least 10, 000 events were
evaluated. The fluorescence emitted from the cells treated with DCFDA,
compared to the untreated cells, was performed using the FL1-A
(530–533 nm) channel. The data obtained as mean fluorescence in-
tensities were analyzed and converted into percentages of ROS by BD
Accuri C6 Software.
2.10. Genomic DNA extraction
Uncaria tomentosa treated and untreated cells were harvested in lysis
buffer (10 mM Tris pH 8.0, 50 mM NaCl, 20 μg/ml di Proteasi K, 20 μg/
ml di RNasi) with 1% SDS. Samples were incubated 2 h at 55 °C and
then treated with 1.5 M of NaCl. A 1:1 vol of chloroform was added and
samples were incubated for 1 h on rotation at room temperature.
Samples were centrifuged at 13,200 rpm for 3 min, then 0.7 vol (com-
pared to volume of lysis buffer) of isopropanol was added to super-
natants.
Samples were centrifuged for 3 min at 13,200 rpm, the white pellet
was resuspended in TE solution. 20 microliters of each sample were
loaded in 1.2% agarose gel in TAE buffer. Images were acquired after
trans-UV irradiation and analyzed by Quantity One W software of
ChemiDoc TM XRS system (Bio-Rad, Milan, Italy).
2.11. Comet assay
The glass slides were coated with 50 μL of normal-melting-point
agarose (0.7%). Then, 200 μL of 1% agarose were applied and allowed
to solidify at 4 °C. Then, 50 μL of cell/agarose mixture, 25 μL of 0.7%
agarose plus 25 μL of cell suspension (105 cells), was applied as a third
layer. After 20 min in ice, 200 μL of 0.7% agarose was applied as a
cover layer of the microgel.
The slides were immersed in cold fresh lysis solution (2.5 M NaCl,
100 mM EDTA, 10 mM Tris) for 1.5 h at 4 °C and then placed for 20 min
in electrophoresis buffer (300 mM NaOH, 1 mM EDTA, pH 13). The
electrophoresis was performed at 25 V at room temperature for 30 min.
The slides were then rinsed twice with the neutralization buffer (0.4 M
Tris, pH 7.5) and stained with DAPI.
Images were acquired with Nikon Eclipse TE-2000U fluorescence
microscope. Cells (100) were counted and those showing the comet
were expressed as percentage of the total.
Fig. 1. (A) Percentage of viability of HaCaT, SCC013, SCC011, SCC022 and A431 cell lines after 48 h of incubation with the indicated doses of UT-ex (mg/ml). Cell viability was measured
by the chromogenic MTT assay and is expressed as the percentage of viable cells compared to cells in the absence of the plant extract (mean± S.D. n = 6 technical replicates). ANOVA *
p<0.05, ** p< 0.005. (B) Bright-field microscopy of representative images of A431, SCC022, SCC011, SCC013 and HaCaT cells after 24 h of incubation with UT-ex at increasing
concentrations from 0 to 10 mg/ml (0, 0.3, 3.0 and 10 mg/ml).
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2.12. Statistical analysis
Statistical significance of difference in measured variables between
control and treated groups was determined by t-test or one-way
ANOVA. Difference was considered significant at P<0.05 (*) and
P<0.005 (**).
2.13. General chemical procedures
Analytical and preparative TLC were performed on silica gel
(Kieselgel 60, F254, 0.20 and 0.5 mm respectively) and on reversed
phase (Kieselgel 60 RP-18, F254, 0.20 mm) plates (Merck, Darmstadt,
Germany). The spots were visualized by exposure to UV radiation
(254), or by spraying first with 10% H2SO4 in MeOH and then with 5%
phosphomolybdic acid in EtOH, followed by heating at 110 °C for
10 min.
The HPLC system (HITACHI) consisted of a pump (5160) and a
spectrophotometric detector (5410). The HPLC separation were per-
formed using a Phenomenex LUNA (C18 (2) 5 u 150 × 4.6 mm). The
mobile phase used to elute the samples was MeOH:H2O, 0.1% TFA at a
flow rate of 0.4 ml/min. The analysis was performed using a linear
gradient starting from 30% of MeOH increased linearly to 50% MeOH
in 10 min and holded this conditions for 25 min. The initial conditions
were restored according to a linear gradient over 5 min and the column
was re-equilibrated under these conditions for 10 min before the next
run. Detection was performed at 250 nm. Samples were injected using a
20-μL loop and monitored for 30 min.
1H NMR spectra were recorded at 400 or 500 MHz in CDCl3 on
Bruker (Karlsruhe, Germany) and Varian (Palo Alto, CA, USA). The
same solvent was used as internal standard.
LC-TOF analysis were performed using the LC/MS TOF system
(AGILENT 6230B, HPLC 1260 Infinity), using the same HPLC condi-
tions.
Spectra/Por Dyalisis Membrane (cut-off 3500 Da) were purchased
from Sigma (Milan, Italy) and the dialyses carried out for two days
against a large volume of distilled water.
3. Results
3.1. UT-ex cytotoxicity in squamous carcinoma cells
Human immortalized HaCaT keratinocytes and keratinocyte-de-
rived squamous carcinoma cells (SCC013, SCC011, SCC022 and A431)
were treated for 48 h with increasing doses of UT-ex, from 0.5 to
10 mg/ml, and cell viability was analyzed by MTT assay. The yellow
tetrazolium salt 3-(4, 5-dimethylthiazol-2-yl)−2, 5-diphenylte-
trazolium bromide (MTT) is widely used to determine cell viability in
cell proliferation and cytotoxic assays. MTT is reduced by metabolically
Fig. 2. (A–E) Percentage of viability of A431, HaCaT, SCC022, SCC011 and SCC013 cells after 24, 48 and 72 h of incubation with increasing doses of UT-ex (0.3, 0.5, 1, 1.5, 2, 2.5, 3.0 and
10 mg/ml). Cell viability was measured by the chromogenic MTT assay and is expressed as the percentage of viable cells compared to cells in the absence of the plant extract (mean± S.D.
n = 6 technical replicates). ANOVA * p<0.05, ** p<0.005.
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active cells to form an insoluble purple formazan product that is
quantifiable by spectrophotometry. At 0.5 mg/ml of UT-ex, im-
mortalized HaCaT, highly metastatic SCC022, and non-metastatic
SCC013 and SCC011 cells were more viable than control cells (ranging
from 1.1 to 1.5 folds) (Fig. 1A). Vulvar epidermoid A431 cells remained
almost unaffected by treatment with 0.5 mg/ml of UT-ex (Fig. 1A). At
higher concentrations, UT-ex was clearly cytotoxic and exhibited a
dose-dependent effects in all tested cell lines (Fig. 1A). Compared to
untreated controls, epidermoid A431 cells were the most susceptible to
UT-ex with a residual cell viability of less than 10% at 10 mg/ml of UT-
ex (Fig. 1A).
Bright-field microscopy and imaging confirmed the major sensitivity
of A431 cells compared to the other cell lines. However, upon treatment
with 10 mg/ml of UT-ex, all tested cells exhibited a round morphology,
a cytoplasmic vacuolization and loss of cell-cell contacts, indicating
severe cell damage (Fig. 1B).
To better examine their different susceptibility, we performed a
more detailed evaluation of UT-ex, cytotoxicity on squamous cancer
cell lines compared to spontaneously immortalized HaCaT keratino-
cytes. We confirmed that A431 cells were the most sensitive to UT-ex
with a half-maximal inhibitory concentration (IC50) between 1.5 and
2.0 mg/ml at 48 h of treatment (Fig. 2A). HaCaT cell viability began to
progressively decline at UT-ex concentration of 1.5 mg/ml of UT-ex,
(Fig. 2B) while viability of SCC022, SCC011 and SCC013 cells dropped
precipitously to 20–30% upon treatment with 10 mg/ml of UT-ex for
48 h (Fig. 2C–E). As shown in Fig. 2A–E, the reduction of cell viability
was most pronounced at 48 and 72 h of treatment in all cell lines thus
revealing a time-dependent toxicity of UT-ex. Remarkably, at 10 mg/ml
of UT-ex, untransformed HaCaT keratinocytes were more resistant than
all squamous carcinoma cell lines tested (Fig. 2A–E). Similar results
were obtained by treating cells with the extract that was first
lyophilized, stored at−20 °C for 1 month and then reconstituted by re-
adding water up to the initial volume (reUT-ex) (Fig. S1).
Using MTT assays, we detected an increase of cell viability at UT-ex
concentrations ranging between 0.3 and 1.5 mg/ml, in all tested cell
lines (Fig. 2A–E). With cell growth profiling, however, we found no
increase in the rate of cell proliferation (Fig. S2 A–C).
Next, we focused our further studies on A431 and SCC022 carci-
noma cells which are the most sensitive and the most resistant to UT-ex,
respectively.
We investigated the effect of low doses of UT-ex (0.3 and 1.5 mg/
ml) on cell cycle distribution by flow cytometry. As shown in Fig. 3A, B
and C, there was a significant change in the cell number in the different
cell cycle phases. Specifically, at 1.5 mg/ml of UT-ex, in HaCaT cells we
observed accumulation of G1 arrested cells (3 A) while the majority of
A431 and SCC022 cells were arrested in the G2/M phase (Fig. 3B and
C). The observed cell cycle arrest was associated with the induction of
the cell cycle inhibitor p21/WAF protein (Fig. 3D).
The presence of cleaved Poly [ADP-ribose] polymerase 1 (PARP-1)
is used diagnostically to detect apoptosis in many cell types (Gobeil
et al., 2001). Thus, we analyzed PARP-1 proteolysis by immunoblot in
HaCaT, A431 and SCC022 cells treated with 0.3, 3.0 and 10 mg/ml of
UT-ex. Based on the MTT assays, at this concentration range, we ex-
pected to detect molecular evidence of UT-ex effects. In fact, at 0.3 mg/
ml of UT-ex all cell lines showed a viability comparable to the control
cells; at 3.0 mg/ml the most resistant cell line (SCC022) exhibited a
clear response to the treatment; finally at 10 mg/ml, all cell lines were
sensitive to UT-ex treatment and underwent cell death.
The appearance of the 89 kDa PARP-1 fragment generated by
Caspase 3 cleavage (Fig. 4A, black arrows) along with the apoptotic
DNA fragmentation pattern observed in UT-ex treated HaCaT cells
suggested the occurrence of apoptosis (Fig. 4B). This was also
Fig. 3. Cell cycle analysis of HaCaT (A), A431 (B) and SCC022 (C) cells treated or not with 0.3 and 1.5 mg/ml of UT-ex. Each plot represents the percentage of cells in the different cell
cycle phases. (D) Immunoblot analysis of extracts from HaCaT, A431 and SCC022 cells treated with 0.3 and 1.5 mg/ml of UT-ex for 24 h. Aliquots of extracts (25 μg) were loaded and
subjected to SDS-PAGE and immunoblot analysis with p21-WAF and GAPDH antibodies.
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confirmed by the comet assay (Fig. S3) and induction of the proa-
poptotic Bax protein in HaCaT and SCC022 cells (Fig. 4C). Un-
fortunately, because of their high sensitivity to UT-ex, very limited
amount of cell extract was recovered from A431 cells treated with
10 mg/ml of UT-ex. However, the strong induction of γ-H2AX histone
protein indicated the occurrence of DNA damage in all tested cell lines
(Fig. 4C).
3.2. UT-ex induces oxidative stress in HaCaT and A431 cells
Previous studies have shown that many natural products cause
apoptosis in cancer cells through the production of Reactive Oxygen
Species (ROS) (Martin-Cordero et al., 2012). Therefore, we tested
whether apoptosis induced by UT-ex was ROS-dependent using flow
cytometry after staining with 2!−7! diclorofluorescin diacetate
(DCFDA). Control cells were incubated for 30 min with DCFDA alone,
while treated cells were incubated with UT-ex (0.3 or 3.0 mg/ml) for
24 h and subsequently with DCFDA for 30 min. The amount of ROS was
normalized for a sample of cells without DCFA. Compared to control
cells, HaCaT and A431 cells treated with 0.3 mg/ml of UT-ex showed a
moderate increase of intracellular ROS (Fig. 5). Treatment with 3 mg/
ml of UT-ex, instead, resulted in a 28% and 70% increase in ROS
production in HaCaT and A431 cells, respectively (Fig. 5). These results
strongly suggest that the observed cell death was ROS-dependent.
3.3. UT-ex influences YB-1 proteolytic cleavage
The multifunctional Y-box binding Protein-1 (YB-1 or YBX-1) pro-
vides cellular protection from oxidative stress and participates in DNA
damage repair mechanisms by interacting with Mre11 and Rad50
complexes (Somasekharan et al., 2015; Kim et al., 2013). It was pre-
viously reported that YB-1 cleavage by the 20 S proteasome leads to the
accumulation of a 36 kDa nuclear form which is recruited to DNA da-
mage sites to participate in DNA repair (Kim et al., 2013).
We tested the effect of increasing the amount of UT-ex (from 0.3 to
10 mg/ml) on YB-1 using immunoblot analyses.
In untreated HaCaT cells, full length YB-1 (50 kDa) was largely
predominant over the 36 kDa form (Fig. 6A, lane 1). However, the
36 kDa proteolytic fragment of YB-1 increased as a result of UT-ex
treatment up to 3.0 mg/ml (Fig. 6A, lanes 2–5) and abruptly dis-
appeared at 10 mg/ml of UT-ex (Fig. 6A, lane 6 and 7). Interestingly, in
untreated SCC022 and A431 cells, the 50 and 36 kDa forms of YB-1
were almost equally represented in (Fig. 6B and C, lanes 1). However,
similarly to what we observed in HaCaT, in SCC022 cells the 36 kDa
Fig. 4. (A) Representative immunoblot analyses of HaCaT, A431 and SCC022 cells after 48 h of treatment with the indicated doses of UT-ex (mg/ml). Equal aliquots of extracts (25 μg)
were subjected to immunoblot analysis with PARP1 antibodies. (B) Electrophoresis on agarose gel (1.2%) of genomic DNA isolated from HaCaT cells treated or not with 10 mg/ml of UT-
ex extract. (C) upper panel Representative immunoblot analyses of HaCaT, A431 and SCC022 cells after 48 h of treatment with the indicated doses of UT-ex (mg/ml). Equal aliquots of
extracts (25 μg) were subjected to immunoblot analysis with Bax and H2AX antibodies. GAPDH antibodies were used as loading control; lower panel Densitometric analysis of Bax protein
levels.
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band of YB-1 was significantly reduced at 10 mg/ml of UT-ex (Fig. 6B,
lane 4). In A431 cells, however, the 36 kDa YB-1 band disappeared in
cells treated with 3.0 mg/ml of UT-ex (Fig. 6C, lanes 3 and 5). In
contrast, the level of full length YB-1 appeared to be unaffected or even
increased thereby suggesting that full length YB-1 was stabilized
(Fig. 6A, B, C). However, it has to be noted that at 10 mg/ml of UT-ex
both YB-1 and GAPDH were undetectable because of extensive cell
death (Fig. 6C, lane 6). Strikingly, the level of hnRNPA1, a RNA-binding
protein that is known to be degraded by caspase 3 (Back et al., 2002),
was completely degraded in cells treated with UT-ex, in a dose-de-
pendent manner (Fig. 6D, E and F).
We have previously shown that YB-1 is polyubiquitinated (Di
Martino et al., 2016). Moreover, under DNA damage conditions, YB-1
undergoes a proteasome-dependent proteolytic cleavage, resulting in
the YB-1 36 kDa form. Accumulation of full length YB-1, with the
parallel disappearance of the YB-1 36 kDa, suggests an impairment of
proteasome activity. Therefore, we investigated whether UT-ex caused
an accumulation of protein ubiquitination. Immunoblot analysis of total
protein extract from untreated and UT-ex treated cells clearly showed
an increase of total ubi-conjugated proteins, thereby confirming a de-
fective proteasomal degradation in the presence of UT-ex (Fig. 7A, B,
C). Finally, we performed a specific immunoprecipitation of YB-1 pro-
tein. YB-1 immunocomplexes were then analyzed by immunoblot with
Ubiquitin (Ubi) antibodies. As shown in Fig. 7D, the signal obtained
from cells treated with UT-ex was enhanced, thus confirming that Ubi-
conjugated YB-1 was accumulated (Fig. 7D).
3.4. Preliminary chemical analysis of aqueous extract
The dried aqueous extract obtained from Uncaria tomentosa cell
cultures was analyzed by TLC in different solvent mixtures: i-PrOH:H2O
8:2, v/v; CHCl3:i-PrOH 9:1, v/v; EtOAc:n-hexane 6:4, v/v that showed
the presence of a mixtures of low and medium molecular weight
compounds. The extract was dissolved in a minimal amount of ultra-
pure Milli-Q water and dialysed (cut-off 3500 Da). The tube content
(IN) and the out fraction (OUT) were collected lyophilized, and re-
suspended in the same initial volume. The fractions were separately
tested for their cytotoxic activity against A431 cells by MTT assay as
previously described. Remarkably, most of cytotoxic activity remained
in the OUT fraction that contains hydrophilic low molecular weight
metabolites (Fig. S4). Therefore, the OUT fraction was analyzed by
HPLC, 1H NMR and LC-TOF.
The HPLC profile of the OUT fraction of the dialyses (Fig. S5)
showed the presence of several peaks. Its 1H NMR (Fig. S6) showed the
presence of two main anomeric protons at δ 5.4 and 5.1 ppm and
complex signals in the region of the hydroxylated protons in the range
of δ 4.1–3.2 ppm, suggesting the presence of saccharide mixtures.
Complex signals were also present in the region of aliphatic protons at δ
2.0–1.5 ppm (Pretsch et al., 2000).
The LC-MS/TOF (Figs. S7 and 8) spectra showed eight main peaks
detected in the molecular weight range of 350–570 m/z that could be
consistent with the nature of metabolites suggested by HPLC and 1H
NMR analysis. In particular, four of them (Fig. S7) showed both the
sodiated [M + Na]+ and the sodiated dimmer [2 M + Na]+ forms at
m/z 383 and 743, 409 and 795, 428 and 833, 501 and 979, consistent
with molecular weight of 360, 386, 405 and 478, respectively.
4. Discussion
Biological effects of complex mixtures of phytochemicals are diffi-
cult to predict from chemical analysis of individual constituents be-
cause they generally combine the advantage of targeting multiple mo-
lecular pathways that are involved in complex disorders with a
considerable reduction in toxic side effects (Wagner et al., 1985b).
Cancer control may benefit from the potential in alternative thera-
pies. Ideally, a phytochemical should possess anti-tumor properties,
minimal, toxicity and a defined mechanism of action. The knowledge of
the mechanism of action and the signaling pathways targeted by natural
compounds can lead to understanding the molecular mechanisms in-
volved in cancer progression and may indicate novel therapeutic ap-
proaches.
Induction of apoptosis is considered one of the most important
markers of cytotoxicity for antitumor agents. Some natural compounds,
including plant metabolites, are able to induce apoptotic pathways that,
through various mechanisms are usually blocked in cancer cells.
We have presented evidence that an aqueous extract from Uncaria
tomentosa barks affects viability of squamous carcinoma cells through a
combination of increased oxidative stress and impaired DNA repair. Our
data are in agreement with previous studies showing that Uncaria to-
mentosa extract is able to enhance chemotherapy-induced apoptosis,
with an increase in caspase activities and DNA fragments in cultures of
neoplastic cells (De Oliveira et al., 2014).
In our study, Uncaria tomentosa water extract exhibited dose-de-
pendent cytotoxic and antimitotic effects on human spontaneously
immortalized HaCaT keratinocytes and squamous carcinoma cells. The
inhibitory effect on cell viability was time and dose-dependent.
Remarkably, compared to the other tumor cell lines used in this
study, the SCC022 cells exhibit a very different response to UT-ex
treatment. However, in a previous work from our group (Troiano et al.,
Fig. 5. Percentage of intracellular ROS levels in HaCaT and A431 cells treated with 0.3 or
3.0 mg/ml UT-ex. Data were analyzed and converted in percentage of ROS by BD Accuri
C6 Software. Representative FACS-derived histograms showing increased ROS in HaCaT
(upper panel) and A431 (lower panel) cells treated with UT-ex 0.3 mg/ml (left panel) or
UT-ex 3.0 mg/ml (right panel) compared with control cells without DCFDA (% of ROS =
1) and untreated cells incubated with DCFDA. 20.000 events were evaluated. Data were
analyzed and converted in percentage of ROS by BD Accuri C6 Software.
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2015) we have shown that this cell line is PTEN-defective and therefore
exhibits constitutive AKTSer473 hyperphosphorylation that was even
potentiated by YB-1 silencing. Constitutive activation of AKT survival
pathway may be the likely explanation for the lower sensitivity of these
cells to UT-ex treatment.
Morphological changes induced by UT-ex were associated with
PARP1 cleavage, increase of BAX protein levels, and internucleosomal
DNA fragmentation indicating apoptosis.
An important finding of our work is that Uncaria-induced
cytotoxicity was associated with ROS production. ROS are also a by-
product of normal metabolism; short exposure of non-proliferating cells
to relatively low doses of ROS was shown to activate signal transduction
pathways comparable to the effects of mitogens (Deavall et al., 2012).
This may be the most likely explanation for the increase of cell viability
observed at low concentrations of UT-ex, in the majority of the cell lines
tested in this work (HaCaT and SCCs). However, when the level of ROS
exceeded the cellular antioxidant capacity, their reactive nature may
otherwise cause damage to key cellular components and induce cell
Fig. 6. (A–C) Immunoblot analysis of HaCaT, SCC022 and A431 cells treated with 0.3, 3.0 and 10 mg/ml of UT-ex for 48 h. Equal aliquots of extracts (25 μg) were loaded and subjected to
SDS-PAGE and immunoblot analysis with YB-1 antibodies. GAPDH antibodies were used as loading control. (D-F) Immunoblot analysis of HaCaT, SCC022 and A431 cells treated with 0.3
and 3.0 and 10 mg/ml of UT-ex for 48 h. Equal aliquots of extracts (25 μg) were loaded and subjected to SDS-PAGE and immunoblot analysis with hnRNPA1 antibodies. Actinin
antibodies were used as loading control.
Fig. 7. (A–C) Immunoblot analysis of HaCaT, A431
and SCC022 cells treated with 0.3, 3.0 and 10 mg/ml
of UT-ex for 48 h. Equal aliquots of extracts (25 μg)
were loaded and subjected to SDS-PAGE and im-
munoblot analysis with Ubiquitin antibodies.
GAPDH antibodies were used as loading control. (D)
Equal aliquots of HaCaT cells treated with 0.3 and
3.0 and 10 mg/ml of UT-ex for 48 h shown in Fig. 7A
were immunoprecipitated (IP) with anti-YB-1 or an
irrelevant α-rabbit antibodies (IgG). Im-
munocomplexes were blotted and probed with Ubi-
quitin (left panel) or YB-1 (right panel) antibodies.
F. Ciani et al. ???????????????????????????????????????????????
???
death.
Because cancer cells are sensitive to oxidative stress, the mechanism
of action for many cancer chemotherapeutic drugs involves ROS-
mediated apoptosis (De Oliveira et al., 2014). Interestingly, after
treatment with low doses of UT-ex, immortalized keratinocytes were
still able to activate a G1/S cell cycle checkpoint, allowing them to
repair DNA damage before DNA duplication. This could potentially
explain their relative resistance to UT-ex induced apoptosis. Under the
same conditions, A431 and SCC022 cancer cells showed a defective G1/
S checkpoint with a consequent accumulation of G2/M arrested cells
followed by massive apoptosis.
Exposure of non-proliferating cells to relatively low doses of ROS
can activate mitogenic signals (Deavall et al., 2012). At low doses, UT-
ex increased HaCaT and A431 cell viability; however, we found no
significant increase in the rate of cell proliferation, thereby suggesting
that, at the concentration tested, UT-ex could enhance cell metabolism
rather than cell proliferation.
Our in vitro studies implicate the Y-Box-binding protein 1 (YB-1) in
UT-ex induced apoptosis. YB-1 is a multifunctional protein participating
in oncogenesis and is an oncomarker of breast, lung, liver, ovarian and
squamous cell carcinoma (Lasham et al., 2013). We have previously
identified YB-1 as a partner of ΔNp63α, the predominant protein ex-
pressed in proliferative squamous epithelia, and demonstrated that YB-
1 and ΔNp63α interplay supports keratinocyte proliferation and pro-
tects keratinocytes from apoptosis under genotoxic stress (Di Martino
et al., 2016; Di Costanzo et al., 2012). YB-1 is predominantly localized
to cytoplasm, where it serves as a sensor of oxidative stress. Indeed, it
was found to be implicated in translational repression and assembly of
Stress Granules upon heat shock and oxidative stress (Kedersha et al.,
2005). However, in response to severe genotoxic insults, UV, doxor-
ubicin, cisplatin, etoposide and prolonged oxidative stress, YB-1 accu-
mulates into the nucleus and participates in DNA damage repair (Kim
et al., 2013). In particular, full length YB-1 (50 kDa) undergoes specific
post-translational modifications and limited cleavage by the protea-
some leading to the nuclear accumulation of the N-terminal YB-1
36 kDa fragment. YB-1 36 kDa form functionally interacts with BER
factors (NEIL1, PARP1 and 2) and Double Strand Break (DSB) repair
proteins MRE11 and Rad50 (Alemasova et al., 2016) and enhances cell
survival (Kim et al., 2013). We believe that the relevance of this me-
chanism in cancer-cell chemo-resistance is still underestimated.
Strikingly, we found that treatment of cells with lethal doses of UT-
ex were associated with the reduction/disappearance of the pro-sur-
vival YB-1 36 kDa form in HaCaT, SCC022 and A431 cells. Because the
level of full length YB-1 was unaffected, or even increased, by UT-ex
treatment, we postulate that UT-ex could have a proteasome-inhibitory
activity. The increase of total protein ubiquitination and the accumu-
lation of Ubiquitin-conjugated YB-1 confirmed our hypothesis. It is not
hard to speculate that other proteasome inhibitors already in clinical
practice such as Bortezomib (Crawford et al., 2011) can exert their
anticancer effects by targeting YB-1, and their relative efficacy may
partly depend upon on their effect on YB-1 proteolytic cleavage. Al-
though not exhaustive, chemical analysis of UT-ex showed that beside a
large amount of saccharides, it contained further low molecular weight
metabolites. Previously, phytochemical investigations on U. tomentosa
and related species suggested the presence of indole and oxindole al-
kaloids, triterpenes and polyphenols (Lock et al., 2016). However,
further purification of the mixture is in progress in order to confirm the
nature of these classes of compounds and identify those that are ef-
fective against squamous carcinoma cells.
5. Conclusion
Being at the interface between oxidative stress and molecular me-
chanisms controlling cell proliferation and DNA damage repair, the YB-
1 protein might not only provide a survival advantage to error-prone
cancer cells, but also protect them from chemotherapy-induced
apoptosis. We have clear evidence that Uncaria tomentosa water extracts
contains bioactive molecules that interfere with the proteasome-medi-
ated YB-1 proteolytic cleavage thus reducing the capacity of cells to
effectively repair damaged DNA. Our study indicates that Uncaria
Tomentosa pro-apoptotic activity results from its ability to simulta-
neously induce oxidative DNA damage and antagonize the mechanisms
of DNA repair relying on the activity of YB-1 36 kDa form. In light of
our current knowledge about the pro-apoptotic effects of UT-ex in
squamous cancer cells, we believe that this plant may have a high po-
tential value as an effective agent for treatment of cancerous skin le-
sions.
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Abstract  38 
Background.	Endogenous reactive oxygen species (ROS) are by-products of the aerobic metabolism of cells 39 
and have an important signalling role as secondary messengers in various physiological processes, including 40 
cell growth and development. However, the excessive production of ROS as well as the exposure to 41 
exogenous ROS, originated, for example, from xenobiotics or foods, can cause protein oxidation, lipid 42 
peroxidation and DNA damages leading to cell damages and a number of health disorders. ROS accumulation 43 
has been associated, for example, to neurodegenerative diseases, progression of arteriosclerosis and 44 
inflammatory bowel diseases. A variety of molecules and live bacteria with antioxidant activity have been 45 
proposed as food additives to avoid ROS accumulation. 46 
Objective.  Here we demonstrate that spores of SF185, a human isolate of Bacillus megaterium, have intrinsic 47 
antioxidant activity and we analyse their effect in vitro and in vitro. 48 
Methods. The antioxidant effects of SF185 spores were tested in vitro on Caco-2 cells measuring the ability 49 
of spores to reduce the toxicity of hydrogen peroxide and in vivo in a murine model of dextran sodium sulfate 50 
(DSS) -induced oxidative stress. 51 
Results. In vitro, spores have a scavenging action reducing the amount of intracellular ROS and so inducing 52 
a protected state in cells. Pre-dosing mice with spores before the treatment with DSS protects the animals 53 
from the chemically-induced damages.  54 
	Conclusions. The consumption of spores-based products could prevent or reduce the damages caused by 55 
oxidative stress. The human origin of SF185, its strong antioxidant activity, and its protective effects both in 56 
vitro and in vivo led to propose the spore of this strain as a new probiotic for gut health.  57 
  58 
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Introduction 59 
Reactive Oxygen Species, including hydrogen peroxide, superoxide and hydroxyl radicals, are common by-60 
products of the aerobic metabolism of all cells [1]. While at low intracellular concentrations ROS are critical 61 
signalling molecules with a role in cell proliferation and survival [2], their accumulation severely damages DNA, 62 
proteins and lipids leading to a variety of chronic diseases, including atherosclerosis, arthritis, diabetes, 63 
neurodegenerative, cardiovascular problems and inflammatory bowel diseases [3-7]. All aerobic organisms 64 
avoid ROS accumulation with a variety of enzymes (catalase, superoxide dismutase, glutathione peroxidase, 65 
and glutathione reductase) and with non-enzymatic molecules with antioxidant activity (glutathione, 66 
thioredoxin, Vitamin C, Vitamin E). The production of an excess of ROS induces the development of a state of 67 
oxidative stress that has a crucial role in the development and perpetuation of an inflammatory status, thus 68 
contributing to the pathophysiology of several diseases [8]. In particular, intestinal epithelial cells are 69 
continuously exposed to ROS derived by their own metabolism, by the metabolism of the huge number of 70 
microbes normally living in the animal gut and by ingested foods [9]. Antioxidant additives contribute to avoid 71 
the accumulation of ROS and thus have a protective role against oxidative damages [10]. During years many 72 
natural antioxidant additives have been proposed and tested. Examples include polyphenols (green tea), 73 
flavones, ginsenosides and more recently carotenoids [11-12]. 74 
Intestinal bacteria have a clear role in protecting the animal body against oxidative damages. A study 75 
performed with a rat model of diet-induced oxidative stress has shown that an antibiotic treatment, as well as 76 
the replacement of the gut microbiota, was able to prevent the oxidative damages in liver and skeletal muscle 77 
[13]. Therefore, it is not surprising that beneficial bacteria (probiotics) with strong antioxidant properties have 78 
been proposed to prevent oxidation of cellular substrates [10]. Examples are species of the Bifidobacterium 79 
and Lactobacillus genera, shown able to scavenge hydroxyl radicals and superoxide anions in vitro and to 80 
enhance the action of antioxidant enzymes in vivo [14-16], or cells of a carotenoid-producing strain of Bacillus 81 
indicus, shown to reduce oxidative markers in plasma and liver in vivo [17]. 82 
In addition to vegetative cells also bacterial spores have been shown to have antioxidant properties. Spores 83 
are quiescent cell forms produced by over 1,000 bacterial species, mainly belonging to the Clostridium or 84 
Bacillus genera [18]. These microorganisms respond to adverse environmental conditions by producing a 85 
highly resistant spore, that can survive indefinitely in the absence of water and nutrient [19]. The dormant 86 
spore can, however, germinate originating a vegetative cell able to grow when appropriate conditions are 87 
encountered [19]. Spores of several Bacillus species are commonly used as probiotics and are known to have 88 
beneficial properties [20, 21]. An in vitro study has recently shown that a pre-treatment with Bacillus subtilis 89 
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spores before a sodium arsenite-induced oxidative stress allows human keratinocytes to keep normal levels 90 
of intracellular ROS, GSH and lipid peroxidation [22]. Spores have been proposed to contribute to cell 91 
protection by inducing the expression of antioxidant enzymes by activating the nuclear translocation of the E2-92 
related factor 2 (Nrf2). In the nucleus, Nrf2 binds to cis-acting Antioxidant Response Elements, present in the 93 
promoter region of genes coding for antioxidant/detoxifying enzymes, activating transcription initiation [3, 22]. 94 
Here, we report that spores of a human isolate of Bacillus megaterium have a strong antioxidant activity and 95 
that a treatment with these spores protects Caco-2 cells from oxidative damages and reduces the DSS-induced 96 
gut damages in mice.  97 
 98 
Methods 99 
Bacterial strains  100 
Sporulation of Bacillus megaterium SF185 and QM B1551 strains was induced by the exhaustion method [23]. 101 
After 30 hours of growth in Difco Sporulation medium (DSM) at 37°C with vigorous shaking, spores were 102 
collected, washed three times with distilled water and purified by gastrografin gradient as described before 103 
[23]. Spore counts were determined by serial dilution and plate-counting.  104 
 105 
Cell culture conditions and MTT assay  106 
Human colon adenocarcinoma Caco-2 cells (ATCC HTB-37) were routinely cultured at 37°C in a humidified 107 
5% CO2 incubator in Dulbecco’s Modified Eagle Medium (DMEM, Gibco) supplemented with 10% (v/v) FBS 108 
(Gibco), 1% penicillin-streptomycin (Gibco), 1% L-glutamine (Gibco) [24]. Cell viability was assessed using the 109 
MTT assay (Sigma-Aldrich). It is based on the reduction of the tetrazolium ring of 3-(4,5-dimethylthiazol-2-yl)-110 
2,5-diphenyltetrazolium bromide (MTT) by mitochondrial dehydrogenases, yielding a purple dye (formazan), 111 
which can be measured spectrophotometrically; the amount of formazan produced is proportional to the 112 
number of viable cells. Cells were incubated for 3 h at 37°C with a 1X MTT solution diluted in DMEM without 113 
Phenol Red, supernatant was removed, and acidic isopropanol 0.01 N was added to each well to dissolve 114 
insoluble formazan crystals formed. The absorbance of the samples was measured at a 570 nm using a 115 
microplate reader (Multiskan spectrum, Thermo) [25].  116 
 117 
DPPH and Catalase Assays  118 
The α,α-diphenyl-β-picrylhydrazyl (DPPH) free radical scavenging method was used to evaluate the potential 119 
antioxidant activity of spores [26]. Different concentrations of spores were incubated in a final volume of 1 ml 120 
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of 100% methanol containing 0.1 mM of freshly prepared DPPH (giving absorbance ≤ 1.0). The reaction was 121 
allowed to proceed for a maximum time of 30 minutes at 25°C, in any case till completion, and followed at λ= 122 
515nm. The DPPH free radical scavenging activity was calculated according to the following equation:  123 
                     !""#	radical	scavenging	activity		 % = 1 −
6789:;<7
6=>?@A>;
×	100  124 
where Asample is the absorbance of the reacted mixture of DPPH with the	with the extract sample, and Acontrol 125 
is the absorbance of the DPPH solution. 126 
Quantitative determination of catalase activity of spores was measured by the loss of absorbance at 240 nm 127 
as previously described by Beers and Sizer [27]. Briefly, spores (5x10
8
 or 1x10
9
) were incubated for 30 min at 128 
room temperature in 1ml of hydrogen peroxide solution [50mM Potassium Phosphate Buffer, pH 7.0; 0.036% 129 
(w/w) H2O2]. Then, samples were centrifuged for 1 min at 13000 g to remove the spores and the hydrogen 130 
peroxide concentration in solution was determined by measuring the absorbance at 240 nm. The percentage 131 
of peroxide removed was calculated as follows:       HEOE	removed	 % = 1 −
6789:;<7
6=>?@A>;
×	100	 132 
Where Acontrol is the absorbance of 1 ml of hydrogen peroxide solution.  133 
For the pH-stability assay, spores were incubated at 37°C for 1 hour in following buffers: 0.1 M Glycine-HCl 134 
pH 2.0; 0.1 M citrate-phosphate pH 4.0 and pH 6.0, or 0.1 M HEPES pH 7.0. The peroxidase activity of the 135 
samples was measured following the protocol described above. For the intestinal-stability assay, spores were 136 
incubated for 1 hour at 37°C in 100 μl of simulated gastric juice (SGF) [1 mg of pepsin (porcine stomach 137 
mucosa; Sigma) per ml of 10mM HCl; pH 2.0] or small intestine fluid (SIF) [1 mg of pancreatin (porcine 138 
pancreas; Sigma) per ml and 0.2% bile salts (50% sodium cholate-50% sodium deoxycholate; Sigma); pH 139 
6.8]. To remove the proteases contained in SIF and SGF, after incubation, spores were washed, collected by 140 
centrifugation (10 min at 13000xg) and then assayed for the peroxidase activity.  141 
 142 
Intracellular ROS evaluation 143 
Intracellular ROS levels were quantified by a DCFDA assay (Abcam), based on the cell permeant reagent 144 
2’,7’- dichlorofluorescin diacetate (DCFDA), a fluorogenic dye that measures reactive oxygen species activity 145 
within the cell. After diffusion in to the cell, DCFDA is deacetylated by cellular esterase to a non-fluorescent 146 
compound, which is later oxidized by ROS into 2’, 7’-dichlorofluorescein (DCF). DCF is a highly fluorescent 147 
compound which can be detected by fluorescence spectroscopy, and the fluorescence intensity is proportional 148 
to intracellular ROS produced. DCFDA (25 µM) was added to cells that were then incubated for 45 min in the 149 
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dark at 37°C. Fluorescence intensity was measured at λexcitation and λemission of 485 nm and 535 nm, 150 
respectively, in a plate reader (Synergy 4, BioTek). 151 
 152 
Lipid peroxidation in Caco-2 cells  153 
Lipid peroxidation products [thiobarbituric acid reactive substances (TBARS) also known as malondialdehyde-154 
equivalents (MDA-equivalents)] from Caco-2 cells were measured by the thiobarbituric acid colorimetric assay, 155 
according to Fernandes et al. [28]. Briefly, Caco-2 cells were preincubated for 24 hours with spores at 1:1 ratio 156 
cells/spores and then subjected to oxidative stress with 100µM H2O2 for 2 hours. Then, the medium was 157 
removed, and cells were washed with PBS, counted and centrifuged at 500 g for 5 min at 25 °C. After removal 158 
of supernatant, 0.5 ml of ice-cold 40% trichloroacetic acid and 0.5 ml of 0.67% of aqueous thiobarbituric acid 159 
were added to the pellet.  The mixtures were heated at 90 °C for 15 min, then cooled in ice for 10 min, and 160 
centrifuged at 800 g for 10 min. The supernatant fractions were collected, and lipid peroxidation estimated 161 
spectrophotometrically at 530 nm. The amount of TBARS formed was calculated using a molar extinction 162 
coefficient of 1.56 × 10
5
/mol/cm and expressed as nmol TBARS/10
6 
cells. 163 
 164 
Mouse model and experimental design 165 
Eight-week-old C57BL-6 mice were housed in standard animal cages under specific pathogen-free conditions. 166 
The mice were maintained in an environment of constant temperature and humidity with a 12-hours light-dark 167 
cycle and were given free access to food and water. Treatment, housing, and euthanasia of the animals met 168 
the guidelines set by the Italian Health Ministry. All experimental procedures involving animals were approved 169 
by “Comitato Etico-Scientifico per la Sperimentazione Animale” of the University “Federico II” of Naples. 170 
Experimental colitis was induced in the C57BL-6 mice by added DSS (2%, wt:vol) in drinking water ad libitum 171 
from day 2 to day 6, followed by DSS-free water for 2 days. Mice were randomly allocated into the three 172 
following groups (n = 6 per group): 1) untreated mice receiving placebo (Control group); 2) mice receiving DSS 173 
in water (DSS group) for 5 days; 3) mice receiving DSS in water for 5 days and spores by gavage, starting 174 
from two days before the DSS treatment, until two days after DSS treatment (DSS spores group). During the 175 
treatments, body weight, food and water intake were monitored daily.  176 
 177 
 178 
 179 
 180 
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Evaluation of experimental colitis 181 
After mice euthanasia, the macroscopic score was evaluated according to the scheme of table1. 182 
The macroscopic score was determined by combining the scores from these 4 categories and dividing the 183 
resulting number by 4. 184 
 185 
Lipid peroxidation in colon samples 186 
Protein extracts from distal colon were assayed for lipid peroxidation as described above. The amount of 187 
TBARS formed was calculated using a molar extinction coefficient of 1.56 × 10
5
/mol/cm and expressed as 188 
nmol TBARS/mg tissue. 189 
 190 
Determination of TNF-α, IL-12 and IL-10 in proximal colon samples 191 
TNF-α and IL-12/IL-10 concentrations in protein extracts from colon were determined using a rat specific 192 
enzyme linked immunosorbent assay (R&D Systems, MN, USA and ThermoFisher Scientific, lL USA, 193 
respectively) according to manufacturer instructions. Briefly, for TNF-α the wells of a microtitre plate were 194 
coated with 100 µl of mouse anti-rat TNF-α (4 µg/ml) in PBS (137 mM NaCl; 2.7 mM KCl; 8.1 mM Na2HPO4;1.5 195 
mM KH2PO4, pH 7.4), and incubated overnight at room temperature. The antibody excess was then removed 196 
by washing with Wash Buffer (containing 0.05% (v/v) Tween 20 in PBS, pH 7.4), and the remaining sites on 197 
the plate were blocked with reagent diluent (PBS containing 1% BSA) (1 h, room temperature). After extensive 198 
washing, 100 μl of samples (1:2-1:10 dilution in reagent diluent) were added to the wells and incubated for 2 199 
hours at room temperature. After further washing, the wells were incubated with biotinylated goat anti-rat TNF-200 
α (225 ng/ml in reagent diluent) followed by treatment with Streptavidin-HRP (1:200 dilution; 1h, room 201 
temperature). For IL-12/IL-10 determination, 50 μl of samples (1:2 dilution in reagent diluent for IL-12, undiluted 202 
for IL-10) were added in the wells of a microtiter plate and incubated for 1 h at 20-25°C for IL-12 and for 3 h at 203 
20-25° for IL-10. After 3 washing with Wash Buffer (provided by the kit), the wells were incubated with 100 µL 204 
for IL-12 and 50 µL for IL-10 of Biotinylated Antibody Reagent (BAR) for 1 hours at 20-25°C. After 3 washing 205 
with wash buffer, the wells were treated with Streptavidin-HRP (1:400 dilution; 30 minutes, 20-25°C). For both 206 
TNF-α and IL-12/IL-10 determination, peroxidase-catalyzed color development from tetramethylbenzidine was 207 
measured at 450 nm. 208 
 209 
Myeloperoxidase (MPO) activity in distal colon 210 
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MPO activity was assessed in colon samples as previously described [29]. Briefly, tissue samples (100 mg) 211 
were homogenized in 1 ml of hexadecyltrimethylammonium bromide (HTAB) buffer (0.5% HTAB in 50 mM 212 
phosphate buffer, pH 6.0) and centrifuged at 13400 x g for 6 minutes at 4°C. MPO activity was measured 213 
spectrophotometrically: 10 µl of supernatant were combined with 200 µl of 50 mM phosphate buffer, pH 6.0, 214 
containing 0.167 mg/ml 0-dianisidine hydrochloride and 1.25% hydrogen peroxide. The change in absorbance 215 
at 450 nm was measured and one unit of MPO activity was defined as that degrading 1 µmol of peroxide per 216 
minute at 25°C.  217 
 218 
Statistical analysis 219 
All data are expressed as means of independent experiments ± standard errors (SE). The analysis of variance 220 
was carried out by using One-way ANOVA or by two-tail unpaired t-test. The statistical analysis of in vitro and 221 
in vivo experiments was performed with the use of Graph-Pad Prism (Graph-Pad Software).  222 
 223 
Results  224 
Spores of B. megaterium have antioxidant activity  225 
Antioxidant activity of the spores of B. megaterium was assayed by two different methods, DPPH free radicals 226 
and catalase assays. For both assays, different number of purified spores of the B. megaterium strains QM 227 
B1551 (reference strain) or SF185 (isolated from human ileal biopsies [31, 32], were added to either 1 mL of 228 
methanol containing 0.1 mM DPPH or of hydrogen peroxide solution (see methods section), for the DPPH and 229 
the catalase assay, respectively. In both assays, spores of both strains showed the ability to scavenge DPPH 230 
(Figure 1a) and H2O2 (Figure 1b) and in both cases the activity increased by increasing the number of spores 231 
used in the assay. Results of Figure 1, thus indicated that spores of the two strains were characterized by 232 
similar antioxidant activities. Based on this, we decided to perform all further experiments using only spores of 233 
the human-isolated strain SF185. 234 
While it is well-established that ingested spores safely transit through the stomach [33], it is not known whether 235 
enzymes present on the spore surface remain active after the exposure to the low pH conditions typical of the 236 
stomach. Therefore, we analysed the stability of the spore-associated catalase at various pH conditions and 237 
after treatment with either simulated gastric or intestinal conditions. To this aim, 1.0 x10
10
 spores of SF185 238 
were incubated for 1 hour either at various acidic conditions or at simulated gastric or simulated intestinal fluid 239 
(SGF or SIF, respectively) and the catalase activity assayed as reported in the Methods section. As shown in 240 
Figure 1C, spores were able to remove hydrogen peroxide at all the pH conditions tested. At pH 2.0 the spore-241 
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associated catalase was still active and able to remove almost 80% of H2O2 (Figure 1c). Incubation of spores 242 
in either SGF or SIF only slightly affected the catalase activity (Figure 1d).  243 
 244 
SF185 spores exert anti-oxidant activity and stimulate Caco-2 cell viability 245 
Measurement of the intracellular ROS levels was carried out on Caco-2 cells by using a well-established 246 
method based on the compound DCFDA that, when administered to cells, becomes deacetylated by cellular 247 
esterase and then oxidized by intracellular ROS into DCF, whose level of fluorescence can be used as an 248 
indirect measurement of intracellular ROS production. We first verified that spores did not germinate when 249 
incubated in standard culture conditions (DMEM +10%FBS) used to cultivate Caco-2 cells in the following 250 
experiments. In agreement with what previously reported for B. subtilis spore [22], we observed that SF185 251 
spores did not germinate after 24 hours of incubation in DMEM at 37°C under CO2 pressure (not shown). Next, 252 
we analysed the oxidative status of Caco-2 cells grown under physiological conditions, in the presence or 253 
absence of B. megaterium spores at a 1:1 ratio spores to cells. As Figure 2a shows, while 2 hours of incubation 254 
with spores caused only a slight reduction in ROS production (light grey bar), an overnight (ON) incubation 255 
induced a drastic effect (dark grey bar), with over 10-fold reduction in ROS production (Figure 2a). The 256 
protective effect exerted by spores was also observed when cells were subjected to oxidative stress by H2O2: 257 
treatment of cells with 100mM H2O2 for 2 hours in the presence of 1:1 ratio spores/cells, induced a less 258 
pronounced oxidative stress in terms of ROS production (Figure 2b). The effect was more pronounced when 259 
Caco-2 cells were pre-incubated ON with spores, washed to eliminate the spores and then challenged with 260 
H2O2 for 2 hours (Figure 2 c, dark grey bars). If spores where re-added during the H2O2 treatment following 261 
the ON pre-incubation with spores, there is only a slight reduction of ROS, further indicating the preventive, 262 
protective effect of spores (Figure 2c light grey bar).  263 
Further, we analyzed ROS-induced oxidative damages through evaluation of lipid peroxidation of the Caco-2 264 
cell membranes. To this purpose, cells were pre-incubated for 24 hours with a 1:1 ratio spores to cells, washed 265 
and challenged with 100 µM H2O2 for 2 hours. The lipid peroxidation level was measured as described in 266 
methods section. Briefly, the end products of lipid peroxidation are reactive aldehydes, such as 267 
Malondialdheyde, whose levels can be quantified through a reaction with a chromogenic reagent, TBA (2-268 
thiobarbituric acid), which yield a chromophore with absorbance maximum at 532 nm. As shown in figure 3, 269 
the TBARS levels, an indirect measurement of lipid peroxidation, was markedly reduced in samples pretreated 270 
with spores with respect to not only H2O2-treated cells but also to control cells, confirming that spores have an 271 
antioxidant activity against both exogenous and endogenous ROS. 272 
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To further analyze the effects of spores on Caco-2 cells, we asked whether they can affect cell viability. 273 
Therefore, an MTT assay was conducted following a 24 hours incubation of Caco-2 cell with B. megaterium 274 
SF185 spores at 1:1 ratio. Interestingly, cell viability increased about 1.5 folds with respect to the control when 275 
cells were incubated with spores (Figure 4), confirming that spores are not only non-toxic for Caco-2 cells but, 276 
instead, exert a beneficial effect. 277 
 278 
In vivo antioxidant activity of SF185 spores 279 
The antioxidant activity of SF185 spores was also tested in vivo, using a mouse model, in which colitis was 280 
induced by DSS administration in drinking water [34]. DSS addition to drinking water did not influence food or 281 
water intake, nor did the administration of spores (Figure 5a-b). Mice treated with DSS showed lower weight 282 
gain, while those treated with DSS+spores exhibited weight gains similar to those of control mice (Figure 5c). 283 
In addition, the induction of colitis by DSS treatment and the protective effect of SF185 spores were confirmed 284 
by the determination of macroscopic score (Figure 5d), that revealed a strong disease activity index in DSS-285 
challenged mice but not in those pre- and post-treated with the spores. The antioxidant protective effect of 286 
SF185 spores was also confirmed in vivo in colon samples of DSS-treated mice by evaluating lipid 287 
peroxidation, MPO activity, the concentration of the inflammatory cytokine TNFa and the IL12/IL10 cytokines 288 
ratio (Figure 6). As Figure 6a shows, lipid peroxidation increased in colon samples of mice treated with DSS 289 
and was restored to levels similar to the control, in mice also treated with spores. Also, MPO activity, colonic 290 
TNFa and IL12/IL10 ratio (two cytokines with inflammatory and anti-inflammatory activities, respectively), 291 
common markers of inflammation [35, 36], are restored in spore treated mice (Figure 6 b, c, d, e). Overall 292 
these in vivo experiments indicate that DSS treatment significantly increases all markers of inflammation in 293 
the colon, while treatment with SF185 spores is able to exert a strong protective effect. 294 
 295 
Discussion 296 
Main conclusions of this work are that spores of B. megaterium have an intrinsic antioxidant activity and that 297 
have protective effects in vitro on Caco-2 cells against exogenous ROS and in vivo on murine intestinal cells 298 
against DSS-induced oxidative damages. The bacterial antioxidant activity is stable at low pH conditions or in 299 
simulated gastric and intestinal conditions (Figure 1c, d), suggesting that SF185 spores are be able to remove 300 
H2O2 and act as antioxidants at the intestinal level upon the ingestion and transit through the gut. 301 
The in vitro experiments clearly suggest that spores act as ROS scavengers reducing free oxidants outside 302 
cells and tissues but also exerting a preventive effect on oxidative stress of the cells. Such scavenging effect 303 
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was also exerted against oxidants produced by the physiological metabolic activity of Caco-2 cells, as shown 304 
by the increased viability of cells incubated with spore but not subjected to H2O2 insults.  305 
Accordingly, a protective effect was also observed when spores were incubated with Caco-2 cells for 18 hours 306 
and then removed before the treatment of cells with hydrogen peroxide. This indicates that a mechanism other 307 
than ROS scavenging is also played by spores. One explanation is that spores are able to reduce oxidants or 308 
catabolites produced by the cell’s metabolism, thus conferring better conditions of growth as indicated by the 309 
observed reduction of intracellular ROS in physiological conditions (Figure 2a). On the other hand, it has been 310 
recently reported that spores of a different Bacillus species, B. subtilis, induce the nuclear translocation of the 311 
Nrf-2 factor with the subsequent activation of stress response genes [22]. We have not investigated this aspect 312 
and can only hypothesize that B. megaterium spores are also able to induce the activation of genes coding for 313 
antioxidant/detoxifying enzymes, rendering the cells more resistant to a subsequent oxidative insult and 314 
allowing us to conclude that spores protect cells against ROS in vitro.  315 
In in vivo assays, the pre and post-dosing treatments with SF185 spores showed marked protective effects 316 
against weight loss and colon damage, reducing inflammation and the oxidative stress damages. The exerted 317 
protection against the DSS-induced colitis symptoms can be due to the scavenging mechanism, to the 318 
activation of stress-response genes or to a combination of the two spore-mediated effects. While additional 319 
experiments are needed to clarify the mechanism of action of spores, the presented experiments strongly 320 
suggest that spores of B. megaterium SF185 represent a promising new probiotic with antioxidant activity and 321 
that administration of spore-based products may have therapeutic and possibly preventive efficacy in human 322 
colitis. 323 
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ABSTRACT
Correct spatial and temporal control of cell proliferation is of fundamental 
importance for tissue homeostasis. Its deregulation has been associated with several 
pathological conditions. In common with almost every aspect of plant and animal 
biology, cell proliferation is dominated by day-night rhythms generated by the 
circadian clock. However, our understanding of the crosstalk between the core clock 
and cell cycle control mechanisms remains incomplete. In this study, using zebrafish 
as a vertebrate model system, we show that the nuclear localization of the Y-box 
binding protein 1 (YB-1), a regulator of cyclin expression and a hallmark of certain 
cancers, is robustly regulated by the circadian clock. We implicate clock-controlled 
changes in YB-1 SUMOylation as one of the mechanisms regulating its periodic nuclear 
entry at the beginning of the light phase. Furthermore, we demonstrate that YB-1 
nuclear protein is able to downregulate cyclin A2 mRNA expression in zebrafish via 
its direct interaction with the cyclin A2 promoter. Thus, by acting as a direct target of 
cyclic posttranslational regulatory mechanisms, YB-1 serves as one bridge between 
the circadian clock and its cell cycle control.
INTRODUCTION
The circadian clock generates day-night rhythms 
in most aspects of physiology and behaviour [1]. Central 
to the circadian timing system is a pacemaker that 
oscillates with a period of circa 24 hours and is reset on 
a daily basis by environmental signals such as light, food 
or temperature, via input pathways. In turn, the master 
clock regulates physiology and behavior via clock output 
pathways [1, 2]. 
At the core of the circadian clock mechanism is a 
transcription-translation feedback loop, which requires 
approximately 24 hours to complete one cycle. In 
vertebrates, the transcription factors CLOCK and BMAL 
activate expression of Period (Per) and Cryptochrome (Cry) 
genes, via binding to E-box enhancers in their promoters. 
Per and Cry in turn inhibit their own transcription by 
blocking CLOCK/BMAL driven transcriptional activation 
[3]. Additional transcriptional regulatory loops stabilize 
the entire timing mechanism [4]. Furthermore, cyclic post 
translational modifications, protein turnover and changes 
in the sub-cellular localization of key clock components all 
combine to reinforce the core clock mechanism’s timing 
function [5–7].
One key mechanism regulated by the circadian 
clock is the timing of cell proliferation and circadian 
clock disruption has been associated with several 
pathological conditions [8–10].  Clock components have 
been implicated in controlling the expression of cell cycle 
regulatory genes in order to “gate” critical cell cycle 
steps to times of day when there is a reduced exposure to 
damaging ultraviolet light. Thus, the expression of several 
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mammalian cell-cycle control genes such as Wee-1 and 
p21 has been found to be regulated in a circadian manner 
[11–13]. In addition, it has been shown that the clock has 
an impact on the cell cycle also through direct protein-
protein interactions [14]. Other clock-controlled cell cycle 
regulators include c-Myc, Mdm2, the D1, A and B cyclins 
and the tumor suppressor p53 [10]. There is also evidence 
that DNA damage can phase advance circadian rhythms 
via its effect on progression of the cell cycle [15]. Thus, 
the cell cycle can in turn also control the circadian clock. 
Therefore, understanding how these two key cellular 
oscillators, the clock and cell cycle, are inter-connected 
at the molecular level has become a major goal in the last 
few years.
The zebrafish (Danio rerio) has been established 
as one of the vertebrate model systems for studying the 
interplay between cell proliferation and the circadian 
timing system. In zebrafish, key cell cycle regulators, 
notably cyclins, are clock regulated and the circadian 
clock generates daily rhythms of S, as well as M phase 
by a cell-autonomous mechanism [16–19]. Most zebrafish 
tissues contain independent “peripheral” circadian 
clocks. However, while in mammals light entrainment of 
peripheral clocks occurs indirectly via the retina and the 
central clock of the suprachiasmatic nucleus (SCN) [20], 
zebrafish peripheral clocks are entrained by direct exposure 
to light [21]. In turn, direct exposure to light dark cycles 
result in high amplitude rhythms of cell proliferation in 
zebrafish cells and tissues.
One of the key regulators of cyclin expression 
during cell cycle progression [22] is the Y box binding 
protein 1 (YB-1, YBX-1). High YB-1 levels are typical 
of regenerating and proliferating cells and its abnormally 
elevated expression is a hallmark of cancer progression 
[23]. YB-1 is a DNA/RNA binding protein involved in 
almost all DNA and mRNA-dependent process, including 
DNA replication and repair, transcription, pre-mRNA 
splicing and translation. This protein is composed of 
three domains: a protein-protein interaction A/P rich 
N-terminal domain; a five stranded β-barrel CSD (Cold 
shock domain) [24] and a large C-terminal domain 
involved in controlling the subcellular localization of 
the protein [22, 25–27]. Although most YB-1 is located 
in the cytoplasm, recent evidence has shown that YB-1 
can shuttle between the nucleus and the cytoplasm 
[28]. In the nucleus, YB-1 orchestrates expression of 
proliferation-related genes, whereas in the cytoplasm 
it associates with mRNA and directs translation. YB-1 
relocalization from the cytoplasm to the nucleus at 
the G1/S phase transition has been associated with its 
function of regulating cyclin gene expression [22, 29, 30]. 
In this regard, in the nucleus YB-1 protein has been 
demonstrated to bind DNA as well as RNA, in a 
sequence-specific fashion to an inverted CCAAT box 
sequence (5′- CTGATTGGC/TC/TAA - 3′), termed the 
Y-box [31]. 
Here, using zebrafish as a model, we implicate YB-1 
as one of the links between the circadian clock and the 
control of cell cycle progression. We reveal a circadian 
clock control of YB-1 sub-cellular nuclear localization 
involving cyclic changes in SUMOylation and that this 
regulation is, at least in part, responsible for circadian cell 
cycle regulation.
RESULTS
Clock regulation of nuclear zfYB-1 
We have previously shown that the transcription 
of cell cycle control genes, including zfcyclin A2 and 
zfcyclin B1, is regulated by the circadian clock in the adult 
zebrafish caudal fin [16]. Given the central role played 
by YB-1 in the control of the cell cycle, we wished to 
investigate its involvement in circadian clock-regulated 
cell proliferation in zebrafish. It is well documented that 
the regulation of gene expression exerted by the human 
YB-1 protein is mainly due to dynamic changes in its 
nuclear localization [22, 32]. Therefore, based on the high 
homology between human and zfYB-1 (Supplementary 
Figure S1), we performed immunohistochemical analysis 
of zebrafish caudal fins at two different times during the 
light-dark cycle (14:10) using three different antibodies 
raised against full length, the N-terminal and the 
C-terminal portions of the human YB-1 protein, named: 
α-YB-1 F, α-YB-1 N-ter and α-YB-1 C-ter, respectively 
(Figure 1 and Supplementary Figure S2A, S2B).  With 
all three antibodies we observed an enriched nuclear 
localization at zeitgeber time (zt) 3 (day time) compared 
with zt 15 (night time), where zt 0 is defined as “lights on“ 
and zt 14 “lights off” (Figure 1A, 1B and Supplementary 
Figure S2B, S2C). This daily change in zfYB-1 nuclear 
localization, was confirmed by western blot analysis of 
fin nuclear extracts harvested at 6 hourly intervals during 
2 Light/Dark (LD) cycles (Figure 2). A statistically 
significant sinusoidal rhythm in the nuclear expression of 
immunoreactive zfYB-1 with a peak at zt 3 and a trough 
at zt 15 was observed (Figure 2A, 2B and Supplementary 
Table S1 for statistical analysis). 
Consistent with previous studies where multiple 
YB-1 immunoreactive bands were associated with 
complex post translational modifications [27, 31, 33], we 
also observed differences in the number and molecular 
weight of immunoreactive bands depending on the 
antibody used (ranging between 45 and 60 kDa). In 
addition, the oscillation of nuclear YB-1 expression 
persisted under constant conditions (constant darkness, 
DD) showing a circadian clock regulation rather than 
simply a light-dependent YB-1 rhythmicity (Figure 2C and 
Supplementary Figure S2C and Supplementary Table S1). 
Then, using a combination of approaches based on siRNA, 
recombinant protein and immunoprecipitation assays, we 
confirmed that the immunoreactive bands observed using 
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the YB-1 antibodies, indeed correspond to zfYB-1 protein 
(Supplementary Figure S3A–S3D). 
One frequently encountered feature of genes that 
serve to bridge the circadian clock with its output pathways 
is that their mRNA expression exhibits clock driven 
rhythms. We thus performed a high-resolution qRT-PCR 
analysis of zfYb-1 mRNA levels in caudal fins prepared 
from zebrafish raised under LD cycles and then transferred 
to constant darkness (DD). At the RNA level, zfYb-1 
showed no significant circadian rhythm (Supplementary 
Figure S4A and Supplementary Table S1), unlike for 
zfper1b and zfcyclin A2 which both show a predominant 
circadian clock regulation (Supplementary Figure S4B, 
S4C and Supplementary Table S1). However, basal zfYb-1 
mRNA levels did show a progressive increase after 
transfer to constant darkness implicating light in setting 
the levels zfYb-1 mRNA expression (Supplementary 
Figure S4A and Supplementary Table S1).
Cell autonomous regulation of nuclear zfYB-1 by 
the circadian clock 
Consistent with a cell autonomous clock-regulation, 
immunohistochemical and western blot analysis also 
revealed a robust oscillation of zfYB-1 nuclear protein in 
zebrafish PAC-2 cells (Figure 3A, 3B and Supplementary 
Figure S5A, S5B and Supplementary Table S1), although 
compared with fins, levels remained elevated in the nuclei 
for a longer period (peak zt3-9). We next wished to test 
whether the observed 24 h rhythmicity of nuclear zfYB-1 
was directly driven by the core circadian clock mechanism 
or merely reflected clock-dependent rhythmicity of cell 
cycle progression. With this goal, we explored the effect 
of genetic clock disruption or cell proliferation arrest 
upon zfYB-1 nuclear rhythmicity. Specifically, in the first 
approach we employed PAC-2 cells stably expressing a 
dominant negative form of the CLOCK1 protein, CLOCK1 
Figure 1: zfYB-1 cellular localization in zebrafish caudal fins. (A) Immunofluorescence analysis of zfYB-1 protein in the caudal 
fin at ZT3 (light phase) and ZT15 (dark phase) using α-YB-1 N-ter and α-YB-1 F antibodies. Panels also show DAPI staining and Merge, 
which combines both the DAPI and YB-1 signals. White and black bars above the panels indicate the corresponding lighting conditions. 
(B) Quantification of the panel A.
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DN, which has been show to disrupt core clock function 
(Supplementary Figure S5C–S5E) [34].  In CLOCK1 DN 
cells exposed to a LD cycle, we observed no significant 
rhythmicity in nuclear zfYB-1 protein (Figure 3C, 3D 
and Supplementary Table S1). In the second approach, we 
inhibited PAC-2 cell proliferation by serum deprivation at 
a high level of cell confluence.  Under this condition, we 
observed rhythmicity of nuclear zfYB-1 levels under LD 
cycles, which also persisted on the second day following 
transfer to DD conditions (Supplementary Figure S5F). 
Together, these data confirm that rather than simply 
reflecting clock-dependent rhythmicity of cell cycle 
progression, zfYB-1 nuclear oscillation is a target of the 
CLOCK/BMAL-based core clock mechanism.
Given the importance of YB-1 function in 
mammalian cells, we also wished to explore whether this 
circadian clock regulation of YB-1 nuclear localization is 
an evolutionary conserved mechanism. Thus, we entrained 
the circadian clock in human HEK 293 cells via transient 
treatment with dexamethasone and then assayed nuclear 
YB-1 levels during the subsequent 48 h (Figure 4). In 
treated cells, clock synchronization was confirmed by 
circadian, antiphase rhythms of mRNA expression in 
two core clock genes, hper2 and hbmal1 (Figure 4A, 4B 
and Supplementary Table S1).  In these cells, we also 
observed a circa 24 h oscillation of nuclear YB-1 protein 
(Figure 4C, 4D and Supplementary Table S1). Therefore, 
all our results point to the cell-autonomous circadian clock 
finely tuning the nuclear localization of the zfYB-1 protein 
via an evolutionary conserved mechanism. 
YB-1 SUMOylation in PAC-2 cells
How does the clock regulate zfYB-1 nuclear 
localization? One mechanism that has been implicated in 
clock-directed shuttling of proteins between the nucleus and 
cytoplasm is SUMOylation [5, 35]. SUMOylation has been 
documented to time the nuclear entry of the BMAL1 clock 
protein. Using GPS-SUMO 1.0 software we identified three 
potential conserved SUMOylation target sites in the zfYB-
1 protein, one of which is a canonical inverted site (DSKA 
in position 287–290) and the other two are non-canonical 
sites (TKED 60–63 and EKRE 151–154) (Supplementary 
Figure S1). Extracts from PAC-2 cells immunoprecipitated 
(IP) at zt 3 with each of the three YB-1 antibodies 
independently, were subjected to immunoblotting for 
SUMO-1. Our results showed that the IP proteins from 
all three YB-1 antibodies were also recognized by the 
SUMO-1 antibody, consistent with the presence of 
SUMOylated YB-1 in zebrafish (Figure 5A). Furthermore, 
overexpression of the SUMO-conjugating enzyme UBC9 
resulted in an increase in the overall quantity of zfYB-1 
nuclear protein at zt 3 and also an increase in molecular 
weight observed at zt 15 (Figure 5B and Supplementary 
Figure S5B for comparison). To explore how the clock 
could regulate the YB-1 SUMOylation events, we next 
investigated the possibility that the expression of a 
subset of genes involved in SUMOylation could also be 
clock regulated.  Real time qRT-PCR analysis in PAC-2 
cells exposed to a LD cycle followed by DD conditions 
revealed daily rhythmic expression of zfubc9 (zfube2ia, 
zfube2ib), zfsumo1, zfsae1 (SUMO1 activating enzyme 
subunit 1) and zfpias1 (E3 SUMO-protein ligase PIAS1) 
with a peak around the light–dark transition, which also 
persisted in most cases under DD conditions (Figure 5C, 
Supplementary Figure S6 and Supplementary Table S1). In 
addition, western blot analysis of PAC-2 cells for proteins 
covalently linked with SUMO-1 groups showed a day-
night rhythm in the global levels of nuclear SUMOylated 
protein that is consistent with the timing of zfYB-1 nuclear 
localization (Figure 5D). Therefore, together these data 
point to a more general control of protein SUMOylation by 
the circadian clock rather than only YB-1.  
Inhibition of zfcyclin A2 expression by zfYB-1
Previous reports have demonstrated that YB-1 plays 
a key role in regulating cell proliferation. In the nucleus, 
YB-1 orchestrates expression of many proliferation-
related genes. Therefore, we wished to explore the 
functional consequences of changes in nuclear YB-1 levels 
in zebrafish cells.  FACS analysis of PAC-2 cells over 
expressing zfYB-1 and exposed to a LD cycle assayed 
at 6 hourly intervals during 24 h showed a loss of cell 
cycle rhythmicity with an elevation in the proportion of 
cells in S and G2/M phase and a reduction in G0/G1 cells 
(Supplementary Figure S7A and Supplementary Table S1). 
Therefore, YB-1 has an impact on the dynamics of cell 
cycle progression in zebrafish cells.
It has been previously shown that the mRNA 
expression of cyclins in zebrafish tissues is clock 
regulated [16, 18, 19]. Consistently, we confirmed the 
clock regulation of zfcyclin A2 mRNA expression in 
PAC-2 cells (Supplementary Figure S7B). To address 
the role of zfYB-1 in cell cycle control we analyzed the 
contribution of zfYB-1 to the regulation of zfcyclin A2 
mRNA expression. Thus, we cloned a 447 bp fragment 
of the zfcyclin A2 promoter including its 5′-UTR region, 
upstream of a luciferase reporter (zf cyclin A2 pr.). This 
region contains 4 putative YB-1 binding sites, 3 of them 
in the promoter and 1 in the 5′UTR region (Supplementary 
Figure S7C). Expression of this reporter construct in 
cells exposed to LD cycles increases progressively over 
the course of the assay but at a significantly higher rate 
during the dark phase (Figure 6A and Supplementary 
Figure S7D). Consistent with this reflecting regulation by 
the circadian clock, in transfected CLOCK1 DN cells this 
rhythmicity was not observed (Figure 6A).  The higher 
cyclin A2 reporter gene expression during the dark period 
correlates with lower nuclear levels of zfYB-1 protein (see 
Figure 4A, 4B). In support of zfYB-1 playing a negative 
regulatory role, we observed a dose dependent inhibition 
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Figure 3: Nuclear zfYB-1 expression in PAC-2 and CLOCK1 DN cells. (A, C) Immunofluorescence analysis and quantification 
of nuclear levels of immunoreactive zfYB-1 in PAC-2 (A) and CLOCK1 DN (C) cells using the α-YB-1 N-ter antibody. Cells maintained 
under an LD cycle were fixed at 4 time points (ZT). A Merge of the DAPI and YB-1 staining images are shown. (B, D) Western blot analysis 
(right) and quantification (left) of α-YB-1 levels in fin nuclear extracts in PAC-2 (C) and CLOCK1 DN (D) cells under LD conditions and 
normalized for H3 expression (α-H3). Quantification was expressed as % of gray scale relative to the highest peak time point  (ZT 9) and is 
plotted on the y-axis. ZT times are plotted on the x-axis. Statistically significant differences between peak and trough points are indicated 
by asterisks (*). Results of the CircWave analysis are represented in Supplementary Table S1.
Figure 2: zfYB-1 protein expression in caudal fins. Western blot analysis and quantification of zfYB-1 levels in nuclear extracts 
under LD cycles (A, B) or during the second day in constant darkness, DD (C). The specific antibody used to detect YB-1 protein is 
indicated above each panel. An α-H3 antibody was used to provide a loading control. Vertical “brackets” on the left side of the panels A 
and B demarcate the YB-1 immunoreactive bands that were quantified using Image Lab™ Software. Quantification was expressed as % of 
gray scale relative to the highest peak of expression and is plotted on the Y-axes. Statistical significance between peak and trough points 
is indicated by asterisks where p < 0.05, p < 0.001 and p < 0.0001 are represented by *, ** and *** respectively. Results of the CircWave 
analysis are represented in Supplementary Table S1.
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of zfcyclin A2 promoter expression after co-transfection 
with the expression constructs for zebrafish YB-1 (5′Myc-
tag or 3′GFP-tag zfYB-1) and human YB-1 (3′GFP-tag 
hYB-1) (Figure 6B, 6C and Supplementary Figure S3D 
for controls) in PAC-2 cells. Finally, using a chromatin 
immunoprecipitation (ChIP) assay, we revealed a direct 
interaction between zfYB-1 and the zfcyclin A2 promoter 
(Figure 6D and Supplementary Figure S7E). Therefore, 
together our results are consistent with a role of zfYB-1 in 
the circadian clock control of cyclin A2 expression.  
DISCUSSION
Circadian rhythmicity is one of the defining 
features of normal cell cycle progression in many highly 
proliferative tissues in vivo. Furthermore, frequent 
disruption of the circadian clock has been linked with 
an increased risk of many pathologies including cancer. 
For this reason, a major goal is to understand the links 
between the core clock mechanism and key cell cycle 
control systems. Here, using the zebrafish as a model, 
we have implicated YB-1 as one such element. The sub-
cellular localization of this protein changes significantly 
with the time of day and high nuclear levels are associated 
with the early day period. These dynamic changes in YB-1 
location are driven by the cell autonomous circadian clock 
mechanism and involve SUMOylation, a post-translational 
modification already implicated in core clock function [5]. 
We show that in the nucleus, YB-1 physically associates 
with the cyclin A2 gene 5′ regulatory region and down-
regulates its expression.
Previous findings have pointed to considerable 
complexity in YB-1 function consistent with a central 
role in the regulation of cell proliferation.  However, the 
majority of these studies have focused on the role of YB-1 
in tumorigenesis with comparatively little attention being 
applied to its normal physiological function. Although 
most YB-1 is located in the cytoplasm, recent evidence 
has shown that YB-1 can shuttle between the nucleus and 
the cytoplasm [28]. In the nucleus, YB-1 orchestrates 
expression of proliferation-related genes, whereas in 
the cytoplasm it associates with mRNA and regulates 
translation. Here we present data linking high nuclear 
levels of YB-1 with repression of cyclin A2 expression. 
Cyclin A2 is synthesized at the onset of S-phase and 
then localizes to the nucleus where it is implicated in the 
initiation and progression of DNA synthesis. Our findings 
are consistent with previous results implicating YB-1 
as a cell cycle stage-specific transcription factor [22] 
present in the nucleus at the boundary between G1 and 
S phase of the cell cycle. However, the precise manner 
whereby YB-1 regulates cyclin gene expression remains 
Figure 4: hYB-1 expression in clock synchronized HEK293 cells. (A, B) Real time qRT-PCR analysis of hper2 and hbmal1 
expression in HEK293 cells during 48 hours following transient treatment with 100 nM of Dexamethazone. Relative mRNA levels are 
plotted on the y-axis. Times after DEX treatment are plotted on the x-axis. Levels of h-gapdh mRNA were used for normalization. Results 
of the CircWave analysis are represented in Supplementary Table S1. (C) Western blot analysis using the α-YB-1 C-ter antibody in HEK293 
cell nuclear extracts prepared after DEX treatment.  H3 expression was used as a loading control. (D) Quantification analysis of panel (C). 
Quantification was expressed as % of gray scale relative to the highest peak time point  (24 hrs) and plotted on the y-axis. Times after DEX 
treatment are plotted on the x-axis. The result of the CircWave analysis is represented in Supplementary Table S1.
Oncotarget7www.impactjournals.com/oncotarget
uncertain. Nevertheless, it is tempting to speculate that 
the clock control of YB-1 might serve as part of a more 
general mechanism to restrict DNA replication to a 
specific temporal window to minimize the impact of UV 
light-induced DNA damage. However, given the multiple 
cellular mechanisms which involve YB-1, this clock 
related function is almost certainly not the only role played 
by the YB-1 protein. 
Many lines of evidence also point to tight control 
of the timing of DNA repair processes during the day-
night cycle. Thus, robust circadian rhythmicity of DNA 
replication which is anti-phase to that of DNA repair 
has been reported [36]. Furthermore, in zebrafish the 
expression of many genes involved in DNA repair is 
strongly induced by light, thus leading to an increase in 
DNA repair capacity during periods of maximum sunlight-
induced DNA damage. In addition, DNA damage itself 
has been shown to constitute a zeitgeber for the circadian 
clock [15]. Thus, circadian clock gating of the cell cycle 
may also optimally time DNA damage repair. In this 
respect, it is interesting to note that nuclear YB-1 has been 
demonstrated to have anti-apoptotic properties based on 
its ability to coordinate DNA excision repair function and 
protect cells against damaging agents [37]. Furthermore, 
various forms of stress, including oxidative, genotoxic 
stress and hyperthermia induce nuclear translocation 
of YB-1 [31, 38] implicating YB-1 in stress and DNA 
damage responses.
Cell autonomous, circadian clock control of cellular 
processes frequently occurs at the level of transcription 
initiation. Circadian rhythms in the expression of many 
clock-controlled genes (ccgs) are directed by circadian 
E-box enhancer promoter elements that represent the 
regulatory targets of the core clock proteins CLOCK and 
BMAL1. However, a host of other proteins, including 
kinases and phosphatases [39], chromatin modifiers 
[40] and RNA-binding factors [41] in turn play essential 
roles in conferring robustness on the core circadian 
clock mechanism. YB-1 is constitutively expressed in 
proliferating tissues and performs a multitude of cellular 
 Figure 5: zf YB-1 SUMOylation. (A) Western blot analysis with the α-SUMO-1 antibody of IPs prepared from total cell extracts using 
each of the three α-YB-1 antibodies. Input and negative controls are indicated. (B) Western blot analysis using the α-YB-1 C-ter antibody in 
PAC-2 cell nuclear extracts prepared at ZT3 and ZT15 under an LD cycle in the absence or presence of over-expressed SUMO-conjugating 
enzyme UBC9 (+Ubc9). H3 expression was used as a loading control. (C) Real time qRT-PCR analysis of zfubc9b expression during 
exposure to a LD cycle followed by transfer to DD. Relative mRNA levels are plotted on the y-axis. ZT and CT times are plotted on the 
x-axis. β-actin mRNA was used for normalization. Statistical significance between peak and trough values in LD and in DD are indicated 
by asterisks. (D) Western blot analysis of SUMO-1 immunoreactive proteins in nuclear extracts prepared from cells under LD cycles. H3 
expression was used as a loading control. Results of the CircWave analysis are represented in Supplementary Table S1.
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functions, thus it is predictable that certain YB-1 functions 
are regulated by reversible post-translational modifications 
(PTM) rather than transcriptional mechanisms. In 
this regard, our results implicate SUMOylation in the 
clock-controlled translocation of YB-1 into the nucleus. 
Interestingly, circadian rhythmicity in the SUMOylation 
of the core clock protein, BMAL1, that is mediated by 
CLOCK, has been implicated in the regulation of nuclear 
entry [42]. Furthermore, our data point to general circadian 
rhythmicity in the mechanisms controlling SUMOylation. 
Thus, we speculate that YB-1 is the target of a cycling 
SUMOylation mechanism that relays timing information 
both within and outwards from the core clock mechanism.
Among the hallmarks of cancer, genome instability 
and mutations in cell cycle genes are recurring enabling 
factors [10]. Indeed mutations in cell cycle genes have 
been encountered in 90% of human cancers [43]. However, 
disruption of normal circadian clock function has also been 
linked with tumorigenesis [44]. At an epidemiological 
level, shift work, chronic jet lag and other environmental 
factors impacting on circadian clock function are also 
linked with increased cancer development and disrupted 
cell proliferation. Many human cancer cell lines that 
by definition exhibit abnormal cell cycle progression, 
also display abnormal circadian clock gene expression 
[9, 10]. Furthermore, mouse knock out lines affecting 
certain core clock genes show an increased susceptibility 
to tumor formation [45, 46].  While expression of YB-1 
protein is frequently elevated in tumors, its precise role in 
tumorigenesis is still poorly understood. In human tumors, 
such as breast, lung and prostate cancer, elevated YB-1 
protein levels and nuclear localization [47] appear to be 
prognostic, indicating poor clinical outcome. Furthermore, 
the accumulation of YB-1 protein in the nucleus is 
associated with increased cell survival and multidrug 
resistance [31, 48]. However, YB-1 over-expression has 
Figure 6: Regulation of zf Cyclin A2 expression by zfYB-1. (A) Graphical representation of the real time bioluminescence assay 
results from PAC-2 (blue trace) and CLOCK1 DN cells (red trace) transfected with the cyclin A2 pr. luciferase reporter. The black trace 
(BLANK) represents the luminescence background of the cell plate. The bioluminescence in counts per second (CPS) is plotted on the y-axis 
and the ZT times on the x-axis. Results are plotted as the mean of 4 independent transfections. Gray bars indicate the corresponding dark 
periods. (B–C) In vitro luciferase assays in cells co-transfected with the cyclin A2 –pr. reporter and (B) 25, 50 and 100 ng of the 5xMyc-
zfYB-1 expression vector or (C) with 50 ng of the zfYB-1-GFP, 5xMyc-zfYB-1 or the hYB-1-GFP expression vectors. Data are represented as 
means of triplicate samples +/– SD. At least three independent experiments were analyzed. Data were standardized for transfection efficiency 
using a β-galactosidase assay. Statistical significance is indicated above the graph by asterisks (*). (D) Agarose gel showing the 447 bp DNA 
promoter product amplified from ChIP assays using primers shown in Supplementary Table S2. Input and negative controls are indicated.
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also been reported to block oncogenic transformation 
[49]. These apparently contradictory results may be the 
consequence of differential sub-cellular localization. 
Specifically, in the cytoplasm YB-1 may interfere with 
oncogenic transformation as a result of its function in 
translational control [25, 50]. YB-1 regulates the expression 
of several tumor-associated genes [51, 52]. As a result, 
elevated levels of YB-1 may play a role in facilitating 
tumor cell invasion and metastasis, as well as enhancing 
cell growth and resistance to chemotherapeutic agents. 
Thus, it is tempting to speculate that disruption of normal 
circadian rhythmicity of YB-1 function may serve as a key 
link with tumorogenesis.
MATERIALS AND METHODS
Fish care, treatment and ethical statements
Zebrafish (D. rerio) were maintained according to 
standard procedures [53] in a re-circulating water system 
at 28°C and under 14:10 light : dark cycles. For each 
experiment 6–12 months old zebrafish males or females 
were used. Under constant darkness, the fish were fed twice 
daily at random time points using automatic feeders. The 
caudal fins were amputated using razor blades following 
anesthesia with 0.02% w/v MS222 (3-aminobenzoate 
methanesulfonic acid, Sigma Aldrich). All zebrafish 
husbandry and experimental procedures were performed 
in accordance with the German animal protection 
standards (Animal Protection Law, BGBl. I, 1934 (2010)) 
and were approved by the Local Government of Baden-
Wurttemberg, Karlsruhe, Germany (Az.: 35-9185.81/G-
130/12 and 35-9185.81/G-131/16). General license for fish 
maintenance and breeding: Az.: 35-9185.64).
Quantitative RT-PCRs 
Total RNA was extracted with Trizol Reagent 
(Gibco, BRL) according to the manufacturer’s 
instructions. Reverse transcription was performed using 
Superscript III RT (Invitrogen). A StepOnePlus Real-
Time qRT-PCR System (Applied Biosystems) and SYBR 
Green I fluorescent dye (Promega) were used. Expression 
levels were normalized using zf β-actin and gapdh 
mRNA expression for zebrafish and human HEK cells, 
respectively. The relative levels of mRNA were calculated 
using the 2−ΔΔCT method. For each gene, primer sequences 
are presented in Supplementary Table S2.
RNA interference
zfYB-1, NM_001126457, transient silencing was 
carried out in PAC-2 cells with increasing concentrations 
of IBONI YB-1 siRNA (RIBOXX GmbH, Germany) 
and FuGene HD reagent (Promega) according to the 
manufacturers’ recommendations. iBONi siRNA Negative 
Control was provided by Riboxx as a pool of 3 different 
siRNA. In Supplementary Table S3, all the siRNA 
sequences utilized are presented.
Protein analysis 
Nuclear and cytoplasmic protein extracts were 
obtained using the NP40 lysis buffer protocol as described 
elsewhere [54]. Total protein extracts were also prepared 
by directly adding 200 μl of 1X Laemmli buffer (6% SDS, 
20% glycerol, 125 mM TrispH6.8, 0,01% bromophenol 
blue, 100 mM DTT) including 1× cocktails of protease and 
phosphatase inhibitors (Sigma Aldrich) to the fin tissue 
or the cells. Gel electrophoresis was performed in a SDS 
polyacrylamide gel and proteins transferred to a Hybond-P 
membrane (Millipore). Binding of each antibody was 
visualized using the ECL detection system (Biorad). All 
images were acquired and analyzed with Image Lab™ 
Software (Bio Rad, USA) or with X-Ray films (Kodak). 
Then, images were quantified using the Scion Image 
software (NIH, http://rsb.info.nih.gov/nihimage/). A list 
of the primary and secondary antibodies used is shown 
in Supplementary Table S4. YB-1 immunofluorescence 
analysis of fins was performed after overnight fixation 
of fin-clips in Carnoy’s solution (60% ethanol, 30% 
chloroform, 10% acetic acid) at 4°C followed by an 
incubation overnight in 100% Methanol and sequential 
rehydration steps in 100%, 66% and 33% methanol in 
PBTX (1XPBS, 0,3% Triton X100). Instead, adherent 
cells (1.2 × 105) were fixed overnight at 4°C in 4% PFA in 
1× PBS and then transferred to PBST (1X PBS plus 0,1% 
Tween 20). At this stage, fins and cells were pre-incubated 
in blocking solution (PBTX and PBST, respectively plus 
1% BSA (GE healthcare) for 3 hrs. Then the primary 
antibody was added and the samples were incubated 
at 4°C overnight.  After several washes, the samples 
were incubated at 4°C with the secondary fluorescent 
antibody (Supplementary Table S4) for 2 hours (cells) or 
overnight (fins). DAPI staining was used for visualization 
of nuclei. The samples were mounting on glass slides 
and photographed using a Confocal Microscope SPE 
(Leica) with a 40X oil immersion objective and the 
quantification of nuclear and cytoplasmic signals was 
calculated using Image Lab™ Software (Bio Rad, USA). 
Co-Immunoprecipitations (Co-IPs) were performed as 
previously described [32]. The antibody concentrations 
used in each IPs and for western blotting analysis were 
chosen according to the manufacturers’ recommendations.
 Cell cultures and clock entrainment
The zebrafish cell line PAC-2 [55] was propagated 
as previously described [56]. 
The zebrafish CLOCK1 DN cells were a kind gift 
of David Whitmore and were propagated as previously 
described (Tamai et al., 2012 ref). The HEK293 (human 
embryonic kidney derived) cell line was cultured at 37°C 
with 5% CO
2
 in Dulbecco’s Modified Eagle’s Medium 
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(DMEM) containing 10% heat inactivated fetal calf serum 
(FCS), 2 mM L-glutamine, 50 µg/ml penicillin and 50 µg/ml 
streptomycin.
The circadian clock in zebrafish cells was entrained 
by direct exposure of the cells to light–dark cycles at a 
constant temperature of 25°C using white light emitting 
diodes (LED, Kopa 440 nm-690 nm) adjusted to deliver 
a photon flux of 1.42 × 1018 ± 0,04 ×1018 photons/s/m2 
· 
The clock entrainment in the HEK293 cells 
was performed by plating the cells at a concentration 
of 2.5 × 106 in DMEM medium (Sigma-Aldrich) in 
the presence of 10% serum. At 80% confluence, the 
concentration of serum was reduced to 2%. After 24 h, 
the cultures were treated with 100 nM water-soluble 
dexamethasone (Sigma-Aldrich) to synchronize the cells 
(time = 0 h), and after 2 h of incubation the medium was 
replaced with DMEM culture medium containing 2% 
serum. All cultures were incubated at 37°C in a humidified 
5% CO
2
 atmosphere until harvesting at specific time 
points after dexamethasone treatment (from 12 h to 48 h) 
according to the specific analysis.
FACS analysis for flow cytometry 
Cells were trypsinized, collected and washed two 
times in cold 1x PBS via centrifugation at 1200 rpm for 
4 minutes at 4°C. Next, the cell pellets were resuspended 
in 0.5 ml of ice-cold 100% methanol and incubated on 
ice for 20 minutes. After centrifugation at 1200 rpm for 
4 minutes at 4°C, the pellets were resuspended again in 
cold 1× PBS and incubated on ice for 30 minutes prior 
to centrifugation and final resuspension in 0.5 ml of 1× 
PBS in the presence of RNAase at a final concentration of 
100 ug/ml. After 20 minutes of incubation in RNAase at 
room temperature, the samples were finally stained with 
50 ug/ml of Propidium iodide (PI) (Sigma) for 30 minutes 
on ice and in darkness. Data acquisition and analysis of 
the cell cycle phases were performed using a BD Accury 
C6 cytometer and software from BD Biosciences. Each 
time point was analyzed in triplicate, 40.000 events were 
analyzed for each sample.
Luciferase assays 
Cell transfections were performed using FuGene 
HD (Promega) or ScreenFect (S-4001 InCella) reagents 
according to the manufacturers’ protocols. β-galactosidase 
expression was used to normalize for transfection 
efficiency using a standard protocol [57]. Luciferase 
activity was measured using the Luciferase Assay System 
kit (Promega) and a VICTOR Multilabel Plate Reader 
(Perkin Elmer). The real-time bioluminescence assays 
were performed and analyzed as described previously 
[56, 58]. Bioluminescence was assayed with a Topcount 
NXT automatic scintillation counter (Perkin Elmer). Data 
were imported into Microsoft Excel using the ‘‘Import and 
Analysis’’ macro (S. Kay, Scripps Research Institute).
Constructs
The expression constructs 5xMyc-zfYB-1 and 
zfYB-1–GFP and the zfcyclin A2 promoter were cloned 
by PCR amplification of PAC-2 cell DNA using pfu 
polymerase (Promega) and then subcloned into the 
pCS2-MTK 5xMyc (Invitrogen), pcDNA6-V5/HisB 
GFP (ThermoFisher) and pGL3 basic-Luc (Promega) 
expression vectors (see Supplementary Table S4 for 
details). The hYB-1-GFP expression vector was previously 
described (24). The p3259 pCMV hUBC 9 mt HA was a 
gift from Peter Howley ADDGENE (14439) [59]. 
Chromatin immunoprecipitation (ChIP)
The ChIP assay was performed as described 
previously [60] with some minor changes described 
below. In brief, 1 × 106 cells were seeded and then, after 
24 hours were fixed for 15 min. at room temperature in 
1× formaldehyde solution (HCOH 1%, NaCl 10 mM, 
EDTA 0.1 mM, EGTA 0.05 mM, Hepes 5 mM in L-15 
cell medium). After cell lysis in buffer L1 (Tris-HCl 
50 mM pH 8.0, EDTA 0.2 mM pH 8.0, NP40 0.1%, 
Glycerol 10% including a 1× cocktail of protease and 
phosphatase inhibitors (Sigma Aldrich)), the nuclei were 
recovered by centrifugation (5 min. at 4°C at 3000 rpm) 
and resuspended in lysis buffer L2 (Tris-HCl 50 mM pH 
8.0, EDTA 5 mM, SDS 1%). The sonicated chromatin 
(8 × 5s pulses) solution was diluted to a final volume of 
3 ml with DB buffer (Tris-HCl 50 mM pH 8.0, EDTA 
5 mM, NaCl 200 mM, NP40 0.5%). For each test (α-YB-1, 
no antibody (Ab) and α-IgG controls), 1 ml of chromatin 
solution was used. Immunoprecipitation was performed 
at 4°C over-night on a rotating platform. The antibody 
concentration was chosen according to the manufacturer’s 
instructions. To recover the immunocomplexes (antibody 
plus chromatin) we used magnetic beads (Dyna beads 
Protein G, ref. 1004D, Novex Life-Technology). After 
extensive washing, bound DNA fragments were eluted 
and subsequently analyzed by PCR. PCR primers are 
reported in Supplementary Table S1. The 150 bp or 
450 bp PCR products were visualized by 2% Agarose Gel 
Electrophoresis.
Statistical analysis
CircWaveBatch 3.3 (by courtesy of Dr. Roelof Hut, 
http://www.euclock.org/component/zoo/item/deliverables.
html) was used to identify sinusoidal differential 
expression during the 24-hour cycle. This statistical 
algorithm tests each expression profile against a harmonic 
curve by varying the phase and period length. A F-test was 
used to measure the goodness-of-fit and the transcript was 
considered rhythmic when the harmonic regression was 
statistically significant (p < 0.05). Results of the CircWave 
analysis are represented in Supplementary Table S1. 
One-way analysis of variance (ANOVA) followed by 
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Bonferroni’s multiple comparison tests was also performed 
using GraphPad Prism 4.0 (http://www.graphpad.com). 
Statistical analysis of the real time bioluminescence 
data from the cyclin A2 luciferase reporter construct 
was performed using the MATLAB R2015b software as 
follows: Each night/day cycle was processed separately. 
A regression routine of order one delivered a mean slope 
per cycle. Equal cycles were averaged per well. To obtain 
cycle changes between night and day, the mean slope 
of all cycles was subtracted. A t-test for differences was 
analysed (see Supplementary Table S1). 
All the statistical results are expressed as means 
+/– SD of three biological replicates where for each 
in vivo experiment a minimum of n = 3 fish were used per 
timepoint. In the statistical tests p < 0.05 was considered 
statistically significant. In each figure, p < 0.05, p < 0.001 
and p < 0.0001 are represented by *, ** and *** 
respectively. 
ACKNOWLEDGMENTS
We thank O. Kassel, R. M. Ceinos and J. Voegele for 
support and discussion and M. Rastetter and T. Liepert for 
excellent technical assistance. We thank Prof. P. Mertens 
for providing us the hYB-1-GFP plasmid. We thank David 
Whitmore for the kind gift of the CLOCK1 DN zebrafish 
cell line and Professor Veronique Orian-Rousseau and 
Giuseppina Pace for kind help with the mammalian cells. 
CONFLICTS OF INTEREST
The authors declare no conflicts of interest in the 
work presented.
GRANT SUPPORT
This research was funded through the Helmholtz 
funding programme BIFTM for D. Vallone and N.S. 
Foulkes; the BMBF project MIE for C. Pagano; By grants 
awarded to V. Calabro’ from PO FESR 2007–2013 “DiMo” 
and Progetto “Campania Research in Experimental 
Medecine” (CREME), POR Campania FSE 2007–2013. 
We thank EMBO for a Short-term Fellowship grant 
awarded to O. di Martino. We acknowledge support by 
the Deutsche Forschungsgemeinschaft and the open access 
publishing fund of Karlsruhe Institute of Technology.
REFERENCES
1. Pittendrigh CS. Temporal organization: reflections of a 
Darwinian clock-watcher. Annu Rev Physiol. 1993; 55:16–54.
2. Wager-Smith K, Kay SA. Circadian rhythm genetics: from 
flies to mice to humans. Nat Genet. 2000; 26:23–27.
3. Reppert SM, Weaver DR. Molecular analysis of mammalian 
circadian rhythms. Annu Rev Physiol. 2001; 63:647–676.
 4. Preitner N, Damiola F, Lopez-Molina L, Zakany J, 
Duboule D, Albrecht U, Schibler U. The orphan nuclear 
receptor REV-ERBalpha controls circadian transcription 
within the positive limb of the mammalian circadian 
oscillator. Cell. 2002; 110:251–260.
 5. Cardone L, Hirayama J, Giordano F, Tamaru T, Palvimo JJ, 
Sassone-Corsi P. Circadian clock control by SUMOylation 
of BMAL1. Science. 2005; 309:1390–1394.
 6. Lee C, Etchegaray JP, Cagampang FR, Loudon AS, 
Reppert SM. Posttranslational mechanisms regulate the 
mammalian circadian clock. Cell. 2001; 107:855–867.
 7. Miyazaki K, Nagase T, Mesaki M, Narukawa J, Ohara O, 
Ishida N. Phosphorylation of clock protein PER1 regulates 
its circadian degradation in normal human fibroblasts. 
Biochem J. 2004; 380:95–103.
 8. Savvidis C, Koutsilieris M. Circadian rhythm disruption in 
cancer biology. Mol Med. 2012; 18:1249–1260.
 9. Fu L, Kettner NM. The circadian clock in cancer 
development and therapy. Prog Mol Biol Transl Sci. 2013; 
119:221–282.
10. Feillet C, van der Horst GT, Levi F, Rand DA, Delaunay F. 
Coupling between the Circadian Clock and Cell Cycle 
Oscillators: Implication for Healthy Cells and Malignant 
Growth. Front Neurol. 2015; 6:96.
11. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, 
Okamura H. Control mechanism of the circadian clock for 
timing of cell division in vivo. Science. 2003; 302:255–259.
12. Hirayama J, Cardone L, Doi M, Sassone-Corsi P. Common 
pathways in circadian and cell cycle clocks: light-dependent 
activation of Fos/AP-1 in zebrafish controls CRY-1a and 
WEE-1. Proc Natl Acad Sci USA. 2005; 102:10194–10199.
13. Grechez-Cassiau A, Rayet B, Guillaumond F, Teboul M, 
Delaunay F. The circadian clock component BMAL1 is 
a critical regulator of p21WAF1/CIP1 expression and 
hepatocyte proliferation. J Biol Chem. 2008; 283:4535–4542.
14. Hunt T, Sassone-Corsi P. Riding tandem: circadian clocks 
and the cell cycle. Cell. 2007; 129:461–464.
15. Oklejewicz M, Destici E, Tamanini F, Hut RA, Janssens R 
and van der Horst GT. Phase resetting of the mammalian 
circadian clock by DNA damage. Curr Biol. 2008; 
18:286–291.
16. Idda ML, Kage E, Lopez-Olmeda JF, Mracek P, 
Foulkes NS, Vallone D. Circadian timing of injury-induced 
cell proliferation in zebrafish. PLoS One. 2012; 7:e34203.
17. Dekens MP, Santoriello C, Vallone D, Grassi G, Whitmore 
D, Foulkes NS. Light regulates the cell cycle in zebrafish. 
Curr Biol. 2003; 13:2051–2057.
18. Laranjeiro R, Tamai TK, Peyric E, Krusche P, Ott S, 
Whitmore D. Cyclin-dependent kinase inhibitor p20 
controls circadian cell-cycle timing. Proc Natl Acad Sci 
USA. 2013; 110:6835–6840.
19. Peyric E, Moore HA, Whitmore D. Circadian clock 
regulation of the cell cycle in the zebrafish intestine. PLoS 
One. 2013; 8:e73209.
Oncotarget12www.impactjournals.com/oncotarget
20. Bailes HJ, Lucas RJ. Melanopsin and inner retinal 
photoreception. Cell Mol Life Sci. 2010; 67:99–111.
21. Whitmore D, Foulkes NS, Sassone-Corsi P. Light acts 
directly on organs and cells in culture to set the vertebrate 
circadian clock. Nature. 2000; 404:87–91.
22. Jurchott K, Bergmann S, Stein U, Walther W, Janz M, 
Manni I, Piaggio G, Fietze E, Dietel M, Royer HD. YB-1 
as a cell cycle-regulated transcription factor facilitating 
cyclin A and cyclin B1 gene expression. J Biol Chem. 2003; 
278:27988–27996.
23. Basaki Y, Taguchi K, Izumi H, Murakami Y, Kubo T, 
Hosoi F, Watari K, Nakano K, Kawaguchi H, Ohno S, 
Kohno K, Ono M, Kuwano M. Y-box binding protein-1 
(YB-1) promotes cell cycle progression through CDC6-
dependent pathway in human cancer cells. Eur J Cancer. 
2010; 46:954–965.
24. Matsumoto K, Wolffe AP. Gene regulation by Y-box 
proteins: coupling control of transcription and translation. 
Trends Cell Biol. 1998; 8:318–323.
25. Bader AG, Vogt PK. Inhibition of protein synthesis by Y 
box-binding protein 1 blocks oncogenic cell transformation. 
Mol Cell Biol. 2005; 25:2095–2106.
26. En-Nia A, Yilmaz E, Klinge U, Lovett DH, Stefanidis I, 
Mertens PR. Transcription factor YB-1 mediates DNA 
polymerase alpha gene expression. J Biol Chem. 2005; 
280:7702–7711.
27. Evdokimova V, Ruzanov P, Anglesio MS, Sorokin AV, 
Ovchinnikov LP, Buckley J, Triche TJ, Sonenberg N, 
Sorensen PH. Akt-mediated YB-1 phosphorylation activates 
translation of silent mRNA species. Mol Cell Biol. 2006; 
26:277–292.
28. Raffetseder U, Frye B, Rauen T, Jurchott K, Royer HD, 
Jansen PL, Mertens PR. Splicing factor SRp30c interaction 
with Y-box protein-1 confers nuclear YB-1 shuttling 
and alternative splice site selection. J Biol Chem. 2003; 
278:18241–18248.
29. Basaki Y, Hosoi F, Oda Y, Fotovati A, Maruyama Y, Oie S, 
Ono M, Izumi H, Kohno K, Sakai K, Shimoyama T, 
Nishio K, Kuwano M. Akt-dependent nuclear localization 
of Y-box-binding protein 1 in acquisition of malignant 
characteristics by human ovarian cancer cells. Oncogene. 
2007; 26:2736–2746.
30. Mertens PR, Harendza S, Pollock AS, Lovett DH. 
Glomerular mesangial cell-specific transactivation of matrix 
metalloproteinase 2 transcription is mediated by YB-1. J 
Biol Chem. 1997; 272:22905–22912.
31. Kohno K, Izumi H, Uchiumi T, Ashizuka M, Kuwano M. The 
pleiotropic functions of the Y-box-binding protein, YB-1. 
Bioessays. 2003; 25:691–698.
32. Di Costanzo A, Troiano A, di Martino O, Cacace A, 
Natale CF, Ventre M, Netti P, Caserta S, Pollice A, 
La Mantia G, Calabro V. The p63 protein isoform 
DeltaNp63alpha modulates Y-box binding protein 1 in its 
subcellular distribution and regulation of cell survival and 
motility genes. J Biol Chem. 2012; 287:30170–30180.
33. di Martino O, Troiano A, Guarino AM, Pollice A, Vivo M, 
La Mantia G, Calabro´ V. ΔNp63α controls YB-1 protein 
stability: evidence on YB-1 as a new player in keratinocyte 
differentiation. Genes to Cells. 2016 in press.
34. Tamai TK, Young LC, Cox CA, Whitmore D. Light acts on 
the zebrafish circadian clock to suppress rhythmic mitosis 
and cell proliferation. J Biol Rhythms. 2012; 27:226–236.
35. Abad-Morales V, Domenech EB, Garanto A, Marfany G. 
mRNA expression analysis of the SUMO pathway genes in 
the adult mouse retina. Biol Open. 2015; 4:224–232.
36. Chen Z, McKnight SL. A conserved DNA damage response 
pathway responsible for coupling the cell division cycle 
to the circadian and metabolic cycles. Cell Cycle. 2007; 
6:2906–2912.
37. Fomina EE, Pestryakov PE, Maltseva EA, Petruseva IO, 
Kretov DA, Ovchinnikov LP, Lavrik OI. Y-box binding 
protein 1 (YB-1) promotes detection of DNA bulky lesions 
by XPC-HR23B factor. Biochemistry (Mosc). 2015; 
80:219–227.
38. Ohga T, Uchiumi T, Makino Y, Koike K, Wada M, 
Kuwano M, Kohno K. Direct involvement of the Y-box 
binding protein YB-1 in genotoxic stress-induced activation 
of the human multidrug resistance 1 gene. J Biol Chem. 
1998; 273:5997–6000.
39. Reischl S, Kramer A. Kinases and phosphatases in 
the mammalian circadian clock. FEBS Lett. 2011; 
585:1393–1399.
40. Sahar S, Sassone-Corsi P. The epigenetic language of 
circadian clocks. Handb Exp Pharmacol. 2013; :29–44.
41. Kowalska E, Ripperger JA, Hoegger DC, Bruegger P, 
Buch T, Birchler T, Mueller A, Albrecht U, Contaldo C, 
Brown SA. NONO couples the circadian clock to the cell 
cycle. Proc Natl Acad Sci USA. 2013; 110:1592–1599.
42. Stojkovic K, Wing SS, Cermakian N. A central role for 
ubiquitination within a circadian clock protein modification 
code. Front Mol Neurosci. 2014; 7:69.
43. Bonelli P, Tuccillo FM, Borrelli A, Schiattarella A, 
Buonaguro FM. CDK/CCN and CDKI alterations for cancer 
prognosis and therapeutic predictivity. Biomed Res Int. 
2014; 2014:361020.
44. Parent ME, El-Zein M, Rousseau MC, Pintos J, 
Siemiatycki J. Night work and the risk of cancer among 
men. Am J Epidemiol. 2012; 176:751–759.
45. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene 
Period2 plays an important role in tumor suppression and 
DNA damage response in vivo. Cell. 2002; 111:41–50.
46. Lee S, Donehower LA, Herron AJ, Moore DD, Fu L. 
Disrupting circadian homeostasis of sympathetic signaling 
promotes tumor development in mice. PLoS One. 2010; 
5:e10995.
47. Shibahara K, Sugio K, Osaki T, Uchiumi T, Maehara Y, 
Kohno K, Yasumoto K, Sugimachi K, Kuwano M. Nuclear 
expression of the Y-box binding protein, YB-1, as a novel 
marker of disease progression in non-small cell lung cancer. 
Clin Cancer Res. 2001; 7:3151–3155.
Oncotarget13www.impactjournals.com/oncotarget
48. Sorokin AV, Selyutina AA, Skabkin MA, Guryanov SG, 
Nazimov IV, Richard C, Th’ng J, Yau J, Sorensen PH, 
Ovchinnikov LP, Evdokimova V. Proteasome-mediated 
cleavage of the Y-box-binding protein 1 is linked to DNA-
damage stress response. EMBO J. 2005; 24:3602–3612.
49. Bader AG, Felts KA, Jiang N, Chang HW, Vogt PK. Y 
box-binding protein 1 induces resistance to oncogenic 
transformation by the phosphatidylinositol 3-kinase 
pathway. Proc Natl Acad Sci USA. 2003; 100:12384–12389.
50. Bader AG, Vogt PK. An essential role for protein synthesis 
in oncogenic cellular transformation. Oncogene. 2004; 
23:3145–3150.
51. Lasham A, Lindridge E, Rudert F, Onrust R, Watson J. 
Regulation of the human fas promoter by YB-1, Puralpha 
and AP-1 transcription factors. Gene. 2000; 252:1–13.
52. Mertens PR, Alfonso-Jaume MA, Steinmann K, Lovett DH. 
A synergistic interaction of transcription factors AP2 
and YB-1 regulates gelatinase A enhancer-dependent 
transcription. J Biol Chem. 1998; 273:32957–32965.
53. Nüsslein-Volhard C, Dahm R. Zebrafish : a practical 
approach. (Oxford: Oxford University Press). 2002
54. Kassel O, Schneider S, Heilbock C, Litfin M, Gottlicher M, 
Herrlich P. A nuclear isoform of the focal adhesion LIM-
domain protein Trip6 integrates activating and repressing 
signals at AP-1- and NF-kappaB-regulated promoters. 
Genes Dev. 2004; 18:2518–2528.
55. Lin S, Gaiano N, Culp P, Burns JC, Friedmann T, Yee JK, 
Hopkins N. Integration and germ-line transmission of a 
pseudotyped retroviral vector in zebrafish. Science. 1994; 
265:666–669.
56. Vatine G, Vallone D, Appelbaum L, Mracek P, Ben-
Moshe Z, Lahiri K, Gothilf Y, Foulkes NS. Light directs 
zebrafish period2 expression via conserved D and E boxes. 
PLoS Biol. 2009; 7:e1000223.
57. Sambrook J, Fritsch EF, Maniatis T. (1989). Molecular 
cloning : a laboratory manual. (Cold Spring Harbor: Cold 
Spring Harbor Laboratory Press).
58. Vallone D, Gondi SB, Whitmore D, Foulkes NS. E-box 
function in a period gene repressed by light. Proc Natl Acad 
Sci USA. 2004; 101:4106–4111.
59. Yasugi T, Howley PM. Identification of the structural 
and functional human homolog of the yeast ubiquitin 
conjugating enzyme UBC9. Nucleic Acids Res. 1996; 
24:2005–2010.
60. Wells J, Boyd KE, Fry CJ, Bartley SM, Farnham PJ. Target 
gene specificity of E2F and pocket protein family members 
in living cells. Mol Cell Biol. 2000; 20:5797–5807.

Current Biology
Article
Modulation of DNA Repair Systems
in Blind Cavefish during Evolution
in Constant Darkness
Haiyu Zhao,1 Giuseppe Di Mauro,1,2 Sebastian Lungu-Mitea,1,3,6 Pietro Negrini,1,2 Andrea Maria Guarino,1,5
Elena Frigato,2 Thomas Braunbeck,3 Hongju Ma,4 Tilman Lamparter,4 Daniela Vallone,1 Cristiano Bertolucci,2
and Nicholas S. Foulkes1,7,*
1Institute of Toxicology and Genetics, Karlsruhe Institute of Technology, Hermann-von-Helmholtz Platz 1, 76344 Eggenstein-Leopoldshafen,
Germany
2Department of Life Science and Biotechnology, University of Ferrara, Via Luigi Borsari 46, 44121 Ferrara, Italy
3Aquatic Ecology and Toxicology, Centre for Organismal Studies, University of Heidelberg, Im Neuenheimer Feld, 69120 Heidelberg,
Germany
4Botanical Institute, Karlsruhe Institute of Technology, 76128 Karlsruhe, Germany
5Department of Biology, University of Naples ‘‘Federico II,’’ 80126 Naples, Italy
6Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, 75007 Uppsala, Sweden
7Lead Contact
*Correspondence: nicholas.foulkes@kit.edu
https://doi.org/10.1016/j.cub.2018.08.039
SUMMARY
How the environment shapes the function and evolu-
tion of DNA repair systems is poorly understood. In a
comparative study using zebrafish and the Somalian
blind cavefish, Phreatichthys andruzzii, we reveal
that during evolution for millions of years in contin-
uous darkness, photoreactivation DNA repair func-
tion has been lost in P. andruzzii. We demonstrate
that this loss results in part from loss-of-functionmu-
tations in pivotal DNA-repair genes. Specifically,
C-terminal truncations in P. andruzzii DASH and 6-4
photolyase render these proteins predominantly
cytoplasmic, with consequent loss in their function-
ality. In addition, we reveal a general absence
of light-, UV-, and ROS-induced expression of
P. andruzzii DNA-repair genes. This results from a
loss of function of the D-box enhancer element,
which coordinates and enhances DNA repair in
response to sunlight. Our results point to
P. andruzzii being the only species described, apart
from placental mammals, that lacks the highly
evolutionary conserved photoreactivation function.
We predict that in the DNA repair systems of
P. andruzzii, we may be witnessing the first stages
in a process that previously occurred in the ances-
tors of placental mammals during the Mesozoic era.
INTRODUCTION
DNA stability is of utmost importance for the maintenance of
normal cellular function. However, it is subject to sustained as-
sault from the environment. Ultraviolet (UV) radiation from sun-
light is the most common and powerful factor that can induce
mutagenic and cytotoxic lesions in DNA, such as cyclobutane-
pyrimidine dimers (CPDs), 6-4 photoproducts (6-4PPs), and their
Dewar valence isomers [1–3]. Such damage must be rapidly
removed to ensure complete and accurate DNA replication
and transcription, so organisms have developed a battery of
DNA-repair mechanisms [4].
Photoreactivation serves as one of the most important
and ubiquitous DNA-repair systems, enzymatically repairing
UV-induced DNA lesions using the energy from violet/blue light
[5–8]. This light-dependent reaction is catalyzed by photolyases.
These represent a highly conserved class of flavoproteins where
the flavin adenine dinucleotide (FAD) molecule serves as a key
light-harvesting cofactor, together with a second antenna chro-
mophore that differs between photolyases and species [2, 6].
Photolyases are subdivided into CPDs and 6-4 photolyases
based on their different substrates (CPDs and 6-4PPs, respec-
tively) [6], while cryptochrome-DASH selectively repairs CPDs
in single-stranded DNA and RNA [9–11]. Nucleotide excision
repair (NER) and base excision repair (BER) are other major
DNA repair mechanisms found in nearly all organisms. NER re-
moves a wide variety of DNA-distorting lesions, including UV-
induced CPDs and 6–4PPs [4, 12, 13], while BER represents
the predominant pathway repairing lesions arising from ionizing
radiation and reactive oxygen species (ROSs) generated by
metabolism or by UV radiation [14–18]. These excision repair
pathways remove DNA lesions by a sequential, multistep pro-
cess ranging from damage recognition to DNA resynthesis and
ligation [13, 15, 19]. Lesion recognition, in the case of NER, is
performed by a complex incorporating XPC and DDB2 (p48),
while the DNA glycosylase Neil1 initiates this first step in BER.
Interestingly, expression of XPC and Neil1 has been reported
to be transcriptionally regulated by UV radiation in mammals
[20]. Furthermore, visible light exposure upregulates photolyase
expression in non-mammalian vertebrates [21, 22]. Thus, spe-
cific transcriptional activation of key DNA-repair genes appears
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to represent part of a strategy whereby DNA repair activity is
enhanced in response to sunlight to counter the detrimental ef-
fects of UV-induced DNA damage. However, the mechanisms
whereby sunlight regulates the expression of DNA repair genes
remain poorly understood.
One key, unanswered question concerns how the environment
influences the evolution of DNA-repair systems. For example,
photolyases are phylogenetically ancient enzymes that are pre-
sent in animals, plants, unicellular organisms, and even bacteria.
However, curiously, humans and other placental mammals lack
photolyases and photoreactivation, relying instead on the more
complex and less efficient NER mechanism [23]. Might a partic-
ular set of environmental conditions, experienced during the
early evolution of placental mammals, have led to the eventual
loss of photoreactivation?
In this manuscript, we aim to investigate how sunlight affects
the evolution of DNA repair systems. Specifically, we address
the consequence of evolution under extreme aphotic conditions
for DNA repair in the Somalian blind cavefish Phreatichthys
andruzzii. This species has evolved in the complete absence of
light and UV-induced DNA damage for millions of years [24]
and so represents a powerful model for exploring the influence
of sunlight on DNA repair function over an evolutionary
timescale. Cave-dwelling organisms share a set of striking
phenotypes—so-called ‘‘troglomorphisms,’’ including notably
complete loss of the eyes and body pigmentation. In certain
cases, alterations in DNA repair function have also been reported
[25–27]. For example, enhanced DNA repair has been encoun-
tered in blind cave forms ofAstyanaxmexicanus [25]. Our chosen
cavefish model, P. andruzzii, shows a more extreme troglomor-
phic phenotype than A. mexicanus, even to the extent of lacking
photic regulation of the circadian clock [28, 29]. In order to study
DNA repair function in this species, we compare it with a more
genetically accessible epigean sighted species: the zebrafish,
Danio rerio. The zebrafish contains nearly all the genes involved
in DNA repair pathways in eukaryotes, including the photo-
lyases, and so represents an ideal model for gaining mechanistic
insight into DNA repair systems [30].
Using this comparative approach, we find that P. andruzzii
represents the only species described, apart from placental
mammals, that lacks the highly evolutionary conserved photore-
activation function. The loss of photoreactivation is associated
with mutations in photolyase genes, as well as impaired light-,
UV-, and ROS-induced transcription of DNA-repair genes result-
ing from loss of D-box enhancer element function.
RESULTS
Loss of Light-Driven DNA Repair in Somalian Cavefish
Following UV irradiation, exposure to a light/dark (LD) cycle
enhances survival of zebrafish embryos [31]. Is this property
conserved during evolution for millions of years in the complete
absence of sunlight? P. andruzzii (PA) and zebrafish (ZF)
embryos raised in complete darkness until 3 days post fertiliza-
tion (dpf) were exposed to different doses of UV-C radiation
ranging from 53 to 424 J/m2. Embryo mortality was then as-
sessed daily under either LD cycle or constant darkness (DD)
conditions (Figure 1A). Under both conditions, we observed a
UV-dose-dependent increase in mortality in the embryos of
each species (Figures 1B–1E and S1A). However, a generally
lower cavefish embryo survival compared with the zebrafish
indicates species-specific differences in sensitivity to UV dam-
age. Importantly, consistent with previous findings [31], zebra-
fish embryos exposed to a LD cycle exhibited a significantly
lower mortality compared with the DD group following UV expo-
sure (Figures 1B–1E and S1A and Table S1). In contrast, the
presence of a LD cycle did not significantly enhance cavefish
survival (Figures 1B–1E and S1A and and Table S1). These
results point to a loss of the protecting effect of LD cycles in
P. andruzzii.
As a first step toward exploring this loss of the protective effect
of visible light in P. andruzzii, we next tested whether the same
phenomenon exists at the cell culture level. P. andruzzii cell lines,
derived from embryos (EPA) [32] and adult fin clips (CF1) [28], as
well as zebrafish embryo-derived (PAC-2) [33] and adult fin-
derived (AB9) [34] cell lines, were irradiated with a range of
UV-C doses and subsequently exposed to either LD or DD con-
ditions. Cell viability was then assessed using a 3-(4,5-dime-
thylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay
(Figures 1F–1J). Consistent with our in vivo experiments, cell
survival was significantly enhanced by the presence of LD cycles
in zebrafish cells, but not in cavefish cells (Figures 1F–1J and
Table S1). We have previously reported that exposure of zebra-
fish cells to LD cycles results in entrainment of the endogenous
circadian clock [35]. However, zebrafish cell survival was also
enhanced under constant light (LL) following UV radiation (Fig-
ures S1B–S1F and Table S1), arguing against clock entrainment
being responsible for the protective effect of light.
Then, to address whether the loss of the protective effect of
light in this cavefish reflects abnormalities in DNA repair, we
assayed DNA repair in cavefish and zebrafish cells under light
(LL or LD) or dark (DD) conditions following UV exposure. We
chose to specifically test the effects of blue light exposure,
given its documented importance in DNA repair system func-
tion [36] (Figures 2 and S2). We first tested the formation of
DNA strand breaks, which are generated during NER- and
BER-based DNA repair, by measuring Histone H2AX phos-
phorylation at Ser 139 (g-H2AX) [37–40]. Consistent with our
cell viability assay results, UV-induced H2AX phosphorylation
was significantly reduced upon exposure to light (LD or LL) in
zebrafish cells, but not in P. andruzzii cells (Figures 2B, 2C,
and S2B–S2D and Table S1). We then performed a single-
cell electrophoresis assay, the comet assay, which also de-
tects the presence of DNA strand breaks [41, 42]. Control
zebrafish cells kept under blue light showed significantly lower
levels of fragmented DNA following UV treatment than cells
maintained in darkness (Figures 2D, S2E, and S2F). In contrast,
in cavefish cells, the levels of fragmented DNA were again
comparable under LD and DD lighting conditions (Figures 2E,
S2G, and S2H).
Since CPD photoproducts account for more than 75% of
UV-induced DNA lesions in the genome [1, 43], we then used
an ELISA assay to directly assay the levels of UV-induced CPD
photoproducts in the zebrafish (ZF-CPD) and cavefish (PA-CPD)
cell lines during exposure to 9 hr of blue light or darkness. Our
results showed that the levels of CPDs in zebrafish were signifi-
cantly reduced upon illumination, while no significant difference
between the illuminated and dark groups was observed in the
2 Current Biology 28, 1–15, October 22, 2018
Please cite this article in press as: Zhao et al., Modulation of DNA Repair Systems in Blind Cavefish during Evolution in Constant Darkness, Current
Biology (2018), https://doi.org/10.1016/j.cub.2018.08.039
case of cavefish (Figures 2F and 2G). Together, these results are
consistent with light exposure enhancing the repair of UV-in-
duced photoproducts by photoreactivation, therefore reducing
excision repair activity in zebrafish. In contrast, during evolution
in the absence of sunlight, P. andruzzii lost the capacity to
harness light for enhancing DNA repair.
Figure 1. UV-Induced Mortality in Larvae and
Cells
(A) Experimental design for data presented in (B)–(E).
(B–E) Survival of Zebrafish (ZF) and P. andruzzii (PA)
embryos irradiated with different doses of UV-C
(B, 53 J/m2; C, 106 J/m2; D, 212 J/m2; E, 424 J/m2)
and subsequently transferred to light (LD) cycles or
constant darkness (DD). Survival rates (%) during
the following 5 days are plotted against time (dpt,
days post treatment). For untreated controls, see
Figure S1. Statistical analysis (log rank [Mantel-Cox]
and Gehan-Breslow-Wilcoxon tests) and the num-
ber of animals analyzed are reported in Table S1.
(F) Experimental design for data presented in panels
(G)–(J).
(G–J) 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetra-
zolium bromide (MTT) cell viability assay in (G and H)
ZF and (I and J) PA cell lines after UV irradiation and
subsequently exposure for 48 hr to DD or LD cycles.
UV-C doses are plotted on the x axes, while cell
viability (%) ± SEM (n = 4) with respect to untreated
cells is plotted on the y axes.
Each experiment was repeated independently three
times. Two-way ANOVA followed by Sidak’s multiple
comparisons test results are reported in Table S1.
Significant differences are indicated by asterisks
(***p < 0.001, **p < 0.01, *p < 0.05; NS, no signifi-
cance). See also Figure S1.
Loss-of-Function Mutations in
Cavefish Photolyase Genes
We next explored the molecular basis of
this loss of light-responsive DNA repair
function. Photolyases are central to the
ability of light to enhance DNA repair
[5–8]. Does P. andruzzii retain normal
photolyase function? We cloned and
sequenced the cavefish photolyase genes
in order to search for loss-of-function mu-
tations. Based on RNA sequencing (RNA-
seq) and RT-PCR using RNA extracted
from a range of cavefish tissues and
cells and consistent with other published
teleost genome sequences [44], we iden-
tified three different photolyase genes in
P. andruzzii (pa 6-4phr, pa DASHphr,
and pa CPDphr) (Figure 3A and Table
S2). In the case of the pa 6-4phr gene,
we identified one cDNA encoding a full-
length form (pa 6-4phr), sharing high
homology (88.8%) with the zebrafish
ortholog, and two additional cDNAs
encoding C-terminally truncated proteins
(pa 6-4phr-MT1 and pa 6-4phr-MT2)
(Figures 3A and S3A). Given that apart
from these mutations, the nucleotide sequences of the
three pa 6-4phr cDNAs were identical, and the fact that
our original RNA samples were derived from pools of in-
dividuals, this points to the existence of multiple pa 6-4phr
gene alleles in the P. andruzzii population. In the case of
the pa DASHphr gene, only two cDNAs encoding C-terminally
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truncated proteins lacking a major portion of the FAD binding
domain were identified, both resulting from aberrant mRNA
splicing (Figures 3A and S3B). Interestingly, in contrast to the
situation observed for these two cavefish photolyase genes,
we only encountered cDNAs encoding a single form of
P. andruzzii CPD photolyase (pa CPDphr) with all predicted
functional domains intact and bearing high homology (84.5%)
with the zebrafish ortholog (Figure 3A and Table S2).
Figure 2. Effect of Blue Light on DNA Repair
(A) Experimental design: cells were maintained in
darkness for 48 hr and then exposed to a 40 J/m2UV-C
pulse followed by DD or blue light prior to harvesting.
(B and C) Immunofluorescence analysis of g-H2AX in
(B) ZF and (C) PA. On the y axes is fluorescence
intensity (n = 200) ± SEM, while times after irradiation
are indicated on the x axes. Representative images of
stained cells are presented below, where nuclei are
blue (DAPI) and g-H2AX is red.
(D and E) Comet assay results from (D) ZF and (E) PA
cells. Times after UV treatment are plotted on the
x axes. On the y axes are indicated the levels of DNA
strand breaks (n = 300) ± SEMexpressed asmeanOlive
tail moment.
(F and G) Representative ELISA assay results of UV-
induced CPD levels in (F) ZF and (G) PA cell lines
exposed to a 20 J/m2 UV-C pulse and then maintained
in DD or blue light. CPD abundance (%) ± SEM (n = 3) is
indicated on the y axes, while times after treatment are
plotted on the x axes.
Each experiment was repeated independently three
times. For each panel, two-way ANOVA followed by
Sidak’s multiple comparisons test results are reported
in Table S1. Significant differences are indicated by
asterisks (***p < 0.001, **p < 0.01, *p < 0.05; NS, no
significance). See also Figure S2.
Since the integrity of the C terminus in the
closely related cryptochrome proteins is crit-
ical for nuclear localization [45, 46], we tested
the subcellular localization of our C-terminally
truncated P. andruzzii photolyase proteins.
N-terminally Myc-tagged versions of all the
photolyase proteins were ectopically ex-
pressed in zebrafish or P. andruzzii cells.
Immunofluorescence staining revealed that
full-length pa 6-4phr, as well as the zebra-
fish zf 6-4phr and zf DASHphr proteins,
exhibited nuclear localization. In contrast,
all the truncated cavefish photolyases
were predominantly cytoplasmic (Figures 3B
and 3C). A bioinformatics search for candi-
date nuclear localization signal (NLS) se-
quences [47] revealed that two putative NLS
sequences (KKNILRMKAAYAKRSPEDKTINK
GEKRKASPSIKEMFQKKAKR) and GPSSSK
GRKGSSYTARQHKDR) present in the C-ter-
minal portion of the zf 6-4phr and zf DASHphr
proteins, respectively, were deleted in the
truncated cavefish pa 6-4phr and pa
DASHphr orthologs. Thus, the mutant cave-
fish photolyases, which lack a significant portion of their
light-harvesting FAD binding domains, are restricted to the cyto-
plasmic compartment and so are unlikely to contribute directly to
nuclear photoreactivation function.
Interestingly, pa CPDphr, like its zebrafish ortholog, contains a
predicted NLS sequence (PDSAGGKQPKLTGGKGRESGWLL
KEVTKLRKAA) at the N terminus of the protein and is localized
predominantly in the nucleus (Figures 3B and 3C). However, to
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Figure 3. Cavefish Photolyase Characterization
(A) Predicted photolyase proteins from ZF and PA. The conserved N-terminal photolyase domain (yellow) and C-terminal FAD binding domain (pink) are indicated.
Premature termination codons are indicated as red boxes (see also Figure S3 and Table S2).
(B) Immunofluorescence images for myc-tagged PA and ZF photolyase proteins (red) expressed in PAC-2 cells, with nuclei stained using DAPI (blue).
(C) Quantitative analysis of the data in (B) presented as box-and-whisker plots. The nuclear localization (%) (n = 30) is indicated on the y axis. The boxes indicate
the degree of dispersion of the data. The horizontal lines within the boxes indicate the median values, and the whiskers represent the 25th and 75th percentiles.
The results of Student’s t test (unpaired, two tailed) statistical analysis are represented by asterisks (***p < 0.001) and reported in Table S1. NS, no significance.
(D and E) HPLC detection of DNA repair mediated by (D) 10 mMor (E) 1 mMCPD photolyase from ZF-CPD and PA-CPD in vitro. A synthetic CPD lesion-containing
oligonucleotide (Control) was incubated with the photolyase proteins and irradiated with blue light (lmax = 400 nm, 250 mmol m
!2 s!1) for 10 min. HPLC analysis
was performed using a detection wavelength of 264 nm. Levels of absorbance are plotted on the y axes and retention time from the HPLC column on the x axes.
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test whether the cavefish CPD photolyase is able to catalyze the
photoreactivation of CPD photoproducts, we performed an
in vitroDNA repair assay. The cavefish and zebrafish CPDphoto-
lyase proteins were expressed in bacteria, purified by Ni affinity
chromatography, and then incubated with synthetic DNA incor-
porating CPD photoproducts during 10min of blue-light illumina-
Figure 4. DNA-Repair Gene Expression
(A–E) qRT-PCR analysis of gene expression (A, 6-4
photolyase; B, CPD photolyase; C, DASH photo-
lyase; D xpc; E, neil1) in PAC-2 (ZF, white) and EPA
(PA, gray) cells during 9 hr of blue-light exposure.
(F–J) Comparable qRT-PCR analysis of gene
expression (F, 6-4 photolyase; G, CPD photolyase;
H, DASH photolyase; I, xpc; J, neil1) in cells during a
60 hr period in DD following exposure to a short
UV-C pulse (20 J/m2).
In each panel, relative mRNA expression levels are
plotted on the y axes as means ± SEM (n = 3) and
times (h) are plotted on the x axes. Two-way
ANOVA followed by Sidak’s multiple comparisons
test results are reported in Table S1. Significant
differences between peak points of expression
and the control untreated (DD) samples are
indicated by asterisks (***p < 0.001, **p < 0.01,
*p < 0.05). See also Figure S4 for the light spec-
trum.
tion. High-performance lipid chromatog-
raphy (HPLC) analysis showed that 10 mM
and 1 mM P. andruzzii CPD photolyase
repairs CPD photo-lesions efficiently
(100% and 12.15%, respectively) in an
equivalent manner to the zebrafish protein
(Figures 3D and 3E).
Loss of Light-Inducible DNA-Repair
Gene Expression in Cavefish
We have revealed that a subset of cavefish
photolyases has lost its nuclear function as
a result of coding sequence mutations.
However, CPD photolyase, which makes a
major contribution to photoreactivation
function [1, 43], exhibits normal enzymatic
activity and nuclear localization in cavefish.
These findings contrast with the observed
loss of photoreactivation function in this
cavefish species. Many genes implicated
in DNA repair, including the photolyase
genes, have been shown in zebrafish to
be transcriptionally activated by visible
light. Without this light-dependent induc-
tion, animals appear to have reduced toler-
ance of environmental stress and increased
mortality [31]. We therefore reasoned that
the loss of light-enhanced DNA repair in
P. andruzzii might involve abnormalities in
the light-inducible expression of DNA repair
genes. qRT-PCR analysis of DNA repair
gene expression in PAC-2 and EPA cell
lines upon exposure to blue light reveals a reduction (xpc) or
complete absence (all photolyase genes and neil1) of light-
inducible gene expression in cavefish cells compared to the
robust induction of all genes observed in zebrafish cells (Figures
4A–4E and Table S1; see also Figure S4 for the blue light
spectrum).
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Figure 5. Light-Responsive Region of the zf 6-4phr Promoter
(A and B) Upper sections: schematic representation of the (A) zf 6-4 photolyase-Luc and (B) zf CPD photolyase-Luc promoter reporter constructs. Transcription
start sites (TSSs) and the luciferase reporter gene (luc+) are indicated. Lower sections: representative real-time bioluminescence assays in PAC-2 or EPA cells
(legend continued on next page)
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It has previously been reported that pre-exposure to UV light
enhances resistance to subsequent UV-induced DNA damage
[48, 49]. We therefore wondered whether the exposure to UV ra-
diation, as well as generating DNA damage, might also influence
the expression of DNA repair-associated genes. qRT-PCR anal-
ysis of DNA-repair gene expression in zebrafish and P. andruzzii
cell lines following acute exposure to a UV pulse revealed that all
zebrafish genes were strongly induced (Figures 4F–4J and
Table S1; see also Figure S4 for the UV spectrum). Interestingly,
UV-induced gene expression in zebrafish showed a significantly
prolonged induction compared to the response trigged by blue
light (peaks at circa 36 hr and 6 hr, respectively). In contrast, in
the case of cavefish DNA-repair genes, we observed an absence
(DASHphr and xpc) or a significant reduction (6-4phr and neil1) in
the amplitude of UV-induced expression (Figures 4F–4J and
Table S1). For CPDphr, although the amplitude of UV-induced
expression was comparable to that in zebrafish, the basal levels
of expression were considerably reduced. Thus, our results point
to a general impairment of the DNA-repair gene expression
response to both visible light and UV in P. andruzzii.
Loss of D-Box-Regulated Transcription in P. andruzzii
To explore the origin of the loss of visible and UV light-induced
expression of cavefish DNA-repair genes, we cloned 4029 bp
and 894 bp promoter regions for the zebrafish 6-4 andCPD pho-
tolyase genes, respectively, into a luciferase reporter vector.
Transient transfection of both reporter constructs into zebrafish
PAC-2 cells followed by exposure to alternating periods of light
and darkness revealed a light-driven induction of biolumines-
cence in zebrafish cells, but not in P. andruzzii cells (Figures 5A
and 5B). To pinpoint precisely the light-responsive region of
the zf 6-4phr promoter, we prepared a series of overlapping pro-
moter deletion and subdeletion constructs (Figure 5C), which
were tested for light-induced expression in PAC-2 cells. We
identified a promoter region (termed SURE for ‘‘sunlight respon-
sive’’ region) that is sufficient to confer light-inducible reporter
gene expression. This region contains two palindromic D-boxes,
two E-boxes and one AP1/CREB binding site (Figures 5C–5E,
6A, and S5).
Systematic deletion of each individual element in the SURE re-
gionwithin the context of zf 6-4 photolyase SURE-Luc (Figure 6A)
revealed that the presence of the two palindromic D-box
elements is crucial for the photic regulation of the zebrafish
6-4phr gene (Figures 6A–6C and S5M–S5U). Specifically, dele-
tion of the two E-boxes together with the AP1/CREB binding
site did not significantly affect the kinetics of light-driven,
SURE-regulated expression. On the contrary, deletion of both
D-boxes resulted in a classical circadian clock-regulated pattern
of expression, with an induction in bioluminescence occurring
prior to the light onset. This clock-regulated behavior correlates
with the presence of the E-box elements in the D-box-mutated
SURE constructs (see also Figures S5M–S5U). The importance
of the D-box enhancer element in shaping zf 6-4phr expression
was confirmed by the lack of light inducibility and reduced basal
levels of expression from the full-length promoter containingmu-
tations in both D-box elements (zf 6-4 photolyase (D-box mut)-
Luc) (Figure S5V, orange trace).
Transfection of the SURE mutant 8 reporter construct, retain-
ing only the D-box enhancers (renamed as D-box6-4phr-Luc), into
cavefish EPA cells showed no light responsiveness compared
with the robust light-driven pattern observed in zebrafish cells
(Figure 6D). Considering the complete conservation of D-box
enhancer sequences between the zebrafish and P. andruzzii
6-4phr promoters (Figure 6F), these results indicate that the
absence of light-induced photolyase gene expression in cave-
fish is due to a loss of function of the light-regulated mechanisms
that control transcription via D-box enhancers.
Expression of the 6-4phr gene is induced in zebrafish by UV
light, and this response is impaired in P. andruzzii (Figure 4).
Therefore, to address whether the D-box enhancer may also
represent a nuclear target for UV, we studied the expression of
the D-box6-4phr-Luc reporter in zebrafish PAC-2 and cavefish
EPA cells following UV exposure. In zebrafish cells, UV treatment
induced bioluminescence with similar kinetics to those of the
endogenous gene, revealing that the palindromic D-box ele-
ments in the SURE region are also sufficient for directing UV-
induced expression (Figure 6E). Furthermore, similar to the
pattern observed for endogenous gene expression (Figure 4F)
in transfected EPA cells, UV-C treatment failed to activate
expression of the D-box6-4phr-Luc reporter (Figure 6E). These re-
sults reveal that the D-box serves as the convergence point for
the mechanisms mediating visible and UV light-induced gene
expression and that this integrating function is absent in
P. andruzzii.
Given the central role played by theD-box in the regulation and
evolution of 6-4phr gene function, we searched the promoter se-
quences of other light-induced DNA-repair genes for this
enhancer element in zebrafish, as well as a broad range of fish
genome sequences (Oryzias latipes,Astyanaxmexicanus,Poeci-
lia Formosa, etc.; see Table S3). Our analysis revealed that the
50-TTTTGTAAC-30 D-box enhancer element is present in many
other DNA-repair genes (CPD and DASH photolyase, as well
as ddb2, xpc, and neil1), in close proximity to their transcription
start sites, and canonical E-box elements (50-CACGTG-30) (Fig-
ure 6G and Table S3). While the E-boxes potentially represent
binding sites for the core circadian clock factors CLOCK and
BMAL, robust circadian rhythms of photolyase gene expression
were not observed following transfer of zebrafish cells from LD to
DD conditions (Figures S6A–S6C). Furthermore, cells trans-
fected with the wild-type 6-4phr gene promoter reporter
construct showed an immediate attenuation of rhythmicity
following transfer from LD to DD (Figure S6D, blue trace). In addi-
tion, cells transfected with the D-box-mutated 6-4phr reporter
construct, where the E-boxes are still intact, failed to show
transfected with each luciferase reporter. Bioluminescence, counts per second (cps), is plotted against time (hr). Black and white bars along the x axes show dark
and light periods. Each time point represents the mean of n = 8 ± SEM.
(C) Schematic representation of zf 6-4 photolyase-Luc and its deletion and subdeletion constructs. The position of the 120 bp zf 6-4phr sunlight responsive region
(SURE) is indicated by horizontal arrowheads.
(D and E) Bioluminescence analysis of cells transfected with (D) zf 6-4 photolyase-Luc subdeletion 1 and (E) subdeletion 2.
See also Figure S5 for the complete promoter analysis.
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rhythmicity either in LD or DD (Figure S6D, orange trace).
Together, these results point to the D-box, rather than the
E-box, playing a highly conserved, coordinating role in the
DNA repair response.
What is the origin of this loss of light- and UV-regulated D-box
enhancer function in P. andruzzii? UV and light exposure both in-
crease intracellular ROS [32, 50–52]. We have recently reported
that elevated levels of ROS are crucial for light-induced clock
gene expression via the D-box [32]. Consistent with ROS also
serving as a key coordinating signal for photolyase genes, pre-
treatment of zebrafish cells with N-acetylcysteine (NAC), a gen-
eral ROS scavenger, efficiently blocked UV-induced, as well as
blue-light-induced, photolyase gene expression (Figures
7A–7C). Furthermore, the expression of photolyase genes and
the 6-4 photolyase D-box reporter are all induced by ROS
(300 mM H2O2) in zebrafish cells (Figures 7D–7G). In contrast,
ROS treatment failed to significantly induce photolyase or
D-box reporter expression in EPA cells (Figures 7D–7G), pointing
to loss of function in ROS-dependent signaling pathways in
P. andruzzii. The MAP kinase (MAPK) signaling pathway plays
a key role in bridging oxidative stress and DNA damage with a
range of cellular responses [53, 54]. By western blot analysis us-
ing phospho-specific MAPK antibodies, we revealed a signifi-
cant attenuation of the levels of phosphorylated (activated) forms
of ERK, JNK, and p38 in cavefish cells following UV exposure
compared with the robust induction observed in zebrafish cells
(Figures 7H–7J and S7). Thus, our data reveal fundamental dif-
ferences in the signaling pathways triggered by UV exposure be-
tween cavefish and zebrafish.
DISCUSSION
Here, by comparing the blind cavefish, P. andruzzii, with the ze-
brafish, we have explored how sunlight shapes the evolution of
DNA repair systems. We have revealed that both the integrity
of photolyase genes, as well as transcriptional control mecha-
nisms regulating the expression of DNA-repair genes in
response to sunlight, have been targeted by evolutionary mech-
anisms operating under extreme aphotic conditions.
Loss of Photolyase Function in P. andruzzii
We have revealed the presence of mutations in the 6-4 and
DASH photolyase gene coding sequences, which result in
C-terminally truncated, cytoplasmic proteins unable to perform
DNA repair. However, the contribution of these mutations to
the observed lack of photoreactivation is unclear given the gen-
eral loss of sunlight-induced photolyase transcription in cavefish
cells.
Curiously, despite the absence of photoreactivation DNA
repair, the pa CPDphr coding sequence carries no apparent
loss-of-function mutations. This may reflect the persistence of
an additional, photoreactivation-independent function for this
photolyase gene in P. andruzzii that continues to confer a selec-
tive advantage during evolution in DD. Indeed, CPD photolyase
has been reported to bind to sites of DNAdamage in the absence
of light and subsequently recruit DNA repair proteins [8, 55].
Another possible function of CPD photolyase relates to its simi-
larity with the cryptochrome proteins [6, 56]. The cryptochrome/
photolyase flavoprotein family share a ‘‘core’’ domain that
contains the binding sites for FAD and a second antenna
chromophore cofactor. This domain has been conserved during
evolution from an ancestral CPD photolyase gene but with diver-
sification of the N-terminal and C-terminal portions of the protein
[57]. In the case of the cryptochrome proteins, an extended
C-terminal portion confers additional functional diversity and is
associated with loss of photoreactivation function. While crypto-
chromes serve as blue-light photoreceptors in plants and
Drosophila, in vertebrates, they act as negative elements within
the core circadian clock mechanism [58, 59]. Recent studies
have shown that CPD photolyase, when ectopically expressed
in mammalian cells, can interact directly with the CLOCK pro-
tein to reduce CLOCK/BMAL-dependent transactivation and
thereby, like the cryptochromes, serve as a clock component
[60]. This indicates that the highly conserved cryptochrome/pho-
tolyase core domain also directly contributes to circadian clock
function. Interestingly, changes in CPD photolyase expression in
cavefish are encountered together with abnormalities in the
circadian clock. Thus, in cave forms of A. mexicanus where
CPDphotolyase expression is upregulated, many light-regulated
clock genes show constitutively elevated expression, reminis-
cent of the clock’s response to constant light exposure [25]. In
contrast, in P. andruzzii, which exhibits a loss of the sunlight-
dependent transcriptional control mechanisms for CPD photo-
lyase, the circadian clock lacks photic entrainment [28].
An alternative explanation for the retention of CPD photolyase
function in cavefishmay relate to the length of time that evolution
has occurred in the dark cave environment. In support of this
interpretation, recent microsatellite polymorphism analysis has
suggested that surface and cave populations of Astyanax that
may have diverged less than 20,000 years ago [61] carry no mu-
tations in the photolyase coding sequences ([25] and AstMex102
database in ENSEMBL vs92). In contrast, geological evidence
Figure 6. Transcriptional Control of the zf 6-4phr Gene via D-Box Enhancers
(A) Schematic representation of SURE and the zf 6-4 photolyase SURE-Luc mutation constructs 1–8. The two E-boxes, the palindromic D-boxes, and the
AP1/CREB binding sites are indicated.
(B and C) Representative real-time bioluminescence assays from PAC-2 cells transfected with (B) zf 6-4 photolyase SURE-Lucmutant 6 and (C) zf 6-4 photolyase
SURE-Luc mutant 8 (also see Figure S5).
(D and E) Bioluminescence results fromPAC-2 (blue) and EPA (orange) cells transfected with the zf 6-4 photolyase SURE-Lucmutant 8 (renamedD-box6-4phr-Luc)
reporter construct. This construct is represented graphically above the panels. After transfection, cells were exposed either (D) to alternating periods of light and
dark or (E) to DD following a short pulse of UV-C (black arrow, 20 J/m2).
(B–E) Mean bioluminescence (n = 8) ± SEM is expressed as counts per second (cps) and is plotted against time (hr).
(F) Sequence alignment of the ZF and PA D-box enhancer element sequences within the 6-4phr SURE and CPDphr promoter region.
(G) Schematic representation of the D-box and E-box elements present in the promoters of DNA-repair genes in the ZF (Danio rerio). These elements are
conserved in a broad range of fish species (see Table S3 for accession numbers).
See also Figure S6.
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Figure 7. D-Box Regulation via ROS Signaling
(A–C) qRT-PCR analysis of gene expression (A, 6-4 photolyase; B,CPD photolyase; C,DASH photolyase) in ZF cells treated with 6mMNAC (gray) or vehicle (Ctrl,
black), following 3 or 6 hr exposure to blue light or 24 hr and 36 hr following a short UV-C pulse (20 J/m2). On the y axes are plotted the fold induction (±SEM) of
expression with respect to samples subjected to identical treatment but maintained under DD. Times and treatments are indicated on the x axes. Statistical
analysis results (Student’s t test [unpaired, two tailed]) are represented by asterisks (***p < 0.001) and reported in Table S1.
(D–F) qRT-PCR analysis of gene expression (D, 6-4 photolyase; E, CPD photolyase; F, DASH photolyase) in ZF PAC-2 (white) and cavefish EPA (gray) cells after
300 mM H2O2 treatment. Relative mRNA expression are plotted on the y axes as mean (n = 3) ± SEM. Times (hr) are plotted on the x axes. Two-way ANOVA
(legend continued on next page)
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suggests that P. andruzzii has been completely isolated from
sunlit surface water for at least 3 million years [24, 29], with the
elimination of any remaining surface populations by desertifica-
tion [62, 63]. In this hypogean species, mutations have already
affected the 6-4 and DASH photolyases, and over a sufficient
evolutionary timescale, all the photolyase genesmight eventually
suffer loss of function or even be lost as in the case of placental
mammals.
Flexibility in D-Box Enhancer Function during
Vertebrate Evolution
In P. andruzzii, we show that the lack of photoreactivation origi-
nates primarily from a loss of D-box enhancer function. We have
identified the D-box in zebrafish as being a central player in coor-
dinating the transcriptional response to visible light, UV, and
ROS [32, 64, 65]. By upregulating the expression of key elements
involved in photoreactivation and NER and BER DNA repair, this
promoter element specifically enhances the capacity of cells to
resolve DNA damage generated by exposure to these cellular
stressors. The D-box elements identified in the light responsive
DNA repair genes reported here are highly conserved in nearly
all published fish genome sequences. Interestingly, circadian
E-box enhancer elements are frequently encountered in close
proximity to the D-boxes, although our data do not support a
strong functional link between the circadian clock and DNA-
repair gene transcriptional regulation. Interaction between a
D-box and E-box enhancer is crucial for light-induced expres-
sion of the period 2 clock gene [64], but the D-box sequence in
the period 2 promoter differs slightly from those identified here
in the DNA-repair gene promoters. Together, our results point
to specific regulatory properties of these 50- TTTTGTAAC !30
D-box elements being linked with DNA repair function. A family
of six bZip/PAR factors, as well as six E4BP4-related tran-
scription factors, can bind to D-box enhancer elements in
homo- and heterodimeric combinations [66]. Differences in the
consensus D-box sequence may therefore lead to differential
binding of factors eliciting different transcriptional responses.
Interestingly, previous evidence points to considerable plasticity
in D-box function over the course of vertebrate evolution. While
in fish, the D-box serves as a light input pathway component for
the entrainment of the circadian clock, in mammals, the D-box is
strictly clock regulated and acts within clock output pathways
[67]. Furthermore, in mammals, the D-box is neither light nor
ROS inducible and is targeted by a smaller family of three
bZip/PAR and one E4BP4 factors [32, 68, 69]. Finally, D-box
enhancer sequences are not encountered in the promoters of
the mammalian DNA-repair gene orthologs such as neil1, xpc,
and ddb2. Taken together, our results point to the occurrence
of major changes in D-box enhancer function during vertebrate
evolution.
Evolution of DNA Repair Systems in Extreme Aphotic
Environments
Does the absence of UV damage and visible light represent the
only feature in the cave environment influencing the evolution
of DNA repair systems? Alternatively, do additional genotoxic
stressors exist, specific to these subterranean aquatic environ-
ments? Elevated levels of CPD photolyase and ddb2 expression
in blind cave forms of A. mexicanus have been speculated to
provide a selective advantage in repairing different types of
DNA damage experienced in the cave environment [25]. For
example, life in the hypoxic and slightly acidic water locked in-
side these cave systems may lead to an increase of intracellular
oxidative stress [70]. This may be exacerbated in certain caves
(e.g., Cueva Chica and El Pacho´n) that serve as roosting sites
for large numbers of bats that bring organic materials (guano
and dead bodies) into the water on a daily basis [25, 70]. Interest-
ingly, an enhancement of DNA repair capacity has also been
identified in the blindmole rat, Spalax carmeli, linked with its hyp-
oxia tolerance [26]. An additional feature of certain cave systems
that might cause elevated DNA damage is the natural radioactive
gas, radon 222Rn, which is released from certain rocks and
concentrated in caves [71]. This source of radioactivity has
been linked with an increase in the rate of deletion of satellite
DNA sequences at the whole-genome level in Dolichopoda
cave crickets [72].
Photoreactivation is a highly conserved DNA repair mecha-
nism encountered in most animal, plant, and unicellular species,
with the curious and unique exception of placental mammals
[73]. Based on the results of this study, we can now add the blind
cavefish P. andruzzii to this small group of exceptions. Why
placental mammals lost this DNA repair function remains a
mystery. Taking into account palaeontological data, one theory
that has been proposed is termed the ‘‘nocturnal bottleneck’’
[74, 75]. This predicts that the ancestors of modern mammals
that lived during the dinosaurs’ domination of the Earth avoided
predation by becoming exclusively nocturnal [74, 76]. It is pre-
dicted that adaptation to this ecological niche may explain
many features of present-daymammals. These include a general
loss of extraretinal photoreception, as well as adaptations in the
eye and retina to facilitate vision under low-lighting conditions
[74, 76]. Interestingly, adaptation to a nocturnal life style is
also predicted to have entailed a general loss of UV protection
mechanisms. These include changes in lens composition, result-
ing in a more efficient penetration of UV light to the retina, as well
as the loss of photolyase genes and photoreactivation function
[74, 77]. However, the mammalian ancestors retained NER
systems in order to repair the limited UV-induced DNA damage
they experienced in their nocturnal environment. Following the
extinction of dinosaurs, mammals subsequently diversified and
occupied new surface habitats but still carried relics of their
followed by Sidak’s multiple comparisons test results are reported in Table S1. Significant differences between peak points of expression and the control un-
treated samples are indicated by asterisks (***p < 0.001, **p < 0.01, *p < 0.05).
(G) Real-time bioluminescence assays from ZF PAC-2 (blue) and cavefish EPA (orange) cells transfected with the 6-4 photolyase D-box reporter represented
above the panel and treated in DD with 300 mM H2O2 at the time point indicated by the blue arrow.
(H–J) Western blot quantification of (H) P-JNK, (I) P-ERK, and (J) P-p38 levels in zebrafish PAC-2 and cavefish EPA cells during a 60 hr period in DD following
exposure to a short UV-C pulse (20 J/m2). Fold induction ± SEM (n = 3) is plotted on the y axis and time (hr) on the x axis. Two-way ANOVA followed by Sidak’s
multiple comparisons test results are reported in Table S1. Significant differences between peak points of expression and the control samples are indicated by
asterisks (***p < 0.001, **p < 0.01, *p < 0.05). Original western blots are presented in Figure S7.
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dark-adapted past existence. It is tempting to speculate that in
the DNA repair systems of the blind cavefish, P. andruzzii, we
may be witnessing the first stages in a process that previously
occurred in the ancestors of placental mammals during the
Mesozoic era.
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A B S T R A C T
The Wound Healing (WH) assay is widely used to investigate cell migration in vitro, in order to reach a better
understanding of many physiological and pathological phenomena.
Several experimental factors, such as uneven cell density among different samples, can affect the
reproducibility and reliability of this assay, leading to a discrepancy in the wound closure kinetics among data
sets corresponding to the same cell sample. We observed a linear relationship between the wound closure
velocity and cell density, and suggested a novel methodological approach, based on transport phenomena
concepts, to overcome this source of error on the analysis of the Wound Healing assay. In particular, we propose
a simple scaling of the experimental data, based on the interpretation of the wound closure as a diffusion-
reaction process. We applied our methodology to the MDA-MB-231 breast cancer cells, whose motility was
perturbed by silencing or over-expressing genes involved in the control of cell migration. Our methodological
approach leads to a significant improvement in the reproducibility and reliability in the in vitro WH assay.
1. Introduction
Cell migration and proliferation play pivotal roles in a variety of
physiological and pathological processes. These include morphogen-
esis, angiogenesis, inflammation, tissue repair, and tumor invasion
[1,2]. Therefore, it is of great interest and potential therapeutic
importance to understand the mechanisms driving cell dynamic
behavior, which are still far from being fully understood [3,4].
The wide range of in vitro assays to quantitatively evaluate cell
motility, invasion and chemotaxis include straightforward and eco-
nomical ones, such as the Boyden Chamber assay [5], or more
expensive, time-consuming and technically demanding as the cell
random motility assay [6,7]. This last one enables the investigation
of cell motility at the level of both individual cells and entire cell
population. The choice of one or the other method depends on the
specific research question and cell type under investigation [8].
One of the most popular, widely used, and straightforward
methods to characterize and quantify cell dynamic behavior in vitro
is the Wound Healing (WH) assay [8], because of its low cost and
simplicity to set-up [9]. Recently, it was proved the results from WH
assay can be used to estimate single cell motility parameters [10],
such as random motility coefficient, typically measured by time
consuming random motility assay. In the conventional WH assay,
also known as scratch test, cells are seeded on a planar surface,
allowed to attach, spread and proliferate until they reach confluency.
An artificial “wound” is then made by dragging a sterile pipette tip or
needle across the cell monolayer [11,12]. Then cells are washed with
an appropriate medium to remove debris and floating cells.
Recently, novel non-mechanical techniques have been developed to
achieve wounding without mechanically disrupting the cell layer
[13-19]. After the wounding, the cells on the edges of the newly
created gap loose the cell-cell contact inhibition and, stimulated by
the availability of free space, start to move and proliferate until new
cell-cell contacts are re-established and the wound is closed [20].
Contact inhibition is a property of normal somatic cells and a key
anticancer mechanism that arrests cell division when cells reach a
high density. Cancerous cells typically lose this property and thus
grow in an uncontrolled manner even when in contact with neigh-
boring cells. Loss of contact-inhibition has important implications
for cancer invasion and metastasis [21,22].
Two different experimental approaches can be followed to monitor
the wound closure process; microscope images within the sample can
http://dx.doi.org/10.1016/j.yexcr.2017.01.005
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be acquired at a limited number of defined time steps [23-26] or by
time-lapse microscopy (TLM), that allows to iteratively image specific
regions along the wound at a fixed time frequency [24], while
controlling the environmental conditions to ensure cell viability
[10,27]. This last approach is more reliable, produces a larger amount
of data for each sample, and allows to reduce the error related to the
random choice of sample position for each acquisition. The wound
closure dynamic is typically quantified by counting cells that repopulate
the wound region at each time step [28,29], or by measuring the
change in the wound size over time [23-26].
The time required and mechanism involved in the healing of the
artificial wound strictly depends on the type of cells. Specifically,
epithelial-like cells cover the wound area in concert as two coherent
cell sheets [30,31], whereas fibroblast-like cells repopulate the wound
region moving as individual units [32] due to the lack of strong cell-cell
contacts [8,11,32,33].
The wound healing process can be modeled according to the Fisher-
Kolmogoroff equation [34-37] (Eq. (1)), which is a diffusion-reaction
equation. Inspired by transport phenomena concepts, this model
mathematically describes the evolution in time of the cell density
special profile u(x,t) as the sum of two contributions, i.e., cell motility
and proliferation, both involved in the spatial spreading of the cells in
the wound region:
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Here, u is cell density at time t at a given distance x, measured from
the wound edge, D is the constant diffusivity (also referred as random
motility coefficient), k is the proliferation rate and uˆ is cell density at
confluency [38]. Cell motility is modeled as a Fickian-like diffusion,
and depends on the differences between cell density at the wound edge
and the cell-free area. Cell proliferation is mathematically described as
a logistic growth, and includes crowding effects by reducing the growth
rate as the cell density approaches confluency. Cell density as a
function of distance is predicted to have a “double s” shaped profile,
being maximum far from the wound and decreasing down to 0 in the
cell nude area. Overall, the Fisher-Kolmogoroff equation predicts that
after a short transient phase, the invading cell front propagates at a
constant speed perpendicularly to the wound edge reducing the size of
the wound area [39].
Easy to perform, the WH assay is particularly suitable to study
and compare cell dynamic behavior in vitro under different
experimental conditions. However, mechanical injure to the cells
on the wound edges [40], attachment of cell debris to the wound
margins and damages to the migrating surface [41] may represent a
limit in accomplishing reproducible and reliable quantitative
results [42]. In particular, equal cell density among different
samples is challenging to achieve and reproduce, because of
possible inaccuracy in cell counting, partial cell seeding, and, in
particular, because of lipofection, electroporation or other invasive
treatments cells can be subjected to before in vitro WH assay [43].
These treatments can result in a poor control of the effective cell
density of the samples. Altogether, the aforementioned drawbacks
affect the direct comparison of WH experiments made in different
experimental conditions.
Here, we propose a novel approach to quantify the wound closure
dynamic. The proposed method is based on transport phenomena
concepts and takes into account the differences in cell density, over-
coming the difficulty to compare samples that have been subjected to
different experimental procedures. As a case study, we have applied our
method to analyze data obtained from WH assays performed with
MDA-MB-231 breast cancer cells, whose motility was perturbed by
depletion or over-expression of genes involved in the control of cell
adhesion and migration.
2. Materials and methods
2.1. Cell culture
MDA-MB-231 cells derived from metastatic breast carcinoma were
purchased from Cell Line Service (CLS, Germany) and cultured at
37 °C and 5% CO2, in DMEM supplemented with 10% FBS.
2.2. Transfection and RNA interference
MDA-MB-231 breast cancer cells were seeded at a density of about
70% confluence and transfected with 2.0 μg of empty or ∆Np63α
expression vector using Lipofectamine 2000 reagent (InVitrogen, Life
Technologies. Inc.). The expression vector encoding ∆Np63α was
previously described [44].
YB-1 transient silencing was carried out by RNA interference with
RIBOXX (IBONI YB-1siRNA pool) and RNAiMAX reagent
(Invitrogen), according to the manufacturer's recommendations.
Briefly, cells were seeded at 70% confluence (1.5×106 cells) in 100-
mm dishes and transiently silenced with IBONI YB-1-siRNA at 20 nm
final concentration. YB-1 guide sequences:
UUUAUCUUCUUCAUUGCCGCCCCC;
UUAUUCUUCUUAUGGCAGCCCCC;
UUCAACAACAUCAAACUCCCCC;
UCAUAUUUCUUCUUGUUGGCCCCC.
“All Star Negative Control siRNA”, provided by Quiagen, was used
as negative control.
2.3. Immunoblot and antibodies
Immunoblot was performed following standard methods [43,45].
Briefly, 30 µg of whole cell extracts were separated by SDS-PAGE,
subjected to western blot and incubated overnight at 4 °C with
antibodies. Antibodies against p63 (4A4) and YB-1 (ab12148) were
from Abcam; actin (1-19) antibody was from Santa Cruz Biotechnology
(Inc. CA, USA). Signal intensities of Western blot bands were quanti-
fied by Quantity One software (Biorad).
2.4. Cell proliferation rate
YB-1 silenced, ∆Np63α and Mock transfected MDA-MB-231 cells
were plated onto 12-well culture plates at 1×104 cells/cm2 with FBS. At
24, 48 and 72 h, cells were harvested by suspension in 0.025% trypsin
in 0.02% EDTA solution. Cell counts were performed in triplicates
using a Neubauer chamber, with trypan blue exclusion assay to identify
viable cells. Growth curves were generated and the cell population
doubling time estimated (PDT).
2.5. WH assays
To perform WH assays, MDA-MB-231 control cells, MDA-MB-231
cells silenced for YB-1 expression and MDA-MB-231 cells transfected
with ∆Np63α were plated on 12-well culture dishes (Corning) at a
density of 7.63×104 cells/cm2 (80% confluence). The cells were allowed
to adhere and grow for 24 h in order to obtain uniform monolayers.
The samples were wounded manually with a p200 pipette tip to
mechanically remove an area of cells. The culture medium was
removed and the wounded monolayers were washed twice with
phosphate-buffered saline (PBS) to remove cell debris and suspended
cells. Before starting TLM image acquisition, cell samples were covered
with fresh culture medium. Each assay was repeated in triplicate.
2.6. Fluorescence microscopy
MDA-MB-231 cells were plated in 35 mm dish (4.2×103 cells/cm2)
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and grown on micro cover glasses (BDH). After 24 h cells were transfected
with ∆Np63α plasmid (mock) or YB-1 siRNA oligos. 24 h after transfec-
tion cells were washed with cold phosphate-buffered saline (PBS) and
fixed with 4% paraformaldehyde (PFA) (Sigma-Aldrich, St. Louis, MO) for
10 min at room temperature. Cells were permeabilized with 0.5% Triton-
PBS for 5 min, blocked with a solution of 3% BSA at room temperature for
20 min, washed with PBS and incubated with YB-1 (Ab12148) antibody
(1:300 dilution). After washing in PBS, samples were incubated with
conjugated anti-rabbit IgGs (Green-Alexa Fluor 488, ThermoFisher) at
room temperature for 45 min. Nuclei were detected by incubating cells
Fig. 1. Image acquisition technique. Scheme of the time-lapse microscopy workstation on the top. In the bottom, two typical images acquired during a WH experiment, corresponding to
t=0 h (left) where the initial wound size A0 is measured, and a generic t > 0 h (right), where the wound size is reduced to A. The cell-free area at t=0 (A0) and at t > 0 (A) is shown in black.
Scale bar=100 µm.
Fig. 2. A representative immunoblot showing the expression level of ∆Np63α and YB-1 in equal aliquots of MDA-MB-231 cell extracts. MDA-MB-231 cells were transfected with
scrambled oligos, YB-1 oligos or ∆Np63α encoding vector. After 24 h total protein extracts were prepared and quantified. Equal aliquots of extracts were loaded on SDS/PAGE gel and
subjected to immunoblot with anti-YB-1, anti-p63, and anti-β-actin antibodies. B. Histograms presenting the ratio of YB-1 over β-actin signals from immunoblot analysis (mean values
and standard deviations were calculated from biological triplicates).
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with Hoechst 33342 (2!-[4-ethoxyphenyl]−5-[4-methyl-1-piperazi-
nyl]−2,5!-bi-1H-benzimidazole trihydrochloride trihydrate) (Thermo
Scientific) for 5 min. Actin bundles were stained with Rhodamine
conjugated phalloidin (Sigma) in PBS for 30 min at room temperature.
Images were digitally acquired using Nikon TE Eclipse E1000 microscope
(40x) and processed using ImageJ Software.
2.7. Time-lapse microscopy
Time-lapse Microscopy (TLM) image acquisition was performed
using an automated workstation [46] based on an inverted microscope
(Zeiss Axiovert 200, Carl Zeiss, Jena Germany) enclosed in a home-
made incubator that allows to keep the sample at constant temperature
(37 ± 0.1 °C) and under 5% CO2, 100% humidified atmosphere. A
scheme of the workstation is reported in Fig. 1. Sample images were
iteratively acquired by a high-resolution high-sensitivity monochro-
matic CCD video camera (Hamamatsu Orca AG, Japan) using a long
working distance 10x objective in phase contrast (CP Achromat Ph1).
The microscope was also equipped with motorized stage and focus
control (Prior, Cambridge, UK) for automated positioning. The work-
station was controlled by homemade control software in Labview. For
each cell sample, several independent fields of view were selected in
different wells of the multiwell culture plate. The delay time between
consecutive image acquisitions was 15 min, and the whole experiment
length was about 50 h.
2.8. Image and data analysis
For each cell sample, overall at least five fields of view from three
independent experimental campaigns were analyzed and compared.
The wound closure dynamics was quantified by measuring the size
of the cell-free area for each time step (A), normalized respect to its
value at time 0 (A0). A homemade automated image analysis software,
based on the analysis of image variance, was used to identify the wound
edge as the boundary of the scattering cells. The result of this
segmentation is reported in Fig. 1, which shows two images corre-
sponding to t=0 h and t > 0 h; the black area represents the cell-free
region, as measured by image analysis. The curves describing the
evolution of the wound area over time showed a linear trend. The
wound closure velocity was determined as the slope of the linear fit of
experimental data (α, h−1).
Cell density at time 0 was measured for each field of view by
manually counting the cells on the left and right wound edge in the
image acquired at time 0. The density value was calculated dividing the
number of cells by the area covered, measured by drawing manually the
cell covered area contour using an image analysis software (Image Pro
Plus).
3. Results and discussion
Y Box binding protein 1 (YB-1 or YBX-1) and ∆Np63α are
interacting partners involved in the control of cell adhesion and
migration [47]. In particular, ∆Np63α is a marker of epithelial basal
cells that provides inhibitory signals for cell motility and spread [48].
To define the role of YB-1 and ∆Np63α in the control of cell
movements, we set out WH assays in MDA-MB-231 cells. MDA-MB-
231 cells lack endogenous ∆Np63α expression and express high level of
YB-1. Cells transfected with ∆Np63α plasmid or depleted of endogen-
ous YB-1 by short interfering RNA (siRNA) were used for WH assays to
compare their behavior to control cells. Immunoblot analysis of total
cell extract was performed to confirm efficient YB-1 knockdown and
∆Np63α transfection (Fig. 2).
Continuous cell monolayers were manually wounded in order to
induce the cells to cover the cell-free region. Wound closure dynamics
was captured by imaging the samples through TLM acquisition. Data sets
from three independent WH experiments were collected and compared.
The wound closure process was quantified measuring by image
analysis the reduction of wound area over time, as described in the
Material and Methods section. In Fig. 3, the evolution of wound area,
normalized respect to the value at time 0 (A/A0), is reported as a
function of time for the control sample (Fig. 3(A)) and the two cell
treatments (Figs. 3(B) and 3(C)). For each of the three distinct
experimental settings (control, YB-1 silenced and ∆Np63α transfected
cells), we produced at least five data sets and plotted them as
independent data series. The obtained profiles, all starting from A/
A0=1 and describing the temporal evolution of the wound area (wound
closure kinetics), exhibited a linear trend until complete wound closure
was reached (A/A0≈0). This suggests that the wound healing process
occurs at a constant velocity, in agreement with the prediction of the
Fig. 3. Evolution in time of the wound area A, normalized to the value A0 at time 0, for
MDA-MB-231 control cells (A, 6 data series), cells silenced for YB-1 expression (B, 8 data
series) and cells transfected with ∆Np63α (C, 8 data series).
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Fisher-Kolmogoroff equation model [20] that describes the process as
wave of the cell density function traveling at constant velocity, after a
short transient phase. The initial lag time can be neglected in our case,
on the time scale of our interest. The slope of the linear fit of
experimental data (α, h−1) can be considered as a direct measurement
of wound closure velocity, and is directly related to the speed of the
propagating cell front (v, μm/h), predicted by the Fischer-Kolmogoroff
model. In particular, v=α* b/2, where b is the width of the wound at
time 0, in μm.
Surprisingly, as shown in Fig. 3, within each experimental setting
we found a strong discrepancy among the data sets although the
samples were technical replicates of a single experiment. In fact,
different wound closure times, corresponding to different wound
closure velocities, can be observed for each cell sample, including the
control cells. For example, in Fig. 3(B) two different trends can be
distinguished; in one case the wound closure was achieved in about
10 h (two data sets), whereas in the other case more than 20 h were
required (three data sets). Similar discrepancies were visible also for
the other samples.
Although unexpected, inconsistency in data from WH statistical
replicates are common in the literature and can lead to results difficult
to interpret, compare or integrate [43,49].
To explore the possible reasons for data discrepancies, the
images acquired at time 0 for each data set were visually inspected
and found to be substantially different in cell density. Fig. 4 shows
the images acquired at time 0 for two samples corresponding to cells
silenced for YB-1 expression (Fig. 3(B)). In particular, Fig. 4(A) is
relative to a cell sample where the complete closure of the wound
region required 10 h, while Fig. 4(B) corresponds to a sample where
the wound closure required about 30 h. Magnification of selected
regions on the wound edge highlights the difference in cell density
between the two samples. A different cell density might reasonably
explain variations in wound closure kinetics, being all the other
conditions the same. Videos of the wound healing process for these
two cell samples are available as Supporting Information (Video 1
and Video 2, referring to the samples in Figs. 4(A) and 4(B)
respectively).
Supplementary material related to this article can be found online
at doi:10.1016/j.yexcr.2017.01.005.
Pharmacological treatment and widely used methods in cell biology
research to modulate gene expression, such as lipofection and electro-
poration, may trigger cellular stress and determine unwanted detach-
ment of a certain amount of cells from the cell monolayer [49,50].
Moreover, static seeding techniques, poor plate quality and uneven
adhesion can lead to non-uniform spatial spreading of the cells in the
culture dish after plating so that fluctuations in cell population density
can also occur in control samples thereby limiting the reproducibility of
the measurements in WH assays.
Our set of experiments was designed to compare the wound healing
kinetic of MDA-MB-231 cells with that of the same cells subjected to
YB-1 silencing by RNA interference or ∆Np63α over-expression by
lipofection.
According to the Fisher-Kolmogoroff model, the wound closure
process can be described as the evolution of cell density in space and
time, due to two mechanisms, i.e., cell motility and proliferation, that
are both involved in the spatial spreading of the cells in the wound
region [39]. Cell motility, mathematically described as diffusion, is
driven by a gradient of cell density generated between the cell
monolayer and the wound area. Cell proliferation, described as a
logistic growth, depends on the local cell density on the wound edge.
Both the motility and the proliferation term of the Fisher-Kolmorgoroff
are related to the cell density, in first approximation in a linear way,
thus suggesting that the wound closure velocity is linearly dependent
with the cell density.
We investigated a possible relationship between the wound closure
velocity and the initial cell density (u) of the samples, as measured from
images acquired at time 0 for each data series (see Material and
Methods section). In order to determine the wound closure velocity,
each data set in Fig. 3 for the three samples under investigation was
fitted assuming a linear trend; the slopes of the lines fitting the curves
of A/A0 versus time (starting from A/A0=1 and stopping at a value
around 0) represent the wound closure velocity for each specific
sample. In Fig. 5, the so determined wound closure velocity (α) is
reported as a function of the corresponding cell density (u). A liner
relationship can be observed between v and u for each cell sample,
suggesting the dependence of the wound closure kinetics on the cell
Fig. 4. Images acquired during a WH experiment at time t=0 for two cell samples silenced for YB-1 expression.
Fig. 5. The wound closure velocity (α) is reported as a function of the cell density at time
0 (u) for the three cell samples under investigation. A linear fit is reported, R2=0.83, 0.95
and 0.93, for MDA-MB-231 control cells, cells silenced for YB-1 expression and cells
transfected with ∆Np63α, respectively.
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density. This result is in agreement with the dependence of the
proliferation and migration mechanisms on the cell density, as
suggested by Fisher-Kolmogoroff equation.
We propose a phenomenological scaling of the experimental data,
which considers the differences we measured in the cell densities at
time 0, and minimizes the differences in wound closure time we
observed in Fig. 3 which are unexpected for technical replicates. The
scaling is described in details in the Supplementary Materials section.
Briefly, the calculation is based on the linear relationship between A/A0
and the time, and between the wound closure velocity v and the cell
density u. The scaling consists in the calculation, for each data series, of
corrected time values tc, obtained multiplying the experimental time t
of each experimental point by a scaling factor, according to Eq. (2). The
scaling factor is the ratio between the cell density at time 0 of the
sample considered (u )i and a reference value of the cell density (u )R , in
principle also arbitrarily chosen:
t =
u
u
*tc
i
R (2)
Reasonable values of uR are close to the cell density at confluency. A
wider description of the calculation of the scaling is reported in the
Supplementary Materials (Fig. S1).
We applied this simple mathematical scaling to each data set
reported in Fig. 3. In Fig. 6, we report the evolution in time of the
cell-free area (A/A0) after data scaling for the control sample
(Fig. 6(A)) and the two cell treatments (Figs. 6(B) and 6(C)) we
considered. A direct comparison between Fig. 3 and Fig. 6 clearly
shows that after the scaling we applied the profiles are significantly
closer to each other.
Fig. 7 provides a direct comparison between the experimental data
before (Fig. 7(A)) and after (Fig. 7(B)) the scaling. Each data series
reported in the chart is calculated as the average of all the available
measurements taken for each cell sample, in agreement with the typical
data processing methods used in the literature to compare different cell
treatments. The reproducibility error can be estimated calculating
different parameters such as standard error of the mean or confidence
intervals, that are all related to the standard deviation [51]. We
reported the value of the standard deviation as error bar in Fig. 7. It
is evident that a relevant improvement of the experimental reprodu-
Fig. 6. Evolution in time of the wound area A, normalized to the value A0 at time 0, after
data scaling for MDA-MB-231 control cells (A), cells silenced for YB-1 expression (B) and
cells transfected with ∆Np63α (C). The symbols are in agreement with the legend in
Fig. 3.
Fig. 7. Comparison of wound closure dynamics before (A) and after (B) data scaling for
the three cell samples under investigation. In each graph the wound area A, normalized
with respect to the initial value A0, is reported as function of time. Each curve is relative
to a specific cell sample. Each data point of the curve represents the average of all the
measurements reported in Figs. 3 and 6, respectively; the standard deviation is reported
as error bars. The inset in B reports the wound closure velocity, reported as the slope of
the normalized wound area reduction over time.
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cibility is achieved after the scaling, as suggested by the shorter error
bars in Fig. 7(B) compared to Fig. 7(A). Such improvement also
highlights the fact that cell density is one of the major factor
responsible for data variability in WH assays.
As shown in Fig. 7(B), cells silenced for YB-1 expression close the
wound region faster than control cells, while cells transfected with
∆Np63α cover the wound area slower than control cells. Remarkably,
the scaling procedure does not change the result of the experiment but
it makes easier and reliable the comparison of data. In the inset of
Fig. 7(B) the wound closure velocity α, calculated as the slope of the
normalized wound area curves vs time, is reported for the three
samples. The differences in wound closure kinetic between YB-1
silenced cells and ∆Np63α transfected cell and the relative controls,
measured as average of all the samples reported in Fig. 6, can be
considered statistically significant, being the p-values 0.0005 and
0.023, respectively.
According to Fisher-Kolmogoroff model, these differences can be
ascribed to either a change in cell proliferation rate, or to an influence
over cell migration. In fact, the wound closure velocity is related to the
speed of the cell front propagation, that according to Fisher-
Kolmogoroff model is v =
τ
4Dln(2) [38], where τ is the cell doubling
time, and D is the random motility coefficient, analogous of a diffusion
coefficient. Starting from the measurement of the wound closure
velocity α (Fig. 7(B), inset), this equation can be used to estimate the
ratio between doubling time τ and the cell random motility coefficient
D, in order to make direct comparison between the values obtained for
different cell samples. In our case, the speed of the cell front
propagation v is 18.7 ± 3.6, 26.1 ± 4.6, and 15.5 ± 2.0 µm/h for control
cells, cells silenced for YB-1 expression and cells transfected with
∆Np63α, respectively. The doubling time of the three cell populations
was estimated by direct cell counting (see Materials and Methods).
∆Np63α transfected cells showed a proliferation rate slightly lower
than MDA-MB-231 control cells, with a duplication time about 10%
higher; given the differences we measured in v, this suggests that the
cells transfected with ∆Np63α show a random motility coefficient D
about 30% lower than control cells. On the other hand, cells silenced
for YB-1 showed a duplication time about 40% lower than control cells,
thus suggesting a random motility coefficient about 37% higher than
the control sample. We should mention that the proliferation measure-
ments showed some scattering, and hence we can consider them only
as indicative of a qualitative trend. However, at least in relative terms,
all our measurements are consistent.
As a summary, the WH assays here performed suggest that cells
silenced for YB-1 exhibit higher motility than MDA-MB-231 control
cells, while the cells transfected with ∆Np63α show a lower motility
compared to control cells.
Finally, we imaged cell samples staining actin fibers using
Phalloidin, a high-affinity F-actin probe. As shown in Fig. 8, control
and ∆Np63α transfected cells show a typical flattened epithelial-like
morphology with well-defined cell margins and a regular network of
cytoskeletal F-actin. According to our data, YB-1 depleted cells,
instead, showed an altered retracted morphology with F-actin puncta
and bundles, suggesting a loss of cell-cell contacts and an increase in
cell motility. This result is in agreement with previous data showing
that YB-1 is essential for organizing and stabilizing F-actin fibers [52].
4. Conclusions
In this work, we proposed a novel methodological approach to
quantify the wound closure dynamic in the classical in vitroWH assay.
Although particularly suitable to investigate and compare cell dynamic
behavior in vitro under different experimental conditions, this assay is
influenced by several factors that can produce misleading results, thus
hindering experimental reproducibility and reliability. In particular,
homogeneous cell density among samples is challenging to achieve and
reproduce, due to inaccuracy in cell counting, uneven cell spatial
Fig. 8. MDA-MB-231 a) control, b) ΔNp63α transfected and c) YB-1 silenced cells were stained for YB-1 (green), Rhodamine Phalloidin (red), nuclei were stained with HOECHST. F-
actin fibers (red) appear altered in panel b) and c) compared to control.
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spreading and because of invasive treatments cells can be subjected to
before the WH assay. This can make it difficult to compare the dynamic
behavior of cell samples undergoing different biological treatments.
The conventional quantitative analysis of this assay typically
neglects the influence of cell density on the wound closure kinetics in
vitro. The focus of our work has been to assess how the density of cell
samples can affect the healing process. In particular, we proposed a
methodology of analysis based on transport phenomena concepts,
mainly addressed to overcome the influence of cell density on the
process. As a case study, we applied our methodological approach to
the comparison of the wound healing kinetic of MDA-MB-231 breast
cancer cells with that of the same cells whose motility was perturbed by
depletion of YB-1 or overexpression of ∆Np63α. We found a linear
relationship between the wound closure velocity of the cell samples
under investigation and cell density. Moreover, we observed a strong
discrepancy in the wound closure among data sets for each cell sample,
including control cells, although they were technical replicates of a
single experiment. The different cell density of the samples can explain
the variation we observed in wound closure kinetics, being all the other
conditions the same. This result is in agreement with Fisher-
Kolmorgoroff model that describes the wound healing as a diffusion-
reaction process, in which the evolution of cell density in time and
space is dependent on cell motility and proliferation mechanisms.
Inspired by the Fisher-Kolmorgoroff model, we proposed a phenom-
enological scaling of the experimental data, according to which the
wound closure time of a sample with a given density is scaled to the
closure time relative to a reference density. We applied this methodol-
ogy to the investigation of MDA-MB-231 breast cancer cells whose
motility was perturbed by depletion or over-expression of genes
involved in the control of cell adhesion and migration. Our results,
supported also by visualization of actin fibers morphology, are that YB-
1 depleted cells show an increase in their migration ability, while
∆Np63α transfected cells have a lower motility compared to control
cells.
The methodological approach here proposed, based on transport
phenomena concepts, can improve reproducibility and reliability in the
WH assay, thus allowing the comparison between different experi-
mental conditions or different sample types. Furthermore, the model
proposed in this work can be used to estimate the relative contributions
of cell motility and cell proliferation in WH assays, comparing the
characteristic time of cell diffusion and the duplication time of the cell
population.
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